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There has been substantial interest in the joint contribution of genetic (G) and envi-
ronmental (E) factors to disease etiology, especially for complex human diseases. The
definition of ‘environment’ can be quite broad, including demographic factors (age, gen-
der), behavioral factors (smoking, alcohol consumption, medication use) and external fac-
tors (exposure to air pollution, radio-active substances). Different study designs can be
gainfully employed depending on the nature of environmental exposure. This dissertation
evolves around the theme of characterizing effect of environmental exposure on health out-
comes under complex sampling designs in the first two projects. In the latter two, we con-
sider the problem of meta-analysis of G-E interactions and how G-E independence and
environmental heterogeneity across studies could influence the operating characteristics of
several meta-analysis approaches. Thus, the dissertation makes important contributions to
environmental epidemiology and its intersection with genetic epidemiology.
In the first project, we considered distance-odds models to investigate elevated dis-
ease odds around point sources of exposure, where there are sub-types within cases un-
der a matched case-control design. We consider models analogous to the polychotomous
logit models and adjacent-category logit models for categorical outcomes and extend them
to the non-linear distance-odds context. Different inference methods including maxi-
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mum likelihood, profile likelihood, iteratively re-weighted least squares and a hierarchical
Bayesian approach using Markov chain Monte Carlo techniques were evaluated under
these distance-odds models. We compare these methods using an extensive simulation
study with multiple outcome categories and a non-linear distance-odds model. Bayesian
methods appear to have advantages in terms of estimation stability, precision and inter-
pretation over frequentist alternatives we considered. The proposed methods were applied
to a population-based matched case-control study investigating associations between acute
asthma outcomes and proximity of residence to major roads by analyzing Medicaid claims
data for the pediatric asthma population in Detroit, MI, from 2004-2006, as part of the
‘Detroit Asthma Morbidity, Air Quality and Traffic’ (DAMAT) study.
The second project considered Bayesian analysis of time-series data under case-crossover
designs. Case-crossover designs are widely used to study short-term exposure effects on
the risk of acute adverse health events. While the frequentist literature on this topic is vast,
there is no Bayesian work in this general area. The contribution of this project is two-fold.
First, we establish Bayesian equivalence results that require characterization of the set of
priors under which the posterior distributions of the risk ratio parameters based on a case-
crossover and time-series analysis are identical. Second, we study more general inferential
issues under case-crossover designs in a Bayesian framework. Traditionally, a conditional
logistic regression is used for inference on risk-ratio parameters in case-crossover stud-
ies. We consider instead a more general full likelihood-based approach which makes less
restrictive assumptions on the health risk models and exposure series. Formulation of a
full likelihood leads to growth in the number of parameters proportional to the sample
size and consequently maximum likelihood estimates are not consistent. We propose a
semi-parametric Bayesian approach using a Dirichlet process prior to handle the random
nuisance parameters that appear in a full likelihood formulation. We carry out a simula-
3
tion study to compare the Bayesian methods based on full and conditional likelihood with
standard frequentist approaches for case-crossover and time-series analysis. The proposed
methods are also illustrated through the DAMAT study, but instead of the distance to the
major roads, we focus on the effect of ambient air pollutant concentrations on the acute
asthma risk.
The third project considered meta-analysis of G-E interaction for quantitative traits.
With heterogeneity in environmental covariate distributions across cohorts and obvious
challenges with data harmonization involving various data sources, meta-analysis of stud-
ies of G-E interaction can often involve subtle statistical issues. In this project we study
the effect of environmental covariate heterogeneity (within and between cohorts) on two
approaches for fixed-effects meta-analysis: the standard inverse variance weighted meta-
analysis and a meta-regression approach. Both are easily implemented for large scale as-
sociation studies using summary statistics or published results. Though meta-regression is
bias-prone and lacks power, the advantage is that the estimates corresponding to marginal
genetic association analysis could be regressed on study-level environmental covariate
means to screen for G-E interaction. Akin to the results obtained in Simmonds and Hig-
gins (2007) in the context of detecting treatment-covariate interactions for randomized
clinical trials, we obtain analytical efficiency/power expressions for both methods under
the assumption of G-E independence. The relative efficiency/power of the two methods
depend on the ratio of within versus between cohort variance of the environmental covari-
ate.
In this project, instead of discretely choosing meta-analysis versus meta-regression
based on this ratio as prescribed in Simmonds and Higgins (2007), or collecting multi-
variate summary statistics, we propose to use an adaptive combination of meta-analysis
and meta-regression estimates that can be used as a default choice, retaining full efficiency
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of the ‘gold standard’ pooled analysis for the interaction parameter using individual pa-
tient data (IPD) under certain natural assumptions. Lin and Zeng (2010) showed that a
multivariate inverse-variance weighted estimator is asymptotically equivalent to the IPD
estimator, given that all the common parameters with full information matrix under the
fixed-effects model are pooled across all studies. They also characterized and quantified
the efficiency loss of using an univariate (as a proper subset of the common parameters)
inverse-variance estimator. We showed connection of our work to Lin and Zeng (2010).
Essentially, the adaptive estimator gains efficiency by combining both meta-analysis ver-
sus meta-regression and using only univariate summary statistics from each study: es-
timates of marginal genetic association, interaction, their standard errors, as well as the
mean of the environmental covariate. As a result, the adaptive approach bypasses issues
with sharing of individual data across studies without sacrificing efficiency. We study the
performance of all the methods under several common scenarios: (1) departures from G-
E independence; (2) heterogeneity in minor allele frequencies across cohorts; (3) lack of
common set of confounders to adjust in each study; (4) misspecification of the genetic sus-
ceptibility model (dominant/co-dominant/additive); (5) non-linear interaction. The results
were illustrated through meta-analysis of interaction between Single Nucleotide Polymor-
phisms (SNPs) on the FTO gene and body mass index on high-density lipoprotein choles-
terol data from a large consortium (Finland-United States Investigation of Noninsulin-
dependent diabetes mellitus (FUSION) genetics study) of Type 2 diabetes.
The last project extends the work of project 3 to dichotomous traits under case-control
studies. Gaining efficiency in studies of G-E interaction by exploiting independence be-
tween G and E under case-control sampling has been noted in multiple papers (Piegorsch
et al. (1994); Umbach and Weinberg (1997); Chatterjee and Carroll (2005)). However,
methods that use G-E independence assumption might produce severely biased estimates
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if the assumption is violated. Several studies have addressed this issue and proposed more
robust strategies for testing G-E interaction (Mukherjee and Chatterjee (2008), Mukher-
jee et al. (2008); Li and Conti (2009); Murcray et al. (2009)). Mukherjee and Chatterjee
(2008) proposed a solution to the bias versus efficiency dilemma, using a retrospective
method that allows for uncertainty around the assumption of G-E independence. Mukher-
jee and Chatterjee (2008) used the estimate of the uncertainty parameter in an empirical
Bayes (EB) fashion to obtain a shrinkage estimator that ’shrinks’ the maximum likelihood
estimates (MLEs) of disease odds ratio parameters under G-E dependence to those under
G-E independence, and showed how the shrinkage factor depends on these MLEs and
their corresponding variances. Further theoretical development regarding this shrinkage
estimator is presented in Chen et al. (2009). It was noted that this EB estimate can op-
timally trade off between bias and efficiency and provide increased power compared to
a standard case-control analysis, with superior control of type 1 error when compared to
a case-only analysis. As the G-E interactions detected so far only have small to modest
effects, there are increasing demands for large sample sizes and collaboration across dif-
ferent study sites in order to perform a pooled or meta-analysis with high confidence and
power. However, there are no papers thus far to study the role of G-E independence in a
meta-analysis setting where the assumption could vary within each study.
In this project, we consider possible extensions of EB shrinkage estimators for a
multiple-study setting, which uses the retrospective likelihood as the basis for influence
and leverages the G-E independence assumption in a data-adaptive way. To handle this
multiple-study problem, we particularly consider strategies to obtain a shrinkage factor in
the EB estimator that can borrow strength across studies, under both IPD analysis using in-
dividual level data and meta-analysis using study level summary statistics. The proposed
shrinkage estimator provides optimal choices for weights corresponding to constrained
6
and unconstrained models by using information on G-E association parameters derived
from multiple studies/cohorts. Our work showed that this novel estimator has better MSE
properties than IVW estimator pooling study specific constrained, unconstrained or EB
estimators. The results were illustrated through the FUSION consortium, which has 6 dif-
ferent case-control studies that were treated as independent contributors to the analysis.
We conducted an IPD/meta-analysis of interactions between SNPs on the FTO gene and
environmental factors on the type 2 diabetes.
In the following chapters 2-5, I described the four dissertation projects sequentially.
More specific background and literature review for these projects appear in their cor-
responding chapters. To summarize, this dissertation work is expected to contribute to
important analytical, methodological questions that have relevance and applications in ge-
netic and environmental epidemiology.
CHAPTER II
Point source modeling of matched case-control data with
multiple disease sub-types
2.1 Introduction
In case-control designs, matching is commonly implemented in order to avoid bias
due to potential confounders. In an individually matched case-control study, effects of
potential risk factors are typically ascertained through a conditional likelihood approach
such as conditional logistic regression (CLR) (Breslow et al. 1978). Extension of CLR to
situations with multiple sub-types of cases or controls has been made through polychoto-
mous CLR (PCLR), which is more efficient than carrying out separate CLRs for sub-
groups (Liang and Stewart 1987). Liang and Stewart (1987), Becher and Jöckel (1990),
and Becher (1991) applied PCLR models to matched case-control studies with two control
groups, typically hospital and population controls. Thomas et al. (1986) and Dubin and
Pasternack (1986) applied PCLR models to analyze multiple disease groups with one set
of controls. Sinha et al. (2004) considered a Bayesian semiparametric model for analyz-
ing matched case-control data with multiple disease states and missing exposure values.
Mukherjee et al. (2007) considered cases having multiple disease states with a natural or-
dering in matched case-control studies. Mukherjee et al. (2009) proposed a methodology
to fit stratified proportional odds models by amalgamating conditional likelihoods obtained
from all possible binary collapsings of the ordinal scale.
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Studies since 1990’s (Diggle (1990); Lawson (1993); Diggle and Rowlingson (1994);
Diggle et al. (1997)) have investigated elevated risk of respiratory diseases around puta-
tive point sources of environmental pollution. Diggle and Rowlingson (1994) extended
the exponential decay function described in Diggle (1990) to a situation where the decay
function will equal to 1 after a certain threshold from the source. Diggle et al. (1997) then
considered another threshold effect where the decay function does not decrease up to a
certain distance from the source. Diggle et al. (2000) described an extension to matched
case-control designs of the parametric modeling framework in Diggle (1990) using a con-
ditional likelihood approach. Asthma and chronic obstructive airways disease were as-
sociated with proximity of residence to major roads in East London. There has been
an increasing interest in modeling disease risk in relation to point sources of pollution
in a Bayesian framework (Wakefield and Morris (2001); Lawson et al. (2003); Congdon
and Congdon (2003)). Wakefield and Morris (2001) described a Bayesian hierarchical
modeling of disease risk around a point source, embedding models proposed by Diggle
et al. (1997). Issues of the sensitivity to prior specification for this class of models were
discussed. Dreassi et al. (2008) performed a sensitivity analysis to investigate how the
specification of the distance-odds functions and the choice of prior distributions affect re-
sults under case-control studies (Dreassi et al. 2008). Rodrigues et al. (2010) provided a
semi-parametric approach for point process modeling using generalized additive model,
and illustrated the flexibility of this approach with applications in epidemiology and crim-
inology. All of the above spatial environmental epidemiology studies considered only the
standard binary case-control states.
The purpose of this project is to incorporate the distance-odds model around point
sources into the analysis of matched case-control data with multiple disease or control
states. We extend the idea of the polychotomous logit model and the adjacent-category
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logit model from the standard categorical data literature (Agresti 2002) to the non-linear
distance-odds model framework. The extensions with non-linear odds function lead to
some unique observations specific to the distance odds model. Maximum likelihood, pro-
file likelihood, iteratively re-weighted least squares (IRLS) and a hierarchical Bayesian
approach using MCMC are evaluated under the proposed models. Inference methods and
various types of point source models are compared using an extensive simulation study.
Simulation studies that compare the frequentist properties (such as bias, mean squared er-
ror (MSE) and coverage probability) of the proposed methods and models are not available
in the literature, not even for binary case-control states.
2.2 Methods
Diggle et al. (1990 and 1994) proposed the distance-odds model for characterizing ele-
vated risk around putative point sources of environmental pollution in case-control studies.
The model assumes that the odds of disease, r(x) as a function of distance x from the point
source, is proportional to the decay function f(x), as given below:
(2.1)
P (Y = 1|x)




= r(x) = ρf(x) and f(x) = 1 + α exp (−(x/β)2),
where Y is the disease status (Y = 1: case; Y = 0: control), x is the distance from the
point source, ρ is the background odds of disease in the case-control population. (For a
case-control study that is embedded in a cohort study, ρ is typically given by ρ = (q1/q2)κ,
where κ is the background odds of disease in the study cohort, q1 and q2 are the proportions
of cases and controls sampled from the cohort respectively.) The parameters (α, β) in
model (2.1) have a natural interpretation: α is proportional to the disease odds at the point
source (α = [r(0)/ρ] − 1); β measures the rate of decay with increasing distance from
the point source, in the unit of distance x. (α, β) ∈ (−1,∞) × (0,∞). Under this model
setting, as x → ∞, we have f(x) → 1 and the risk function p(x) = P (Y = 1|x) =
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ρf(x)/(1 + ρf(x)) → ρ/(1 + ρ), i.e. the background risk in the case-control population
(Diggle et al. 2000). Note that, if f(x) = exp (βx) is chosen with r(x) = ρf(x) in
model (2.1), then one would have that log(r(x)) = log(ρ) + βx, which becomes the
usual logistic regression model that assumes a linear distance-odds relationship with log
odds ratio β and intercept log(ρ). However, usually the odds of disease changes non-
linearly with increasing distance from the point source, e.g., with increasing distance to
an industrial park, the odds of asthma might decrease much faster within 0-200 meters
than within 1000-1200 meters. Another possible disadvantage of the log-linear model is
that for β < 0 (that implies increasing odds with decreasing distance), r(x) → 0 and
p(x) → 0 as x → ∞, but these do not converge to background odds or risk which would
be a desirable property. For non-rare diseases such as asthma, the log-linear distance-odds
model is questionable. These disadvantages of log-linear model lead us to focus on the
non-linear distance-odds model (2.1) proposed by Diggle (1990).
As an extension to model (2.1), Diggle and Rowlingson (1994) assumed multiplicative
risk factors for the combined effects of S point sources, and allowed for covariate adjust-
ment via additional log-linear terms. In the presence of S point sources and W spatially
referenced covariates Zw(x), w = 1, ...,W , the resulting distance-odds model is







where x = (x1, ..., xS), xs and fs(xs) are the distance and the decay function for the s-th
point source respectively. Here each fs(xs) takes the same functional form as in model
(2.1), that is, fs(xs) = 1 + αs exp (−(xs/βs)2).
For a 1:M matched case-control study with N matched pairs, the risk of disease for an
individual at distance x in the i-th stratum can be expressed as Diggle et al. (2000)






, i = 1, ..., N,
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where the baseline odds ρi for the i-th stratum can potentially vary across matched pairs
under the matched case-control design. The conditional likelihood, given the exposure at
distance xi = (xi1, xi2, ..., xi(M+1)) for the i-th stratum, that the case is at distance xi1 is














where Yij and xij are the disease status and distance for the j-th individual in the i-th
stratum respectively, i = 1, ..., N ; j = 1, ...,M + 1. The general form of the conditional
likelihood is (2.3). For one point source binary model, f(x) is as given in (2.1), where
as for multiple point sources binary model (with possible covariate adjustment) f(x) is as
given in (2.2).





i=1 li), and the parameters to be estimated by θ. The maxi-
mum likelihood estimates (MLEs) of θ = (α, β) in the one point source binary outcome












( 1 + α exp (−(xi1/β)2)∑M+1
j=1 [1 + α exp (−(xij/β)2)]
)
.
Similarly, the MLEs of θ = (α,β,φ) = (α1, ..., αS, β1, ..., βS, φ1, ..., φW ) in the S point












s=1(1 + αs exp (−(xijs/βs)2))
]),
where xij = (xij1, ..., xijS) and xijs is the distance of the j-th individual in the i-th stratum
from the s-th point source. More detailed discussion of parameter estimation and inference
for the models with binary outcomes can be found in Diggle et al. (2000).
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2.2.1 Distance-odds model with polychotomous outcome
In this section, the distance-odds model is extended to situations where cases can have
multiple disease states. Without loss of generality, the methods and formulation in the
following sections are illustrated for a 1:M matched case-control data set with N matched
pairs, where outcomes can belong to one of the K disease categories (For example, with
K = 2. poor prognosis: Y = 2; fair prognosis: Y = 1) and one control group (Y = 0).
These methods can be readily applied to situations with multiple control states, and to
situations with variable matching ratios. The distance-odds model is adapted to both
polychotomous-category model (PCM) and adjacent-category model (ACM) setting. The
PCMs are considered when one tries to distinguish nominal disease sub-types to the con-
trols. The ACMs are more appropriate when there is a natural ordering of the disease
sub-classifications.
Polychotomous-category distance-odds model
For the polychotomous-category model, the odds of disease for the j-th individual in
the i-th stratum at distance xij is modeled as
(2.4)
rk(xij) =
P (Yij = k|xij)
P (Yij = 0|xij)
= ρikfk(xij), i = 1, ..., N ; j = 1, ...,M + 1; k = 1, ..., K,
where the baseline odds ρik can potentially vary across matched pairs i and disease cat-
egories k, and the distance-odds function fk(x) can also vary among disease categories.
Note that, if fk(x) = exp (βkx) is chosen in model (2.4) with multiplicative nuisance
parameters ρik = γi × λk, one would have that
(2.5) log(rk(xij)) = log
(P (Yij = k|xij)
P (Yij = 0|xij)
)
= log(γi) + log(λk) + βkxij,
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which becomes the polychotomous logistic regression models (Agresti 2002) that assumes
a linear distance-odds relationship. Non-linear distance-odds models such as (2.1) are
desired, with advantages over log-linear models. Using the K equations in (2.4) along
with one more constraint that
∑K
k=0 P (Yij = k|xij) = 1, the risk of disease can be written
in terms of ρik and fk for the corresponding individual, i.e.











, k = 1, ..., K.
Let ki denote the disease states of the case subject in matched set i, ki ∈ (1, ..., K). The
conditional likelihood for the i-th stratum, given a matched case-control pair at distance
xi = (xi1, xi2, ..., xi(M+1)), that the case (in category ki) is at distance xi1 is
















The general form of the conditional likelihood is (2.6). For one point source PCM, fk(x) is
given as fk(x) = 1+αk exp (−(x/βk)2); for multiple point sources PCM fk(x) is given as




s=1 fks(xs) where fks(xs) = 1 + αks exp (−(xs/βks)2).
Adjacent-category distance-odds model
For the adjacent-category model setting, the adjacent odds of disease between category
K versus K − 1 for the j-th individual in the i-th stratum can be modeled as
(2.7)
rk(xij) =
P (Yij = k|xij)
P (Yij = k − 1|xij)
= ρikfk(xij), i = 1, ..., N ; j = 1, ...,M+1; k = 1, ..., K.
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Again, the baseline odds ρik can vary across matched pairs i and disease categories k,
and the distance-odds function fk(x) can vary across disease categories. One point source
ACM and multiple point sources ACM (with possible covariate adjustment) can be formu-
lated similarly as PCM with different choices of fk. For these non-linear settings, ACM
can not be represented as a re-parameterization of PCM as in log-linear models. Thus,
both ACM and PCM are needed for ordered and nominal disease sub-classifications re-
spectively. Note that if fk(x) = exp (β∗kx) is chosen in model (2.7) with multiplicative
nuisance parameters ρik = γ∗i × λ∗k, one would have that
(2.8) log(rk(xij)) = log
( P (Yij = k|xij)
P (Yij = k − 1|xij)
)





which reduces to the polychotomous logistic regression models in adjacent category set-
ting (Agresti 2002) that assumes a linear distance-odds relationship. The risk of disease
can be represented in terms of ρik and fk as
















, k = 1, ..., K.
It follows that the conditional likelihood for the i-th stratum is
































One special case of interest is the homogeneity of the adjacent odds ratios (homogeneous










α1 = α2 = ... = αK and β1 = β2 = ... = βK .(2.10)
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2.2.2 Estimation and inference
Maximum likelihood approach
Without loss of generality, the first subject in each stratum is always considered as the
case when deriving the likelihood and fitting the models, i.e., Yi1 = ki, ki ∈ (1, ..., K).
Thus, the actual contribution of the i-th stratum to the conditional likelihood is Lkii as given
in (2.6) for PCM or as given in (2.9) for ACM respectively. For example, the MLEs for












h=1(1 + αh exp (−(xi1/βh)2))∑M+1
j=1
∏ki
























Under the homogeneity assumption in (2.10), maximizing (2.11) or (2.12) would be re-
duced to the constrained optimization problem with restriction (α1 = ... = αK , β1 = ... =
βK) or (α1s = ... = αKs, β1s = ... = βKs,∀s) respectively. The MLEs of PCMs can
be obtained similarly. Standard errors of the parameter estimates can be calculated from
the square root of the diagonal elements of the inverse of the Hessian matrix of the cor-
responding conditional likelihood, and then the 95% Wald-type confidence intervals (CI)
can be constructed.
Parameter estimates and CIs can also be obtained using the profile likelihood. This
approach reduces the number of independent parameters by expressing some of them as
functions of the others, instead of dealing with all the parameters simultaneously. It is
helpful in the presence of many parameters, such as in (2.11) and (2.12).
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Remark 2.1: Identifiability and Monte Carlo tests. The likelihood based inference described
above assumes that usual regularity conditions hold (Breslow et al. 1980). Under these
regularity conditions, approximate CIs for the MLEs can be derived from the asymptotic
multivariate normality of the MLEs and the estimated Hessian matrix. The likelihood ra-
tio statistics for testing H0 : f(x) = 1 has an asymptotic chi-squared distribution under
the same regularity conditions. Diggle et al. (2000) pointed out that with an insufficient
sample size, the log-likelihood surface of (α, β) may be far from quadratic and standard
likelihood-based asymptotics are unreliable. Moreover, these models have an irregularity
at the null hypothesis of H0 : f(x) = 1, since f(x) = 1 corresponds to one of the two
parameters of (α, β) equal to 0 with the other indeterminate, in the situation where there
is no covariate adjustment. Monte Carlo tests can be used as an alternative. 1000 data sets
can be simulated under the null and the observed values of the likelihood ratio statistics
LR = 2 × (l(α̂, β̂) − l(α = 0 or β = 0)) = 2(l(α̂, β̂) − N log( 1
M+1
)) can be ranked
among the 1000 simulated LR values. If the observed LR ranks k-th largest among 1000
simulated values, the p-value of the Monte Carlo test is k/1001 and the test is exact (Diggle
et al. 2000).
Iteratively reweighted least square regression
Another alternative approach is IRLS regression. As the strata are mutually indepen-
dent under the matched case-control design, it is not necessary to further consider the cor-
relation between the residuals from different strata. Typically, one can write the non-linear
regression model with binary response Yi as
Yi = pi(xi, θ) + εi,
where Yi is the observed binary response, pi(xi, θ) is the predicted probability from the
model for subject i, and εi ∼ N(0, σ2) are independent and identically distributed random
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errors, i = 1, ..., N . Under the conditional framework given there being a matched case-
control pair at distance xi, we can treat each stratum as a single ‘subject’ with response∑M+1
j=1 I(Yij = ki) = I(Yi1 = ki) (assumed the first subject to be the case) and predicted
probability Lkii . One can further assume that the variance structure of the errors to be
εi ∼ N(0, σ2k) for {i : ki = k}, i.e., for all the strata where case response equals to k.















where Σk is the pooled variance of errors from all strata where the case response equals
k. In the initial step of IRLS, θ is estimated by minimizing the weighted SSE with all
Σ
(0)
k set to identity. An estimate for Σ
(1)






the residuals r(0)i = I(Yi1 = ki) − L
ki
i1(xi, θ̂
(0)) and dfk is the degree of freedom (the
size of the set {i : ki = k} minus the number of parameters in the model). The estimated
Σ̂
(1)
k are used as the weights in the next step of IRLS to minimize the weighted SSE. Pa-
rameter estimation is simply realized by iterating this process further, calculating updated
estimates for Σk’s, estimating the model parameters θ with updated weights and iterating
















IRLS estimate and MLE were shown to be consistent and asymptotically normal under
the assumption that the errors are normally distributed as εi ∼ N(0, σ2k) for {i : ki = k}
(Gallant 2009).
For the three methods described above, instead of working directly on (αks, βks) with
a range of (−1,∞)× (0,∞), we performed unrestricted optimizations on the one-to-one
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transformed parameters (uks, vks) = (log(1 + αks), log(βks)) that span the whole real
plane, and then transformed the results back in terms of the original parameters (αks, βks).
Bayesian approach
The Bayesian approach provides an alternative to the frequentist inferential strategies.
A proper Bayesian approach would be to use the full likelihood and specify a prior distri-
bution on the nuisance parameters ρ = (ρ1, ..., ρN). However, the full likelihood approach
would encounter the difficulty of prior specification and estimation of ρ. One can use a
marginal likelihood instead, that integrates out the nuisance parameters with respect to a
random distribution. The equivalence between the use of conditional and marginal likeli-
hoods for matched case-control study was discussed by Rice (2008). Diggle et al. (2000)
pointed out that the conditional likelihood approach is consistent with the full likelihood
approach for the binary outcome model with independent priors for ρ and θ (Diggle et al.
2000). Therefore, we proceed with the conditional likelihood as the basis for Bayesian
inference.
The following sets of mutually independent prior distributions on (u,v) = (u11, ..., uKS,
v11, ..., vKS) were primarily considered,




log(βks) = vks ∼ N(µvks , σ
2
vks
), k = 1, ...K; s = 1, ...S,
where the mean and variance of αks are µαks = exp(µuks +
1
2




(exp(σ2uks) − 1) exp(2µuks + σ
2
uks




and σ2βks = (exp(σ
2
vks
) − 1) exp(2µvks + σ2vks). Both informative and noninformative (or
vague) prior distributions were considered. For informative priors, based on our knowl-
edge of roadway effects on asthma and the literature reviewed in introduction, the prior
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distribution of αks was set with mean µαks = 0.5 and variance σ
2
αks
= 0.25 (thus P (0.1 <
αks < 1.0) ≈ 0.95). For other types of health outcomes or pollution sources, different
informative priors could be used. Given the fact that the point source effects on health
outcomes (e.g. roadway effects on asthma) last only for a few hundred meters in most
of the literature, prior distributions of βks were set with means µβks = 400 and variance
σ2βks = 150 (thus P (50 < βks < 750) ≈ 0.95). For noninformative priors, the same mean
(µαks , µβks) = (0.5, 400) with large variance (σ
2
αks
, σ2βks) = (0.5, 400) were used for (αks,
βks). It follows that P (−0.2 < αks < 2.0) ≈ 0.95 and P (50 < βks < 1500) ≈ 0.95,
which should contain the prior knowledge about (α, β). For the rest of this chapter, we
focus on (α,β) and primarily proceed using models without covariate adjustment.
A sensitivity analysis is performed by comparing the posterior distributions derived




). Wakefield and Morris (2001) suggested using independent Uniform prior
distribution on (α, β) on the range of (−1, αmax) × (0, βmax) for the one point source
binary model (2.1), where αmax and βmax are the maximum plausible values based on
current epidemiological knowledge. This Uniform prior distribution on (αks, βks) with
different choices of αmax and βmax is also considered as part of the sensitivity analysis.
Since the full conditional distributions of the parameters do not follow a standard dis-
tributional form, the MCMC method is used to generate random draws from the posterior
distributions. For two-parameter models such as the one point source homogeneous ACM,
the random walk Metropolis-Hastings algorithm is used to generate a Markov chain which
has the limit distribution equal to the target posterior distribution. For four(or more)-
parameter models such as one point source ACM, computationally it is hard to draw si-
multaneously from the joint distribution using Metropolis-Hastings algorithm. Instead,
we use a component-wise Metropolis-Hastings within Gibbs algorithm. The computa-
20
tional strategy corresponding to these MCMC algorithms is discussed in Appendix B.1.
The convergence of these Markov chains are examined using Gelman and Rubin’s conver-
gence diagnostic (Gelman and Rubin 1992). In this study, the random walk Metropolis-
Hastings or Metropolis-Hastings within Gibbs algorithm for the proposed models converge
to their limit distributions after 2000-4000 runs. The chains have auto-correlations up to
20. Therefore, the chains are refined by choosing a common burn-in period of 5000, and a
common thinning frequency of 20. These MCMC algorithms were performed for a length
of T = 45000. After burn-in and thinning, the resulting Markov chains of length 2000 are
treated as random draws from the target posterior distribution.
As a Bayesian counterpart to the Monte Carlo test, Bayes factors (Kass and Raftery
1995) are considered to test the null hypothesis that H0 : f(x) = 1. The Bayes factor
for comparing the current model M1 to the null model M0 is defined as the ratio of the
posterior probability to the prior probability, which is given by
B =












The calculation of the Bayes factor B is not straightforward using MCMC. We used the




t)π(θt)/g(θt)] as suggested by Diggle et al.
(2000), where the prior distribution on θ is used as the importance distribution g(θ), and
θt are sampled from g(θ). Kass and Raftery (1995) suggested calculating 2 log(B) as a
Bayesian analogue of a log-likelihood ratio statistics or deviance. Values greater than 2
indicate increasing evidence against M0: between 2 and 6 is ‘positive’ evidence, 6 to 10
is ‘strong’ and over 10 is ‘very strong’ evidence against M0 (Diggle et al. (2000)Kass and
Raftery (1995)). A number of alternatives can be found in DiCiccio et al. (1997).
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2.3 A Simulation Study
Simulation scenarios
Two case subgroups (K = 2) and one control group, and up to two point sources
are considered in the following simulation study. Specifically, four different settings of
simulations are conducted where the true models are: 1) one point source PCM; 2) one
point source ACM; 3) one point source homogeneous ACM; and 4) two point sources
homogeneous ACM.
A large cohort of L = 1, 000, 000 people is generated initially. Two independent risk
factors, age and gender, are included for this cohort, of which the distributions are set sim-
ilar to those for the pediatric population of the Detroit Medicaid data source. Specifically,
gender is generated from a Bernoulli distribution with probability 0.55 for being a male;
age is generated from a piecewise Uniform distribution with a range of 2-18, and then
rounded to integer values. The exposure variable, distance to the point source, is gener-
ated from a mixture distribution of Uniform and Gamma. Specifically, distances (in me-
ters) from the first and second sources are generated from 0.15 ·Uniform(0, 500) + 0.85 ·
Gamma(shape = 3, rate = 0.003) and 0.2 ·Uniform(0, 500) + 0.8 ·Gamma(shape =
3, rate = 0.005) respectively. Simulation studies are based on this fixed cohort with mu-
tually independent covariates of age, gender and distances with distributions described
above.
The disease status for the cohort would be different for different choices of distance-
odds model or true parameter settings. For example, one point source ACM, the disease
states (k = 0, 1, 2) are generated using the subject specific risk functions p(x) in (2.14)
with certain fixed values of (α1, β1, α2, β2). Specifically, the outcome for the l-th patient
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Yl is generated from the multinomial distribution with probabilities
P (Yl = 0|xl) =
1
1 + ρl1f1(xl) + ρl1ρl2f1(xl)f2(xl)
,
P (Yl = 1|xl) =
ρl1f1(xl)
1 + ρl1f1(xl) + ρl1ρl2f1(xl)f2(xl)
,
P (Yl = 2|xl) =
ρl1ρl2f1(xl)f2(xl)
1 + ρl1f1(xl) + ρl1ρl2f1(xl)f2(xl)
, l = 1, ..., L.(2.14)
The subject specific nuisance parameter for the l-th patient can be generated using ρlk =
exp(b0k + b1 × agel + b2 × genderl), k = 1, 2. The parameters (b01, b02, b1, b2) can be
obtained from the Detroit Medicaid data. Here b1 = −0.05 and b2 = 0.3 are used. The
intercepts b01 and b02 can be varied within a range of (−2.0,−0.5) to generate different
desired disease prevalence. Typically, about 20% subjects of the cohort are generated
as cases, of which all disease sub-categories have roughly the same proportion (k = 1,≈
10%; k = 2,≈ 10%). After the disease status is generated for the cohort,R = 500 matched
case-control data sets are then generated, each withN 1:1 matched pairs. Different sample
sizesN = 500, 1000 and 2000 are also considered. Specifically, for each of theRmatched
case-control data sets, N cases are randomly drawn from the cohort, and then they are
randomly matched with controls by age (within 2 years) and gender. Covariate adjustment
was not considered in the simulation study since both covariates of age and gender are
matched.
Under each model setting, parameter estimates with 95% CIs are calculated using
MLE, profile likelihood and IRLS. Due to the identifiability problem of the likelihoods
for the proposed models, there are a few runs (< 5%) that fail to converge, or converge for
the point estimates but can not obtain CIs (for example, failure to invert the Hessian ma-
trix using maximum likelihood method). The non-converged data sets among theR = 500
ones were removed. The simulation results are summarized on the remaining R′ data sets
where all three frequentist methods converge. The R′ estimates are summarized in terms
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MSE (e.g. MSE = 1
R′
∑R′
i=1(θ̂(i) − θtrue)2) and coverage probability (the proportion that
the 95% CIs cover the true value is calculated as an ad hoc estimate of the true coverage
probability among these R′ runs). For the Bayesian approach, the posterior mode as well
as 95% highest posterior density (HPD) interval are estimated based on 2000 draws (after
burn-in and thinning) from the posterior distribution. Since the posterior distributions of α
and β are both positively skewed (a heavy right tail for β), the posterior mean is not used.
In order to compare with the frequentist results such as MLE, the posterior mode is used
instead of the median because the posterior mode asymptotically converges to MLE. The
R′ posterior modes are summarized in terms of relative bias and MSE for the same R′ data
sets. The coverage probability is calculated as the proportion of times that the 95% HPD
intervals cover the true value.
Simulation results
A summary of the simulation results comparing convergence rate, relative bias and
coverage probability by different methods and by different sample sizes is shown in Table
2.1, for the four distance-odds models (i.e. one point source PCM, ACM and homogeneous
ACM, and two point sources homogeneous ACM). The MSE comparison is summarized
in Figure 2.1. Since the three frequentist methods of MLE, Profile likelihood and IRLS
regression provide very similar and consistent results, we primarily focus on the difference
between the broad class of frequentist and Bayesian approaches which is described below
in terms of convergence, relative bias, MSE and coverage probability separately. Addi-
tionally, the following results hold for α’s and β’s. The complete numerical simulation
results can be found in Appendix A.1.
Convergence: For all four distance-odds models with a large sample size such as N =
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2000, the frequentist methods perform well in terms of convergence with a joint conver-
gence rate R′/R > 90%. Typically, less than 5% of runs failed to converge for each of
the three frequentist methods. With a decreased sample size of N = 500, the 90% joint
convergence rate remains for the two homogeneous models. However, failures increase to
30% for one point source PCM and ACM using frequentist methods. Thus, the simula-
tions for these two models were performed and presented for a sample size of N = 1000
in Table 2.1, where a joint convergence rate of 85% occur using frequentist methods. In
the Bayesian approach we numerically assessed the convergence of the posterior chains
by the Gelman-Rubin convergence diagnostic (Gelman and Rubin 1992). No problems
were detected either numerically or via examining the trace plots in our limited simulation
study. The MCMC method does not require the usual regularity conditions (Breslow et al.
1980) or any asymptotic normality assumption, and it yields exact posterior distributions
for all sample sizes. It also avoids the identifiability issue, but needs a careful choice of
the covariance matrix of the proposal distribution because of the strong correlations among
the model parameters.
Relative bias: When N = 2000, low relative biases (with range (−9.2, 10.7)% for α’s
and (−2.9, 4.2)% for β’s) are observed for both frequentist and Bayesian methods for all
models with different choices of true parameter settings (shown in Table 2.1, numerical
details can be found in Appendix A.1). Thus, both methods have performed well with
large sample size in terms of relative bias. For smaller sample sizes (N = 500 for the two
homogeneous models; N = 1000 for one point source PCM and ACM), relative biases of
α are usually as high as 25%, while relative biases of β are still well controlled (< 5%,
except few extreme setting). Note that, estimates of α are biased upwards (Table 2.1)
using frequentist methods with these small sample sizes, while Bayesian methods do not
suffer as much. The above results are consistent across inference methods for each model
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as shown in Table 2.1.
Mean squared error: When the sample size N = 2000, the MSEs are consistent across
methods for each distance-odds models with different true parameters. Figure 2.1 shows
the MSEs corresponding to each method with smaller sample sizes of N = 500 or 1000.
The three frequentist approaches using MLE, profile and IRLS method show very similar
MSE values, while the Bayesian approach shows consistently lower MSEs than frequentist
approach for each distance-odds model regardless of true parameters values. Note that,
for the Bayesian approach, the MSEs derived from informative priors are much lower
than those from noninformative (vague) priors for each setting as expected. Thus, if prior
knowledge is available, it should be used to enhance precision for these distance-odds
models.
Coverage probability: In Table 2.1, when N = 2000, the coverage probabilities are
around 95% for all the models and methods in our simulation study. For smaller sample
sizes of N = 500 or 1000, the coverage probabilities fall below the nominal level for
some parameter settings, however, they are still around 95% on average (shown in Table
2.1, numerical details can be found in Appendix A.1). Note that these percentages are
estimated based on the R′ data sets where all three frequentist methods converge. In
addition, the Bayesian approach provides comparable percentages based on all R = 500
data sets. Therefore, it is more stable than the frequentist methods in terms of coverage
probability and convergence.
In summary, Bayesian methods, especially incorporated with prior knowledge, have
advantages in terms of estimation stability and precision for the proposed non-linear distance-
odds models with multiple disease sub-types.
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2.4 Application: Data analysis for the DAMAT Study
The Detroit asthma morbidity, air quality and traffic study describes a population-based
matched case-control analysis investigating associations between acute asthma outcomes
and proximity of residence to major roads in Detroit, MI. We examined the pediatric pop-
ulation (2-18 years of age) served by Medicaid for the study period 2004 through 2006.
The Medicaid data provide the most complete and readily available source of healthcare
utilization across Detroit. The population consists mainly of African American children
from lower income families, and is considered a high risk population for asthma-related
events. The data included an encrypted Medicaid identifier, age, sex, race/ethnicity, uti-
lization dates and diagnostic codes for inpatient admissions and emergency department
visits, and geo-coded home residence at the time of each health care visit. To ensure a
full claims history, the study population was restricted to those with continuous Medicaid
enrollment (more than 11 months in each year), full Medicaid coverage, and no other in-
surance. Asthma cases were identified as all children who made at least one asthma claim
during the three-year study period, indicated by primary diagnostic code 493.X (Interna-
tional Classification of Diseases, 9th Revision, Clinical Modification). Controls were de-
fined as children whose primary diagnosis was injury or poisoning. Each asthma case was
matched with one control based on gender, race and age (within 2 years). Asthma cases
were further grouped into multiple disease categories (K = 2), based on the frequency of
acute asthma outcomes (Y = 2: claimants with 2 or more asthma claims; Y = 1 claimants
with exactly 1 asthma claim). Details on the descriptive analysis of this data set can be
found in Li et al. (2011).
The geo-coded residence information was used to estimate the distance to major roads
in Detroit, defined as state and interstate freeways and major arterials with annual average
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daily traffic (AADT) flows exceeding 50,000 and 20,000 vehicles per day, respectively.
The freeways and the arterials are considered as the first and second point sources re-
spectively. Shape files providing coordinates of road centerlines were obtained from the
Southeast Michigan Council of Governments. These files and the geo-coded claim data
were merged into ARCGIS 9.3 to determine the proximity to each major road. Due to
confidentiality concerns, claim locations were reported only to the closest 10 m. The road
centerline does not account for the width of the highway and median strip, if any, which
can exceed 30 m for sections of some freeways. Taken together, these factors suggested
that differences on the order of at least 20 to 50 m would be meaningful.
Separate analyses were performed for one and two point source(s) models. For one
point source (freeways) models, the study region was restricted to 1,000 m buffer of free-
ways, which consisted of 2669 1:1 matched case-control pairs. For two point sources
(freeways and arterials) models, the study region was restricted to 1,000 m buffer of free-
ways or arterials, which consisted of 4081 1:1 matched case-control pairs. Figure 2.2 illus-
trates the natural spline fit and 95% confidence band for the relationship between distance
to roadways and odds of being an asthma claimant, using a CLR model with only spline
of distance as its argument. These plots provide an exploratory analysis of the data which
indicate increasing risk with proximity to both types of roads, where the freeways appear
to have stronger effects. There may be a threshold distance beyond which the roadway
effect vanishes. The increase of odds at 600m of freeways is not statistically significant,
which could be an artifact of the smoothing parameter (df = 3 in the natural spline).
Method comparison: The frequentist methods of MLE, profile likelihood and IRLS pro-
vide similar point estimates and CIs with essentially the same Akaike information criterion
(AIC) values for each distance-odds model. Thus, we primarily discuss results as frequen-
tist method (MLE as demonstration) versus Bayesian method in the main text. Table 2.2
28
shows the parameter estimates and 95% CIs using likelihood method and posterior modes
with 95% HPD intervals using Bayesian methods, for one point source models. Note that
these log-likelihood surfaces are not far from quadratic in shape given the large sample
size of 2669 asthma cases in the DAMAT study. Note also that the contour lines near
u = 0 (or equivalently α = 0 ) are almost vertical, which implies the identifiability issue
that a wide range of β can provide the same value of likelihood values. Fortunately, the
peaks of the likelihood surfaces are not close to the null for these one point source models.
For the Bayesian method, the locations of the posterior modes for one point source models
are close to each other for the two prior choices for each parameter under each model.
Posterior densities of β are highly right-skewed, especially for noninformative prior dis-
tribution with much wider HPDs than those derived from informative priors (shown in
Table 2.2). Thus, the frequentist likelihood based inference method or a noninformative
Bayesian method should be avoided for these distance-odds models in presence of well
elicited prior knowledge.
Model selection: Generally, the distance-odds models are selected a priori in the study
design stage. For example, different choices of the numbers of point sources would pro-
vide different study regions with different sample sizes. The choice between PCMs and
ACMs can also be considered a priori based on the interest of nominal or ordered disease
sub-classifications. Model selection can also be based on AICs for frequentist method or
DICs for Bayesian method. For example, ACM (homogeneous) has the smallest AIC value
among the four one point source models as shown in Table 2.2. However, the differences
among these AICs are very small and of little practical concern. In this case, all these
one point source models fit almost equally well. For both informative and noninformative
priors, one point source PCM and ACM have similar and relatively lower DIC values than
the other two models. There is evidence that the more sophisticated models that allow
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different functional forms of odds between case sub-types are preferred even after penal-
izing for the additional number of parameters using the Bayesian approach. Therefore, a
PCM (smallest DIC) with informative priors is the preferred approach among all one point
source models for the DAMAT study (different numbers of point sources with different
sample sizes are not directly comparable). Similarly, Table 2.3 shows the corresponding
results for the two point sources binary model and homogeneous ACM, where the later
one with an informative prior Bayesian approach is preferred.
Estimation and interpretation: Table 2.2 shows the parameter estimates and 95% CIs
using MLE, and posterior modes with 95% HPD intervals using Bayesian methods, for
the one point source models (binary/ACM/PCM). Generally, the point estimates of α̂ and
β̂ lay within 0.1− 0.4 and 100− 300 respectively for the one point source models, which
implies that the roadway effect on asthma only lasts up to a few hundred meters and that
the increase in risk is modest. Take the one point source PCM that has the smallest DIC
as an example, the MLE (or Posterior Mode) α̂2 = 0.39(0.32) is slightly larger than
α̂1 = 0.21(0.25) as shown in Table 2.2. It implies that, at the point source, the odds of
asthma for claimants with 2 or more claims (k = 2) versus controls is slightly higher than
the odds for claimant with exactly 1 claim (k = 1) versus controls. Table 2.3 shows the
results for two point sources models. In general, we have α̂11 > α̂12 and β̂11 > β̂12, which
implies the odds of asthma at freeways is higher than the odds at arterials, and the freeways
effects last longer than arterials. Figure 2.3 shows the estimated distance-odds functions
f̂k for the one point source PCM, using MLE and Bayesian method with informative
priors. Note that the Bayesian method with prior knowledge provides consistently higher
estimates of fk than MLE. For both case subgroups, f̂k deceases rapidly within 0 − 300
meters, and then the roadway effect on asthma lasts up to 400 meters off freeways using
MLE method and 600 meters using Bayesian method respectively. The 95% credible
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regions are above unity up to a distance of 350 meter. Note that the MLE of fk(α,β) is
estimated by plugging in the MLE of (α,β) using their invariant property; the posterior
distribution of fk(α,β) is estimated by draws from the posterior distribution of (α,β)
for fixed grid values of distance x (every half meter). Note also that, for interval estimates
of a function of parameters, the 95% Bayesian credible region can be directly obtained
from the draws, however, the calculation of the frequentist confidence bands for the MLE
of fk(α,β) is not straight forward, this requires the Delta theorem (calculation of the
first and second derivatives of the complex likelihood function) and relies on asymptotic
properties needing a large sample size.
Table 2.4 shows the p-values of the Monte Carlo test and Bayes factors for testing
H0 : f(x) = 1 for one and two point source(s) distance-odds models. Evidence of asso-
ciations (H1 : f(x) > 1) is found for most models using the MC test (P-value< 0.05) or
Bayes factors (B > 2). Strongest associations are found for PCM among one point source
models and for homogeneous ACM among two point sources models respectively, which
is consistent with the results in Tables 2.2 and 2.3.
Sensitivity analysis: The results in Tables 2.2, 2.3 and 2.4 show consistency for different
choices of the distance-odds models under a matched case-control study. Similar con-
clusion can be drawn using these models that there is evidence of the roadway effect on
asthma, and that the effect is modest and only lasts up to a few hundred meters. As a
sensitivity analysis of the prior specification, posterior densities are derived and compared
from different choices of prior distributions for the one point source PCM. For normal pri-
ors on (u, v) with different variances (σ2u, σ
2
v), the posterior modes are close to each other
for each parameter under each model (shown in Appendix A.1). However, the posterior
modes are sensitive to the choice of αmax and βmax using Uniform priors on (−1, αmax)
and (0, βmax). When αmax and βmax are large, these Uniform priors still put equals weights
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on the whole range of (−1, αmax) and (0, βmax) that may overly weight the upper extreme
values. Wakefield and Morris (2001) have also pointed out the influence of the Uniform
priors, which reflects the fact that there is little information in the likelihood due to sparsity
of data in the upper extremes. Thus the parameterization (u, v) with normal priors appear
to be more robust.
2.5 Discussion
In this chapter, we extended the distance-odds model of Diggle et al. (2000) to models
where there are sub-types within cases under a matched case-control design. The extension
to sub-classification within cases is non-trivial with these non-linear odds functions under a
matched design. Maximum likelihood, profile likelihood, IRLS and a Bayesian approach
using MCMC methods were evaluated under the proposed models. We compared these
methods via an extensive simulation study evaluating frequentist properties such as relative
bias, MSE and coverage probability, and showed that Bayesian methods have advantages
in terms of estimation stability, precision and interpretation. The Bayesian methods are
able to yield direct HPD for complex non-linear distance-odds functions, and does not re-
quire large sample approximation. There is no simulation study in literature that compares
the convergence, relative bias, MSE or coverage probability for these point source models,
even for the basic binary outcome model. The proposed models and methods are applied
to a population-based matched case-control study investigating associations between acute
asthma outcomes and proximity of residence to major roads by analyzing Medicaid claims
data for the pediatric asthma population in Detroit, MI, from 2004-2006. We also perform
a sensitivity analysis to investigate how the choice of distance-odds models and specifica-
tion of the prior distributions affect the results. Typically, the results were consistent for
different choices of models and normal prior distributions on the transformed parameters
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for the DAMAT study.
The current study has several limitations which may lead to future research. The ex-
tension of the non-linear distance-odds model to the proportional odds model setting is
not considered in the study, which is most commonly used for ordered data. We realize
that the conditional likelihood does not apply to this model due to the nuisance parameters
remaining in the non-linear odds functions. The prospective-retrospective conversion for
case-control data is only valid for a multiplicative intercept model. Moreover, the way of
modeling the point source as a function of distance assumed that the distance is the only
factor that matters but not the other factors at the position where the individual lives (e.g.
wind speed, wind direction, barrier not allowing the pollution to travel). Two individuals
could live at the same distance from the freeway but in two different residence and experi-
ence different amount of air pollution simply because of the way the wind usually blows.
One way to handle this problem is to replace the odds ratio function with a Gaussian
correlation function that is not isotropic. Examples of anisotropic correlation functions
can be found in Banerjee et al. (2003) and Baddeley et al. (2010). Many literatures (HEI
2010) have addressed the issues of modeling near-road concentrations that take wind speed
and wind direction into account, e.g. a reduced-form dispersion model (Batterman et al.
2010). However, in this project we only considered point source modeling as a function of
distance only, which can be assumed as a model where the average effect of all the other
factors (e.g. the wind direction across time for a three-year period) are canceled out. These
issues remain to be explored in future research.
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Figure 2.1: Mean squared errors for two settings of true parameter values under vari-
ous distance-odds models, using MLE, profile likelihood, IRLS and Bayesian
methods with R = 500 simulations. Bayesian P1 and P2 refer to two
choices of prior distributions; Prior 1: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) =
(0.25, 150); Prior 2: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.5, 400). Y-axis



























(a) one point source homogeneous adjacent category model. Sample size










































setting I setting II
log(1 + α1) log(β1) log(1 + α2) log(β2)
(b) one point source adjacent category model. Sample size N = 1000; Settings I and II refer








































setting I setting II
log(1 + α1) log(β1) log(1 + α2) log(β2)
(c) one point source polychotomous category model. Sample size N = 1000; Settings I and
II refer to (α1, β1, α2, β2) = (0.3, 300, 0.7, 500) and (0.4, 500, 0.4, 500) respectively.





































setting I setting II
log(1 + α11) log(β11) log(1 + α12) log(β12)
(d) two point sources homogeneous adjacent category model. Sample sizeN = 500; Settings
I and II refer to (α11, β11, α12, β12) = (0.5, 500, 0.3, 300) and (0.4, 500, 0.4, 500) respectively.
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Figure 2.2: Estimated natural spline terms of distance showing the distance-odds relation-
ships for asthma claimants versus controls, using (binary) conditional logistic
regression model with spline of distance as its argument. The solid lines show
the point estimates; the dashed lines show the 95% confidence bands.
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Figure 2.3: Estimated distance-odds functions for the one point source polychotomous cat-
egory model. The solid blue line shows the MLE of the odds function; the solid
red line shows the Bayesian posterior mode estimate with 95% credible region
(dashed lines). Parameters of prior distribution used are (µα, µβ) = (0.5, 400)
and (σ2α, σ
2
β) = (0.25, 150).












































































Bayesian point estimate (Mode)
Bayesion 95% credible region























































































































































































































































































































































































































































































































































































































































































































































Table 2.2: Parameter estimates with 95% confidence intervals for one point source mod-
els using MLE, profile likelihood and IRLS methods; and posterior modes with
95% highest posterior density (HPD) credible intervals using MCMC.
MLEa Binary Model α β AIC
Estimate 0.258 174.1 3699.9
CIa (-0.042, 0.558) (55.7, 292.4)
ACM (Homogeneous) α1 β1
Estimate 0.188 168.8 3699.8
CI (-0.023, 0.398) (57.8, 279.8)
ACM (General) α1 β1 α2 β2
Estimate 0.215 176.0 0.130 153.4 3703.7
CI (-0.126, 0.557) (41.6, 310.4) (-0.484, 0.744) (87.5, 394.2)
PCM α1 β1 α2 β2
Estimate 0.208 191.8 0.392 154.1 3703.6
CI (-0.118, 0.534) (9.1, 374.6) (-0.242, 1.025) (26.5, 281.7)
Bayesian P1a Binary Model α β DIC
Posterior mode 0.247 228.6 3686.2
Posterior median 0.289 290.7
CI (HPD)a (0.034, 0.487) (121.0, 592.1)
ACM (Homogeneous) α1 β1
Posterior mode 0.177 182.7 3686.8
Posterior median 0.156 202.5
CI (HPD) (0.025, 0.361) (118.1, 550.0)
ACM (General) α1 β1 α2 β2
Posterior mode 0.194 192.5 0.242 222.5 3675.3
Posterior median 0.244 287.2 0.261 326.8
CI (HPD) (0.004, 0.461) (125.5, 667.8) (-0.072, 0.505) (116.7, 623.3)
PCM α1 β1 α2 β2
Posterior mode 0.246 231.3 0.320 259.0 3674.9
Posterior median 0.298 256.8 0.366 269.7
CI (HPD) (0.028, 0.514) (113.3, 737.8) (0.049, 0.649) (115.3, 602.6)
Bayesian P2a Binary Model α β DIC
Posterior mode 0.285 152.7 3682.7
Posterior median 0.203 398.2
CI (HPD) (0.027, 1.308) (154.6, 1401.2)
ACM (Homogeneous) α1 β1
Posterior mode 0.192 160.5 3683.2
Posterior median 0.216 395.2
CI (HPD) (0.005, 1.086) (79.3, 1263.2)
ACM (General) α1 β1 α2 β2
Posterior mode 0.212 177.5 0.162 172.5 3670.4
Posterior median 0.312 425.7 0.188 256.7
CI (HPD) (-0.039, 0.896) (96.5, 1347.8) (-0.181, 0.840) (39.5, 1123.9)
PCM α1 β1 α2 β2
Posterior mode 0.258 243.2 0.286 147.0 3669.4
Posterior median 0.346 566.4 0.367 218.9
CI (HPD) (-0.056, 0.822) (76.5, 1490.9) (-0.080, 0.818) (44.9, 1267.8)
a MLE: maximum likelihood estimate; CI: confidence/credible interval; HPD: highest posterior density; Bayesian P1
and P2 refer to two settings of prior choice; Prior 1: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.25, 150); Prior 2:
(µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.5, 400).
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Table 2.3: Parameter estimates with 95% confidence intervals for two point sources mod-
els using MLE, profile likelihood and IRLS methods; and posterior modes with
95% highest posterior density (HPD) credible intervals using MCMC.
First point source Second point source
MLEa Binary Model α11 β11 α12 β12 AIC
Estimate 0.228 309.2 -0.098 180.5 5657.5
CI (-0.177, 0.663) (97.3, 575.8) (-0.420, 0.223) (17.4, 376.2)
ACM (Homogeneous) α11 β11 α12 β12
Estimate 0.179 283.6 -0.134 114.8 5656.0
CI (0.001, 0.360) (68.4, 535.1) (-0.357, 0.093) (6.5, 233.2)
Bayesian P1a Binary Model α11 β11 α12 β12 DIC
Posterior mode 0.280 257.9 0.061 270.0 5609.1
Posterior median 0.304 302.1 0.089 300.1
CI (HPD)a (0.127, 0.462) (171.9, 533.2) (-0.072, 0.200) (132.1, 543.7)
ACM (Homogeneous) α11 β11 α12 β12
Posterior mode 0.205 294.0 0.019 261.4 5593.8
Posterior median 0.212 360.2 0.021 340.4
CI (HPD) (0.075, 0.354) (155.0, 509.8) (-0.083, 0.122) (143.1, 633.2)
Bayesian P2a Binary Model α11 β11 α12 β12 DIC
Posterior mode 0.248 327.5 0.007 182.3 5604.6
Posterior median 0.303 430.2 0.011 434.6
CI (HPD) (0.069, 0.474) (122.9, 627.2) (-0.131, 0.134) (75.1, 1225.7)
ACM (Homogeneous) α11 β11 α12 β12
Posterior mode 0.186 228.0 -0.006 149.4 5595.2
Posterior median 0.222 340.4 0.011 480.9
CI (HPD) (0.051, 0.354) (129.0, 645.8) (-0.120, 0.108) (70.1, 1243.2)
a MLE: maximum likelihood estimate; CI: confidence/credible interval; HPD: highest posterior density; Bayesian P1
and P2 refer to two settings of prior choice; Prior 1: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.25, 150); Prior 2:
(µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.5, 400).
Table 2.4: Monte Carlo test p-values and Bayes factors 2 log(B) for the null hypothesis
thatH0 : f(x) = 1 for various point source(s) models. Bayesian P1 and P2 refer
to two settings of prior choice; Prior 1: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) =
(0.25, 150); Prior 2: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.5, 400).
Models MC test Bayes factors
p-values P1 P2
One point source
Binary model 0.04 3.52 2.89
ACM (Homogeneous) 0.06 4.32 3.41
ACM (General) 0.02 6.29 6.16
PCM < 0.01 7.12 6.04
Two point source
Binary model 0.04 3.11 2.57
ACM (Homogeneous) < 0.01 6.69 5.98
CHAPTER III
Bayesian analysis of time-series data under case-crossover
designs
3.1 Introduction
Case-crossover design, originally proposed by Maclure (1991), has been widely used
to study the effect of short-term exposure on the risk of acute adverse health events, such
as temperature on mortality (Basu et al. 2005) and ambient air pollution on asthma (Li
et al. 2011). Under this design, exposure at the event time of each case is compared
to exposure at some referent times (times within a certain period where the same case
did not experience any event). For each case, a ‘referent window’ is defined as a set
of time points consisting of the event time and all referent times for the same case. It
can be viewed as a hybrid of case-control (comparing exposure distribution of cases and
controls through a retrospective design) and crossover (the case serves as its own control)
studies. The case-crossover design inherently controls for time-invariant confounders (e.g.
gender and race) by making within-person comparisons, and controls for potential time-
varying confounders (e.g. seasonal trends) by proper choice of the referent times. The
time-stratified case-crossover design divides time a priori into disjoint strata, uses the
event time to determine which stratum is selected, and selects all or a sub-sample of the
remaining times in the stratum as referent times for a given case (Janes et al. 2005a). For
example, time stratum based on the same day of the week in the same calender month that
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controls for confounding due to day of the week, seasonal and long-term effects is often
recommended (Janes et al. 2005a).
The design and analytic issues related to the referent time selection have been com-
prehensively discussed (Lumley and Levy (2000); Levy et al. (2001); Janes et al. (2005a);
Janes et al. (2005b); Mittleman (2005)). The traditional approach for analyzing case-
crossover data is to treat them as coming from a matched case-control structure, where
each stratum consists of exposures at event and referent times of a given case. A con-
ditional logistic regression (CLR) is routinely used to obtain estimates of the underlying
risk ratio parameters. In terms of referent time selection, a ‘non-localizable’ design (Janes
et al. 2005a) is a case-crossover design for which the CLR estimating equation under the
choices of referent times is biased, such as unidirectional (Maclure 1991), bidirectional
(Navidi 1998) and symmetric bidirectional designs (SBD) (Bateson and Schwartz 1999).
The bias has been termed ‘overlap bias’ (Lumley and Levy 2000). In contrast, a ‘local-
izable’ design (Janes et al. 2005a) is a case-crossover design for which there exists an
unbiased CLR estimating equation, such as the time-stratified design (TSD) (Janes et al.
2005a) and semi-symmetric bidirectional design (Navidi and Weinhandl 2002). Appendix
A.2 Figure 1 shows several illustrations of common referent time selection strategies. The
TSD is generally preferred compared to any of the alternatives thus far proposed (Janes
et al. (2005b); Mittleman (2005)). Based on a 2010 review article (Carracedo-Martı́nez
et al. 2010), though 42% of case-crossover studies during 1999-2008 used SBD, the TSD
has become the most popular design since 2005.
An alternative analysis of such exposure and event series data is to use a standard
time-series analysis. Lu and Zeger (2007) have shown that the traditional CLR approach
to analyze case-crossover data can be viewed as a time-series analysis with an underlying
log-linear model of a specific form. This equivalence has also been noted in special cases
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by Levy et al. (2001) and by Janes et al. (2005a).
Bayesian data analysis under case-crossover designs appear to be non-existent in the
literature though there is substantial work on Bayesian modeling of matched case-control
data (Ghosh and Chen (2002); Sinha et al. (2004)). It is true that the use of CLR remains
identical in the two contexts for certain ‘localizable’ designs. However, the assumptions
and the data structure make the statistical points of discussion distinct in a case-crossover
study compared to a matched case-control study under a Bayesian paradigm. In this chap-
ter we consider a comprehensive treatment of the problem starting with some posterior
equivalence results, followed by alternative Bayesian proposals beyond using CLR as the
basis for inference in case-crossover studies.
This chapter is structured as follows. In section 3.2, we describe the disease-exposure
association model, underlying assumptions and two potential likelihood formulations, the
conditional and the full likelihood, under the case-crossover design. We then consider
equivalence results analogous to Lu and Zeger (2007) in a Bayesian framework under
both formulations. Bayesian equivalence results are intended to characterize the priors
that ensure identical posterior inference regarding the risk ratio parameters as derived un-
der case-crossover designs and from time-series analysis. Bayesian equivalence results
for case-control studies, relating prospective and retrospective likelihoods appear in sev-
eral recent papers (Seaman and Richardson (2004); Staicu (2010); Ghosh et al. (2012)).
The full likelihood formulation requires less restrictive assumptions than the conditional
one, however, it involves a set of nuisance parameters corresponding to each individual or
day that grows with sample size. Thus maximum likelihood estimators (MLE) of the risk
ratio parameters can be potentially inconsistent. We present a semi-parametric Bayesian
approach using a Dirichlet process prior (Ferguson (1973); Antoniak (1974); Müller and
Quintana (2004)) to handle the random nuisance parameters in the full likelihood formu-
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lation. Section 3.3 presents a simulation study where we evaluate the performance of
both conditional and full likelihood approaches under two common referent time selection
strategies: TSD (‘localizable’) and SBD (‘non-localizable’). We study frequentist proper-
ties such as bias and mean-squared error (MSE) of the proposed methods. Our numerical
results indicate that Bayesian analysis based on the full likelihood has advantages in re-
laxing certain model assumptions and reducing bias, but both Bayesian and frequentist
inference based on conditional likelihood are fairly robust with respect to design choices
and model assumptions. Section 3.4 demonstrates the proposed methods through a study
examining the association between acute asthma risk and ambient air pollutant concentra-
tions. We discussed how to use information from published studies through formulation
of an informative prior in the context of the example.
We would like to highlight the two fundamentally novel aspects of our study. The
present study is the first to consider Bayesian equivalence results between case-crossover
and time-series analysis. The proposal to use a full likelihood and use semi-parametric
Bayes technique to make the estimation of the nuisance parameters feasible is also com-
pletely new in the case-crossover context. The numerical comparison of all proposed
Bayesian methods with frequentist alternatives is an added asset of the chapter.
3.2 Methods
3.2.1 Case-crossover and time-series: disease risk model
Suppose that a population ofN+M initially disease-free individuals are being followed
forward in time. Let time point t (follow-up day, say) stand for the time interval [t, t + 1)
throughout this chapter. Let Yit be the binary indicator whether subject i has the disease
occurring at time t (Yit = 1 if yes; Yit = 0 if no). LetN and T be the total number of cases
at the end of the follow-up period and the total number of the discrete set of time points t
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respectively, and let, without loss of generality, the first N of the N+M individuals denote
the cases. We start with the risk ratio model using similar notation as in Lu and Zeger
(2007), where the risk of an event for individual i at time t is assumed as
P
(





1 + λ0it exp(β
>X it)
.(3.1)
X it = (Xit1, ..., Xitp)
> is the p-dimensional exposure variable for individual i at time t,
β = (β1, ..., βp)
> is the common set of log risk ratio parameters. Each individual i is
assumed to have his/her own baseline risk λ0it.
If the risk of the disease for individual i at time t is small, it will imply the following:
Assumption 3.1. P
(
Yit = 1 | X it
)
= λ0it exp(β
>X it)/{1 + λ0it exp(β>X it)} ≈
λ0it exp(β
>X it).
For the case-crossover analysis, we do not require assumption 3.1 and can proceed with
the likelihood governed by model (3.1); while for the time-series analysis, assumption 3.1
is required.
A traditional conditional likelihood approach
The log risk ratio parameter β in model (3.1) can be ascertained under a case-crossover
design. We consider the situation where the diseased individuals can have multiple occur-
rences of events during the whole follow-up period, but the referent windows correspond-
ing to these multiple events from the same individual must not overlap. We ignore the
within-individual correlation among the multiple occurrences of events, and treat these
multiple events as independent ‘cases’. Without loss of generality, we still denote N as
the number of ‘cases’.
Let ti and Wi be the event time and referent window for case i. The following assump-
tion on the baseline risk is often made under a case-crossover design, which is natural if
the length of Wi is short (typically a month, as in Janes et al. (2005a)).
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Assumption 3.2. For each case iwith event time ti, the baseline risk λ0it is constant within
the referent window Wi, i.e., λ0it = λ0iti , for any t ∈ Wi, i = 1, ..., N .
Given the exposure X = (X it)N×T , the referent windows Wi’s and that
∑
t∈Wi Yit =




































In (3.2), the third equality holds under a ‘localizable’ design (Lumley and Levy (2000),
Janes et al. (2005b)), under which an unbiased estimate of β can be obtained using a
CLR. Under assumption 3.2, the fourth equality holds. The nuisance parameter λ0iti was
eliminated by conditioning on the sufficient statistic
∑
t∈Wi Yit.
The case-crossover design is similar to a matched case-control design in the sense that
the exposure at the event time of each case is compared to exposures at all referent times
for the same case, i.e., a matched set of exposures corresponding to each Wi. Lumley and
Levy (2000) discussed the differences between the two designs, such as the dependency
of exposures between and within stratum. Due to these dependencies, they showed that
(3.2) can be treated as a conditional likelihood of a matched case-control study only under
‘localizable’ referent window. They also showed that, with a ‘non-localizable’ referent
window such as a SBD, ti and Wi are simple functions of each other (ti is the mid-point
of Wi), and P
(
Yit = 1, Yis = 0,∀s 6= t | X,Wi
)
= I(t = ti) is deterministic. Thus,
Lcc(β,λ) = 1, i.e., uninformative. The estimating equation for β corresponding to Lcc(β)
is biased under ‘non-localizable’ designs, and ‘overlap bias’ is incurred if β is naively
estimated using Lcc(β) (Lumley and Levy (2000)).
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The case-crossover design is commonly used in ecological studies concerning issues
such as effect of climate change and air pollution on human health, where personal ex-
posure is often not assessed at an individual level. For example, ambient air pollutant
concentrations are usually measured from monitoring sites representing the exposure of
the nearby population.
Assumption 3.3. The study population has experienced shared exposure at each time t
such thatX it = X t, for i = 1, ..., N+M .
Under assumption 3.3, the conditional likelihood in (3.2) can be rearranged in terms




















where W (t) is the referent window containing t as the event time, Yt =
∑N
i=1 Yit is the
count of events at time t. Assumption 3.3 can be relaxed and individual exposure values
can be accommodated as in our earlier formulation (3.1) or (3.2).
A full likelihood approach
We propose an alternative full likelihood formulation of model (3.1). From (3.1), be-
fore enforcing either assumption 3.2 or 3.3, the full likelihood of a case-crossover design















1 + λ0is exp(β
>X is)}
,(3.4)
which allows for a completely general form of λ0it. We refer to LNTfull(β,λ) in (3.4) as
full likelihood with individual and day level intercepts. If the baseline risk for individual i
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does not change in its referent window and depends only on the event time ti as in assump-













. We refer to LNfull(β,λ) as full likelihood with individual level inter-
cepts. In this case, the full likelihood LNfull(β,λ) under a case-crossover design is exactly
analogous to deriving the full likelihood of a matched case-control study under a stratified
logistic regression model logitP (Yis = 1 | X is) = log(λ0iti) + β>X is, s ∈ Wi, i =
1, ..., N . Under both assumptions 2 and 3, one can alternatively translate the likelihood in
terms of common nuisance parameters log(λ0iti) = νti for all cases i that have event time




[ exp(νt + β>X t)∏




where ν = (ν1, .., νT ). We refer to LTfull(β,ν) as full likelihood with day level intercepts.
Time-series Analysis
The log risk ratio parameter β in model (3.1) can also be estimated using an alter-
native time-series analysis. The expected number of events at time t can be expressed
as the sum of the individual level probabilities (3.1) over the population. Under both
assumptions 1 and 3, log(E(Yt)) = log(
∑N+M
i=1 E(Yit)) = β
>X t + log(
∑N+M
i=1 λ0it).
For exposures varying at an individual level X it, generally one can not aggregate the risk
λ0it exp(β
>X it) as above to obtain a standard time-series structure involving the day level
counts and exposures. Consider log(
∑N+M
i=1 λ0it) as a function of time only, say St. Then
β can be estimated through the log-linear Poisson model
(3.6) log(E(Yt)) = β>X t + St,
where St is typically modeled as parametric (e.g., season) and/or non-parametric (e.g.,
natural spline of time) terms. The likelihood corresponding to the log-linear model in
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(3.6) is given by
(3.7) Lll(β, St) ∝
T∏
t=1
{exp(β>X t + St)}Yt exp{− exp(β>X t + St)}.
Frequentist equivalence between time-series analysis and case-crossover design using
conditional likelihood

















respectively. By comparing Ucc(β) and Ull(β), Lu and Zeger (2007)
showed that, for a certain choice of window W (t) in (3.3) of a ‘localizable’ design, there
exists a choice of St in log-linear model (3.6) such that the two estimating equations pro-
vide the same estimate of β. For example, for a TSD withW (t) representing the time stra-






linear model (3.6) will provide the same estimate of β as (3.3). Note that Ŝt′(β) = Ŝt(β)
for any t′ ∈ W (t), implying St is a step function of t with a separate value at each time
stratum. As the conditional likelihood is uninformative under a ‘non-localizable’ design,
there is no equivalence between time-series analysis using a log-linear model and case-
crossover design.
Frequentist equivalence using full likelihood
Similarly, by comparing the two estimating equations corresponding to LTfull(β,ν) and
Lll(β, St), we showed (in Appendix B.2) that, for a certain choice of window W (t) of a
‘localizable’ design, there exists a choice of St in the log-linear model such that the two
estimating equations provide the same estimate of β. Under a TSD, while the conditional
likelihood approach or an equivalent log-linear model would only allow the baseline risk to
change discontinuously among different time strata, the full likelihood approach does not
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require such constraints. However, both the full likelihood method and its equivalent log-
linear model encounter difficulty in estimating β in the presence of T day level nuisance
parameters using maximum likelihood. As an alternative estimation strategy, a random ef-
fects Bayesian approach could be used to handle these random nuisance parameters under
the full likelihood formulations, which are described in section 3.2.3.
3.2.2 Bayesian equivalence between case-crossover design and time-series model
Bayesian equivalence with conditional likelihood
We focus on the posterior distributions of the log risk ratio parameter β derived under
case-crossover and time-series analysis. The Bayesian equivalence result for β requires
that the posterior distribution of β derived from Lcc(β) in (3.3) and from Lll(β, St) in
(3.7) are identical under certain forms of St and certain prior distributions on β and St.
The validity of using a conditional likelihood as the basis for Bayesian inference has been
discussed in previous studies. For example, Rice (2004) and Rice (2008) discussed the
equivalence between the use of conditional and marginal likelihoods for matched case-
control study. Since the conditional likelihood approach is only valid for a ‘localizable’
design, we restrict our attention specifically to a TSD in this section.
THEOREM 3.1. Suppose the follow-up time points t = 1, ..., T are divided a priori
into K disjoint time strata ts(k) under a TSD, k = 1, ..., K. If St in log-linear model (3.6)
is defined as a step function with distinct values of St be S ′k on ts(k), k = 1, ..., K, and
if independent improper priors π(S ′k) ∝ 1 for S ′k and a proper prior π(β) for β are used
where S ′k and β are mutually independent, then the posterior distribution of β derived
from Lcc(β) in (3.3) is identical to the marginal posterior distribution of β derived from
Lll(β, St) in (3.7).
Proof of Theorem 3.1 is given in Appendix B.2. We showed that, given the choice of St
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and prior distribution on St and β as in Theorem 3.1, the marginal posterior distribution of








1 · · · dS ′K
∝ π(β)Lcc(β), i.e., the posterior distribution of β derived from Lcc(β).
With shared exposure data across all individuals, the time-series model in (3.6) is more
flexible than a case-crossover design using conditional likelihood, in the sense that model
(3.6) allows various smoothing functions of time for St where one special choice is equiv-
alent to the analysis of data under case-crossover design. Log-linear models can also
account for over-dispersion of the Poisson variance that is typically present in air pollu-
tion studies, while case-crossover studies can not. In contrast, case-crossover design has
the advantage of controlling for personal level confounders, and modeling individual level
exposures over time-series models.
Bayesian equivalence with full likelihood
We aim to show the marginal posterior distribution ofβ derived fromLTfull(ν,β) under
the shared exposure assumption is identical to that derived from a Poisson likelihood. Let
ys1t and ys0t be the numbers of potential event and referent times that equals to t in the
s-th time stratum. ysdt is assumed to follow a Poisson distribution Poisson(µsdt) with
mean µsdt = exp(φst + d(νs + β>X t)), d = 0, 1; s = 1, ..., T ; t = 1, ..., T . The Poisson









exp{φst + d(νs + β>X t)}
]ysdt exp [− exp{φst + d(νs + β>X t)}]
With independent improper priors π(φst) ∝ 1 and proper prior on ν and β, the joint
posterior distribution of (ν,β) derived (in Appendix B.2) from Lp(φ,ν,β) is




So the marginal posterior distribution of β derived from Lp(φ,ν,β) and from LTfull(ν,β)
are the same. This method is inspired by the Multinomial-Poisson transformation (Baker
1994) and its Bayesian counterpart (Seaman and Richardson (2004); Ghosh et al. (2006)).
Though this proves theoretical Bayesian equivalence between using a case-crossover full
likelihood and a Poisson likelihood, the Poisson model has a large number of nuisance
parameters φ. Moreover, the interpretation of the artificially constructed Poisson model
is practically not very meaningful. Thus, we focus on full likelihood based methods with
more flexible semi-parametric prior distributions on the intercepts in the following section,
instead of an equivalent time-series formulation.
3.2.3 Bayesian inference
Traditionally, CLR models were routinely used for frequentist inference on β under
case-crossover designs. A naive approach would be to also use the conditional likelihood
Lcc(β) as the basis for Bayesian inference, where prior specification on only β is needed.
The posterior distribution of β is not a standard distribution, but posterior draws could be
generated by using a Gibbs sampler (Appendix B.2).
For the full likelihood approach, though the number of nuisance parameters grows with
the sample size, a random effects model can be used to reduce the problem to estimating
the parameters corresponding to the random effects distribution. For example, the stratified
logistic regression model with likelihoodLTfull(β,ν) in (3.5) can be readily fitted through a
generalized linear mixed model with νt
iid∼ N(µν , σ2ν). Methods such as penalized pseudo-
likelihood (Breslow and Clayton 1993) can be used for inference in such models, which is
available in standard statistical software.
The misspecification of the random effects distribution could lead to potential bias
in the estimation of β (Mukherjee et al. 2009). To avoid assuming a parametric nor-
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mal distribution on the nuisance parameters, we consider a more robust semi-parametric
Bayesian approach that allows the random effects to have a nonparametric distribution. To
this end, we use the Dirichlet process prior (Ferguson (1973); Antoniak (1974); Müller
and Quintana (2004)) to handle the random intercepts. In particular, for example with
LTfull(β,ν) in (3.5), we assume νt | G
iid∼ G, where G is a random distribution generated
from a Dirichlet process with concentration parameter α and base distribution G0, i.e.,
G | α,G0 ∼ DP (α,G0). Let ν−t = (ν1, ..., νt−1, νt+1, ..., νT ), for t = 1, ..., T . The joint
prior distribution π(ν) can be represented in terms of leave-one-out conditional distribu-




s=1, s 6=t Iνs(·) (Blackwell and MacQueen 1973).
Thus, (ν1, ..., νT ) will be adaptively reduced to fewer distinct clusters with positive proba-
bility. As α → ∞, the Dirichlet process model reduces to specifying a parametric model
νt
iid∼ G0; whereas α → 0 implies a parametric model with a common stratum effect,
namely νt = ν∗ for t = 1, ..., T , where ν∗ ∼ G0.
To complete the hierarchy, independent hyperpriors are considered as follows: α |
a0, b0 ∼ Gamma(a0, b0), G0 ∼ N(µ, σ2), µ | µ0, σ0 ∼ N(µ0, σ20), σ−2 | c0, d0 ∼
Gamma(c0, d0). We consider mutually independent normal priors β ∼ N(µβ, σ2βIp).
The posterior distributions of ν and β can be obtained by using a Metropolis-Hastings
within Gibbs algorithm as described in Neal (2000) and Sinha et al. (2004). The details
are presented in Appendix B.2. Similarly, for the individual specific stratum effects in
LNfull(β,λ), we assume log(λ0iti) | G
iid∼ G, for i = 1, 2, ..., N . For LNTfull(β,λ), we only
consider a special case by assuming a multiplicative structure on the nuisance parameters:
λ0it = λ0i exp(ωt), where λ0i is a constant frailty for person i and ωt is the time varying
effect on the risk. We model log(λ0i) and ωt through random distributions generated from
two independent Dirichlet processes.
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3.3 A Simulation Study
Simulation scenarios
In our simulation, we used λ0it = λ0i exp(ωt) as the form of the true baseline risk.
Under both assumptions 1 and 3, we have log(E(Yt)) = β>X t + log(
∑N+M
i=1 λ0it) =
β>X t + ωt + η, where η = log(
∑N+M
i=1 λ0i). We generated the number of events per day
from a Poisson model
(3.8) Yt ∼ Poisson(µt), where µt = exp(β>X t + ωt + η).
We considered various simulation scenarios with different choices of time effects ωt on the
baseline risk, true effect sizes β∗, and exposure series Xt. Without loss of generality, we
considered β and X t to be univariate in our simulation study. We convert the time-series
data in the form of individual event referent times according to a given case-crossover
design.
Temporal trends on the baseline risk: In order to examine whether the full likelihood
method under a case-crossover design is more robust to various baseline risk specifica-
tions than the conditional likelihood method, we considered three forms of time-varying
effect ωt involved in the baseline risk. In particular, B1: ωt = ω that satisfies assumption
3.2; B2: ωt = c(1 − 0.001t)[1 + 0.5cos(2πt/365)] that combines seasonal and long-term
decreasing trends, where c is a positive scaling factor; B3: B3 is a mixture of B2 (with
probability 0.9) and random spikes (with probability 0.1), where the spikes follow a uni-
form distribution U(2c, 4c). Note that B2 and B3 both violate assumption 3.2.
Effect sizes: We considered two typical true effect sizes β∗ = 0.1 (a risk ratio of 1.1,
e.g. reflecting the effect of 10 µgm−3 increase of PM2.5 (particulate matter less than 2.5
micrometers in diameter) on the risk of acute asthma (Li et al. 2011) or 10 degree (F)
change of temperature on mortality risk (Basu et al. 2005)) and β∗ = 1 (a risk ratio of 2.7,
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e.g. reflecting the effect of medication use on preventing elderly falls in case-crossover
intervention trials (Luo and Sorock 2008)).
Exposure series: We simulated exposure series Xt over a 3-year (T=1096) period under
two settings. E1: Xt has auto-correlation structureAR(1) (ρ = 0.6); E2: Xt has long-term
decreasing trend plus seasonal and day of week effects, with the same auto-correlation
structure as in E1. We generated E1 and E2 to have the same marginal distributions.
Likelihoods/Methods: We would like to compare time-series analysis using log-linear
models with the analysis under case-crossover designs. The methods can broadly be di-
vided into three classes in terms of likelihoods we considered. In particular, M1: log-linear
models, adjusted for the true temporal trend ωt as offset (this is the closest to the true gen-
erating model) or adjusted for a natural spline term on time t; M2: conditional likelihood
approach under a case-crossover design, using both frequentist and Bayesian treatment;
M3: full likelihood approach under a case-crossover design, with the random intercepts
handled by a Dirichlet process. Within case-crossover analysis, we also compared the two
commonly used referent time selection strategies, TSD with SBD, to possibly quantify the
‘overlap bias’.
Prior choices: Within the Bayesian alternatives we implemented two choices of prior dis-
tributions on β: non-informative and informative. For non-informative prior, we used a
vague prior β ∼ N(0, 102); for informative prior, we considered β ∼ N(µβ, σ2β) with µβ
and σβ potentially elicited from historical data. We described the details of incorporating
historical data to construct informative priors under a concrete data example framework
in section 3.4. We used β ∼ N(0.08, 0.032) when β∗ = 0.1, and β ∼ N(0.8, 0.22) when
β∗ = 1 in our simulations. Justification for these prior choices on µβ and σβ as well as on
the full set of parameters are provided in Appendix B.2.
The simulation was repeated 1000 times under each scenario. We summarized the
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results in terms of relative bias (RB = ( 1
1000
∑1000




i=1 (β̂i − β∗)2) corresponding to the log risk ratio parameter β. Ta-
bles 3.1 and 3.2 present results corresponding to 6 baseline×exposure (3× 2) settings, for
β∗ = 0.1 and 1 respectively. As the individual level model LNTfull(β,λ) and L
N
full(β,λ) are
computationally intensive with large N (N ≈ 20, 000 for β∗ = 0.1 in our simulations),
we only considered LTfull(β,ν) under β
∗ = 0.1. We considered all three versions of full
likelihoods under β∗ = 1 with N ≈ 1000.
Simulation results
Likelihoods/Methods: We present the estimates from the log-linear model using offset
terms to be the true values of ωt as a reference benchmark, against which each of our
methods is compared. In practice, while carrying out a time-series analysis, one will not
know the true time effect terms and will use a flexible nonparametric spline term (Dominici
et al. (2002), Dominici et al. (2003)). The log-linear model adjusted for a natural cubic
spline term of time with 7 degrees of freedom per year approximates the true model quite
accurately. The two log-linear models both have smaller bias and MSE than the case-
crossover designs, especially under B2 or B3. Note that the log-linear models fitted here
were not chosen to be the equivalent models to case-crossover designs.
(a) Design effect: In comparing the two designs, we found that the TSD generally has
smaller bias and MSE than the SBD. Under B1, the only source of bias is the ‘overlap
bias’ of a SBD. We observed up to 5% difference in bias between TSD and SBD (Tables
3.1 and 3.2). However, the magnitude and direction of the ‘overlap bias’ depend on the
particular exposure series and effect size, as previously noted in Janes et al. (2005a).
(b) Conditional versus full likelihood formulation (with non-informative priors): The




require assumption 3.2 of constancy of ωt in each referent window and only allows the
risk to change discontinuously across referent windows. The most general form of the full
likelihood LNTfull(β,λ) does not require this assumption. As for bias, we note that the bias
due to violation of assumption 3.2 (under B2 and B3) is typically very small (< 1%) when
β∗ = 0.1 (Table 3.1), and up to 3% when β∗ = 1 (Table 3.2). However, full likelihood
methods have greater MSE than conditional counterparts under non-informative priors.
This is expected as another level of hierarchy was added to model the uncertainty in the
random nuisance parameters.
Prior sensitivity: Both conditional and full likelihood methods show substantial reduction
in MSE when informative priors on β are used as shown in Tables 3.1 and 3.2, which also
lead to substantial shrinkage towards the prior mean. Thus, given the context of the study
and prior information, Bayesian methods that utilize informative priors can potentially
have advantage over their frequentist counterparts in terms of MSE.
Remark 3.1: Note that the full likelihood has additional analytic flexibility to handle indi-
vidual level data and incorporate interaction terms that account for subject level covariates.
We generated time-series data with shared exposure for the present simulation study for
illustration purposes, leading to best performance by the log-linear models. If we had gen-
erated individual level data with personal factors, the time-series analysis would have been
more susceptible to residual bias from ignoring personal level confounders.
3.4 Application: Data analysis for the DAMAT Study
We illustrate the proposed methods through the ‘Detroit Asthma Morbidity, Air Qual-
ity and Traffic’ (DAMAT) study originally analyzed by Li et al. (2011). One primary goal
of the study was to examine the association between acute asthma risk and ambient air pol-
lutant levels, especially PM2.5, for the pediatric (children 2-18 years) Medicaid population
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in Detroit, Michigan, during the 2004-2006 study period (T = 1096 days). Daily counts
of asthma events, including emergency department visits and hospitalizations, were used
as the outcome series Yt, for t = 1, ..., 1096. Figure 3.1 shows the smoothed trend of Yt
indicating a strong seasonal pattern, with the highest frequency during fall, and the lowest
during summer. A total of 12,933 asthma events were observed during the 1096 days, rep-
resenting an average rate of 11.8 events per day. Daily PM2.5 concentration was computed
as the average concentration across the air quality monitoring sites in the Detroit area.
Daily PM2.5 data also show a strong seasonal pattern with a mean level of 15.0 µgm−3.
Daily meteorological variables, including temperature (TP) and relative humidity (RH),
were obtained similarly. To account for other temporal trends that were not controlled by
the case-crossover design, a natural quadratic spline term (denoted by ns(·)) was used on
the TP variable.




[ exp{βPM2.5PM2.5, t + βRHRHt + ns(TPt)}∑
s∈W (t) exp{βPM2.5PM2.5, s + βRHRHs + ns(TPs)}
]Yt
,(3.9)
where we used the 5-day moving average of PM2.5 concentration prior to the asthma events
on day t as PM2.5, t. The Medicaid data was also analyzed using the equivalent log-linear
model of (3.9). In particular, for a TSD with time stratum as the same day of the week in
the same calender month, we compare it with the following equivalent log-linear model
log(E(Yt)) = β0 + βPM2.5PM2.5, t + βRHRHt + ns(TPt) + St,(3.10)
where St represents all possible combinations among the three factors of day of the week,
month and year, having a total of 7× 12× 3 = 252 levels. We refer to (3.10) as the time-
stratified log-linear (TSLL) model. For inference on β, models (3.9) and (3.10) are equiv-
alent under both the frequentist and Bayesian framework (with prior specification as de-
scribed in Theorem 3.1). Similarly, a case-crossover SBD using referent times as 7 and 14
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days before and after the event day was compared to the corresponding symmetric bidirec-




r=s, s±7, s±14 exp(β
>Xr)}].
Joint estimation of β and St was performed iteratively as St potentially depends on β. The
comparison between SBD and SBLL is pertinent only under the frequentist framework.
Prior choices: We used LTfull(β,ν) under the full likelihood approach. We first consid-
ered the random effects model assuming νt
iid∼ N(0, 102) without further prior specifi-
cation on β, and proceeded with the marginal likelihood to estimate β. Then we con-
sidered the full Bayesian treatment using Dirichlet process prior νt | G
iid∼ G where
G | α,G0 ∼ DP (α,G0). α ∼ Gamma(0.5, 0.1), G0 ∼ N(µ, σ2), µ ∼ N(0, 10)
and σ−2 ∼ Gamma(4, 1) were used as the base prior setting in our data example. As part
of our sensitivity analysis, we varied the priors on α across four Gamma distributions,
and two extreme cases when α → 0 (corresponding to νt = ν∗ for t = 1, ..., T , where
ν∗ ∼ G0) and α→∞ (corresponding to νt
iid∼ G0). More details were provided in Figure
3.2(c).
We considered both informative and non-informative priors on βPM2.5 . For nonin-
formative prior, we used a vague prior βPM2.5 ∼ N(0, 102). For informative prior, we
considered an ad-hoc way of eliciting prior information from published results. From a
recent review (Li et al. 2011), we a priori postulated that the asthma-PM2.5 association
is in general modest with a risk ratio ranging in (1.01-1.09) for 10 µgm−3 increase in
PM2.5. Assuming βPM2.5 ∼ N(µβ, σ2β), if we believed that the 95% confidence interval
(CI) for exp(βPM2.5) is (1.01,1.09), the approximate values for µβ and σβ can be obtained
as µβ = [log(1.09) + log(1.01)]/2 = 0.05 and σβ = [log(1.09) − log(1.01)]/4 = 0.02.
Then our informative prior was chosen as N(0.05, 0.022). There is no general consensus
on the best way to elicit a subjective prior though this topic has been studied vastly (Dey
and Liu 2007).
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While non-informative or non-subjective priors are often quite adequate as default pri-
ors for many Bayesian analyses, prior elicitation when possible can lead to more meaning-
ful results from the data. This is especially true in the presence of historical data, available
from series of past studies, e.g., past studies relating asthma-PM2.5 associations in our
context. These elicited priors based on historical data, when proper, have an operational
advantage over non-subjective improper priors. Proper priors are required for computing
Bayes factors and posterior model probabilities.
Ibrahim and Chen (2000) proposed a particular approach towards the development of
priors based on historical data. They referred to these priors as ‘power priors’. Specifically,
if D0 denotes the historical data from a previous study, the power prior for β is defined
as π(β|D0, a0, c0) ∝ La0(β|D0)π0(β|c0). Here π0(β|c0) is the initial prior before the data
D0 were observed and c0 is a specified hyperparameter. The parameter a0 ∈ [0, 1] is a
scalar parameter which controls the influence of the historical data on the current data. In
particular, a0 = 1 corresponds to the past posterior which has become the present prior.
On the other hand, a0 = 0 corresponds to a prior specification which ignores completely
the historical data. While one can do the analysis by simply assigning also a prior on a0,
we will pursue our analysis both when a0 is fixed or random, assigning Beta priors to a0 in
the latter case. If π0(β|c0) is proper, then the power prior π(β|D0, a0, c0) is guaranteed to
be proper; further, π(β|D0, a0, c0) can be proper under certain regression settings even if
π0(β|c0) is an improper uniform prior (Ibrahim and Chen 2000). We used a vague initial
prior N(0, 102) for π0(β|c0), such that the prior π(β|D0, a0, c0) is a handy proper prior.
L(β|D0) was constructed based on several published studies of asthma-PM2.5 associations
reviewed in (Li et al. 2011). Further details regarding the construction of L(β|D0) are
given in Appendix B.2.
Results: The results are shown in Table 3.3 and Figure 3.2. In general, evidence of signif-
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icant increases in acute asthma risk was found with 10 µgm−3 increase in PM2.5 concen-
trations leading to a risk ratio ranging from 1.02 to 1.06 across different methods.
(a) Design effect: Comparing TSD with SBD, β̂PM2.5 estimated under a TSD (ranging
from 1.05 to 1.06 in Table 3.3) are larger than those estimated under a SBD (from 1.02 to
1.04). The overall pattern of the attenuated effects under the SBD is probably due to the
choice of the window and potential ‘overlap bias’, though this direction does not hold in
general as noted in our simulation study.
Comparing the case-crossover TSD with corresponding TSLL model (in Table 3.3),
we noted that they provided identical numerical results for β̂PM2.5 under both frequentist
and Bayesian framework (except possible Monte Carlo errors), indicating the numerical
validity of our equivalence results. Frequentist equivalence results also appear to hold
numerically for the case-crossover SBD and the corresponding time-series SBLL.
(b) Conditional versus full likelihood: Under a case-crossover TSD, full likelihood meth-
ods provided slightly stronger effects (risk ratio ranging from 1.05 to 1.06 in Table 3.3)
than those derived using conditional likelihood (from 1.04 to 1.05). As noted in our sim-
ulation study, the violation of the constant baseline risk assumption within each window
probably led to this difference. We also fit a log-linear model adjusted for a natural cubic
spline term of time with 7 degrees of freedom per year, which shows an estimate of 1.055
(95% CI: (1.027, 1.084)) that is similar to the results using LTfull(β,ν). Under SBD, there
is no substantial difference of using full versus conditional likelihood.
Prior sensitivity: (a) Priors on βPM2.5: When a vague prior βPM2.5 ∼ N(0, 102) is used,
the Bayesian approaches yielded results that are quite similar to maximum likelihood-
based inferences (Table 3.3). It is reassuring that with modest to large sample sizes, we
observed similar results from Bayesian and frequentist methods. With a smaller sample
size using only one-year data (T = 365), even the use of non-informative prior increased
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the precision as compared to the frequentist methods. In Table 3.3, the use of informative
priors (including the ad-hoc prior 2 and the four power priors) increased the precision as
compared to the results under the vague prior. Given one historical study having relatively
larger effect (Appendix B.2), the use of power priors 2 (a0 = 1) and 4 (a0 ∼ Beta(50, 1)
with prior mean ≈ 1) provided stronger effects than those under power priors 1 (a0 = 0.5)
and 3 (a0 ∼ Beta(20, 20) with prior mean 0.5), because power priors 2 and 4 put more
weight on L(β|D0). The use of another layer of uncertainty on a0 (power priors 3 and 4)
creates a heavier tail for the marginal power prior distribution of βPM2.5 than that using a
fixed a0 (power priors 1 and 2), and thus provides wider HPD credible intervals.
(b) Priors on ν: Figure 3.2(c) shows the posterior distributions of βPM2.5 derived under
the 6 different prior settings on α, where the posterior distributions of βPM2.5 remain ro-
bust. We observed that the random effects model and the Dirichlet process prior model
provided very similar results in Table 3.3. Although the prior support allows the number
of clusters ranging from 1 to 252, we observed only 1 cluster under 4 out of the 6 prior set-
tings (shown in Appendix A.2 Table 1). The results suggested that a parametric constant
random intercept model was adequate for this data set.
(c) Priors on St: For TSLL (3.10), we considered a sensitivity analysis of prior on St in-
stead of the flat prior (∝ 1) indicated in Theorem 3.1. In particular, a Dirichlet process
prior as well as an i.i.d. normal prior N(0, 102) on S ′k was also used. Figure 3.2(d) shows
that the posterior distribution of βPM2.5 remained very similar for all these priors on S
′
k.




The chapter presents two novel ideas in the context of case-crossover studies, and
it is the first treatment of the problem in a Bayesian domain. The first contribution is
to study equivalence properties in terms of obtaining identical posterior inference under
case-crossover and time-series analysis. The second and more important contribution is
to propose different forms of full likelihood and strategies for flexible semi-parametric
Bayesian estimation and inference under such likelihoods. Our numerical example and
simulation studies illustrate that the Bayesian specification has advantages in terms of
robustness to model misspecification on the baseline risks and efficiency advantages if
an informative prior is used on the risk ratio parameter. A major potential advantage for
using the full likelihood could be to include individual level data. This formulation makes
it possible to test for evidence of effect modification of exposure effect by individual level
factors, an analysis that is not feasible under a conditional likelihood formulation.
This work leads to many other potential extensions where a Bayesian analysis may
have attractive features under a case-crossover design. For example, extensions to dis-
tributed lag linear/non-linear models (Welty et al. (2009); Gasparrini et al. (2010)), hierar-
chical models for meta-analysis (e.g., Dominici et al. (2000), Dominici et al. (2002)), and
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Figure 3.1: Temporal trend of daily counts of acute asthma events (shown as points) for the
pediatric Medicaid population in Detroit, Michigan, 2004-2006, as obtained in









TSD: conditional likelihood     
TSD: full likelihood
TSLL
(a) Posterior densities using likelihood under TSD
βPM2.5
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SBD: conditional likelihood
SBD: full likelihood
(b) Posterior densities using likelihood under SBD
βPM2.5











(c) TSD using LTfull(β,ν) and 6 different DP priors
βPM2.5




(d) TSLL using 3 different priors on St
Figure 3.2: Posterior density plots for the log risk ratio parameter βPM2.5 correspond-
ing to acute asthma events for a 10 µgm−3 increase in PM2.5 based on
data from the DAMAT study, where vague prior βPM2.5 ∼ N(0, 102) was
used. Panels (a) and (b) used the base prior setting as described in section
3.4. Panels (c) and (d) varied prior choices on ν and St as a sensitivity analysis.
[Priors on ν (panel (c)): A: νt = ν∗ for t = 1, ..., 1096, where ν∗ ∼ N(0, 102); B:
νt
iid∼ N(0, 102);
G1: α ∼ Gamma(0.5, 0.1); G2: α ∼ Gamma(2, 0.2); G3:
α ∼ Gamma(10, 0.5); G4: α ∼ Gamma(20, 1).
Priors on St (panel (d)): S1: π(S′k) ∝ 1; S2: S′k
iid∼ N(0, 102); S3: S′k | G
iid∼ G,
where G | α,G0 ∼ DP (α,G0).]
[TSD: time-stratified design; SBD: symmetric bidirectional design; TSLL:





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.3: Risk ratios of acute asthma events corresponding to a 10 µgm−3 increase in
PM2.5 in the DAMAT study. The model was adjusted for temperature and rela-
tive humidity.
TSDa SBDa
Frequentist MLEa 95% CIa MLE 95% CI
Conditional likelihood 1.049 (1.019, 1.080) Conditional likelihood 1.022 (0.992, 1.052)
TSLLa 1.049 (1.019, 1.080) SBLLa 1.022 (0.992, 1.052)
Full likelihood REMa(T) 1.055 (1.026, 1.085) Full likelihood REM (T) 1.020 (0.991, 1.048)
Bayesian (prior 1b) Bayesa 95% HPDa Bayes 95% HPD
Conditional likelihood 1.049 (1.021, 1.081) Conditional likelihood 1.023 (0.993, 1.053)
TSLL 1.049 (1.021, 1.081)
Full likelihood DPb(T) 1.055 (1.026, 1.086) Full likelihood DP (T) 1.020 (0.992, 1.049)
Bayesian (prior 2b) Bayes 95% HPD Bayes 95% HPD
Conditional likelihood 1.052 (1.027, 1.075) Conditional likelihood 1.035 (1.012, 1.058)
TSLL 1.052 (1.028, 1.076)
Full likelihood DP (T) 1.055 (1.030, 1.076) Full likelihood DP (T) 1.034 (1.011, 1.056)
Bayesian (power prior 1b) Bayes 95% HPD Bayes 95% HPD
Conditional likelihood 1.045 (1.024, 1.068) Conditional likelihood 1.033 (1.010, 1.059)
TSLL 1.045 (1.024, 1.068)
Full likelihood DP (T) 1.049 (1.025, 1.069) Full likelihood DP (T) 1.031 (1.008, 1.058)
Bayesian (power prior 2b) Bayes 95% HPD Bayes 95% HPD
Conditional likelihood 1.054 (1.027, 1.080) Conditional likelihood 1.040 (1.015, 1.068)
TSLL 1.054 (1.027, 1.080)
Full likelihood DP (T) 1.059 (1.036, 1.085) Full likelihood DP (T) 1.041 (1.014, 1.070)
Bayesian (power prior 3b) Bayes 95% HPD Bayes 95% HPD
Conditional likelihood 1.046 (1.018, 1.075) Conditional likelihood 1.031 (1.007, 1.063)
TSLL 1.046 (1.017, 1.074)
Full likelihood DP (T) 1.050 (1.022, 1.076) Full likelihood DP (T) 1.030 (1.005, 1.063)
Bayesian (power prior 4b) Bayes 95% HPD Bayes 95% HPD
Conditional likelihood 1.055 (1.027, 1.084) Conditional likelihood 1.041 (1.012, 1.070)
TSLL 1.055 (1.027, 1.083)
Full likelihood DP (T) 1.060 (1.030, 1.087) Full likelihood DP (T) 1.040 (1.011, 1.069)
a TSD: time-stratified design; SBD: symmetric bidirectional design; TSLL: time-stratified log-linear;
SBLL: symmetric bidirectional log-linear; REM: random effects model; MLE: maximum likelihood
estimate (penalized pseudo-likelihood for REM); CI: confidence interval; Bayes: Bayes estimates in
terms of posterior mean; HPD: highest posterior density.
b DP (T): Dirichlet process prior DP (α,G0) on ν in LTfull(β,ν) under the base prior setting described
in section 3.4; Prior 1: non-informative prior βPM2.5 ∼ N(0, 102); Prior 2: informative prior βPM2.5 ∼
N(0.05, 0.022); Power prior 1: a0 = 0.5; Power prior 2: a0 = 1.0; Power prior 3: a0 ∼ Beta(20, 20)
with mean 0.50 and variance 0.08; Power prior 4: a0 ∼ Beta(50, 1) with mean 0.98 and variance 0.02.
CHAPTER IV
The role of covariate heterogeneity in the meta-analysis of
gene-environment interactions on quantitative traits
4.1 Introduction
Genome-wide association studies (GWAS) provide tremendous opportunities for large-
scale exploration of associations between genetic variants and complex human traits. Search-
ing genetic associations based on GWAS has been successfully identifying many suscep-
tibility loci for a wide spectrum of phenotypes, e.g. type 2 diabetes (T2D) (Scott et al.
(2007), Zeggini et al. (2008), Morris et al. (2012), Saxena et al. (2013)), cardiovascular
outcomes (Psaty et al. (2009), Sarwar et al. (2012)) and breast cancer (Song et al. 2013).
Many studies have found that the risk of most complex traits are influenced by both genetic
and environmental factors. The definition of ‘environment’ can be quite broad, including
demographic factors (age, gender etc.), behavioral factors (smoking, alcohol consumption,
diet, medication use etc.), and external factors (exposure to air pollution, radio-active sub-
stances etc.). The agnostic discovery strategy of GWAS may also be used to detect gene-
environment interactions (GEI) that explain components of the unexplained heritability.
Detecting reproducible GEI can help to further characterize the genetic architecture of hu-
man traits through sub-group or joint effects (Khoury and Wacholder (2009); Mukherjee
et al. (2012)). Therefore, researchers are now looking beyond the marginal genetic ef-
fects and searching for GEI, with limited number of findings so far. For example, body
66
67
mass index (BMI) and PPARG variants appear to have a synergistic effect on fasting in-
sulin levels and T2D (Manning et al. 2011); physical activity has been shown to attenuate
the effect of fat mass associated (FTO) gene variants on obesity risk (Kilpeläinen et al.
2011). The associated common variants or GEIs detected so far, typically have only small
to modest effects, warranting the need for large sample sizes and collaboration across dif-
ferent study sites for joint or meta-analysis. A number of new loci have been discovered,
as well as existing loci that were initially ambiguous from individual GWAS have been
validated, with high confidence through GWA meta-analysis (GWAMA) (e.g. Zeggini
et al. (2008), Voight et al. (2010), Morris et al. (2012)). Many consortia have been formed
to share individual level data from multiple GWAS of related traits, e.g. the DIAGRAM
(T2D) (Zeggini et al. (2008), Voight et al. (2010), Morris et al. (2012)), MAGIC (glu-
cose and insulin) (Dupuis et al. (2010), Scott et al. (2012)), CHARGE (heart and aging
research) (Psaty et al. 2009), GIANT (anthropometrics) (Speliotes et al. 2010), and Global
Lipids (Teslovich et al. 2010) GWAS consortia. There are also computationally efficient
tools to implement GWAMA (e.g. METAL (Willer et al. 2010)). While the work on the
meta-analysis of marginal genetic association effects on a binary or quantitative trait is
vast, currently there are relatively few papers that explore analytical issues associated with
meta-analysis of GEI (e.g. Manning et al. (2011), Aschard et al. (2011)).
There is a large variety of literature on meta-analytical technique for randomized clin-
ical trials that can be implemented in genetic epidemiology, e.g., the fixed-effects model
(FEM) (Whitehead and Whitehead 1991) and random-effects model (REM) (DerSimo-
nian and Laird 1986). The term FEM in the classical literature (Fleiss 1993) most often
refer to a model with fixed and common or identical effect. In general, a fixed-effects
model only requires that there are fixed and unrelated effects in each study, irrespective of
similarity of these effects across studies. However, one has to be cautious about the sci-
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entific interpretation of a standard inverse-variance weighted (IVW) estimator under the
general fixed-effects model where the corresponding parameters could vary across studies
as opposed to a single common parameters. The REM on the other hand assumes that the
parameters in each study represent random draws from a single mixing distribution. The
parameters of this mixing distribution are fit by available data. The choice of FEM versus
REM depends on whether the population of studies is limited to only the ones presented
in meta-analysis or a larger population of studies from which the current studies are a ran-
domly drawn sample. Even without the common effect assumption, assessment of effect
homogeneity may be desirable in FEM. The most commonly used test of homogeneity is
the Cochran’s Q-test (Cochran 1954). In all our subsequent discussions, we will assume a
common fixed effect model, consider estimation of the corresponding common parameter
and testing the null hypotheses that this common parameter is zero.
The joint analysis of individual patient data (IPD) from all studies is typically regarded
as the ‘gold standard’ for evidence synthesis. However, considerable time and resources
are required to share individual level data even in an existing consortium. We refer to
the joint analysis of IPD as IPD analysis (also called mega-analysis in some papers, e.g.
Lin and Zeng (2010), LZ from now on), and classify the methods that combine summary
statistics derived from analysis of different cohorts as meta-analysis. A natural question
to ask is how much efficiency gain can be achieved by analyzing IPD over meta-analysis.
Recently, LZ had considered a general multivariate inverse-variance weighted (MIVW)
estimator. MIVW estimator was shown to be asymptotically equivalent to the IPD estima-
tor, given that all the common parameters with full covariance matrix under the underlying
FEM are pooled across studies in the MIVW. However, in meta-analysis of published re-
sults, it is often difficult to obtain the full covariance matrix, while univariate summary
statistics (e.g. estimate and standard error) for the effects of interest are in general readily
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available. LZ also characterized and quantified the efficiency loss of using an univariate
IVW (UIVW) versus a MIVW estimator. The results of LZ are in a general setting but
do not target towards interactions. In this chapter, we specifically focus on the estimation
and testing of GEI parameter under a meta-analytic setting, and propose an adaptively
weighted estimator (AWE) that uses univariate summary statistics and achieves the same
asymptotic efficiency as IPD or MIVW estimator.
Another pragmatic question to ask is whether we can detect GEI from summary statis-
tics obtained from previously conducted genome-wide meta-analysis of marginal genetic
effects, without the knowledge of IPD. Meta-regression (MR) is a regression-based tech-
nique to investigate whether some particular study-level covariates explain heterogeneity
among effect estimates from multiple studies. Many studies (e.g., Simmonds and Hig-
gins (2007), SH from now on; Kovalchik (2013)) have compared aggregate data analysis
(e.g. MR) with IPD analysis to detect treatment-covariate interactions for randomized
clinical trials (analogous to gene-environment interactions in our case). SH showed that,
under the three methods of IPD, UIVW and MR, analytical power formula to detect in-
teractions can be expressed in terms of total, within and between study sum of squares
corresponding to the covariate under certain natural assumptions. In absence of IPD, SH
recommended using UIVW versus MR if the within study heterogeneity exceeds between
study heterogeneity in covariates and vice versa. We borrow from their work to derive
similar analytical expressions for testing GEI.
The novel adaptively weighted estimator (AWE), instead of a discrete choice of UIVW
versus MR, combines UIVW and MR to archive the same asymptotic efficiency as the
IPD estimator under certain conditions. The AWE has some advantages over the MIVW
estimator: (1) AWE requires only univariate summary statistics from each study (study-
specific estimate and standard error for the marginal association of G and GEI parameter,
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and study-level mean of E); and (2) when the effect of G or E are uncommon across
studies, or when covariate E is centered (very common in interaction models), MIVW
will lose precision but AWE is robust to these situations.
The rest of the chapter is organized as follows. In the methods section we describe
different strategies for meta-analysis of GEI, followed by analytical results on bias, vari-
ance and power properties of these estimators. A comprehensive simulation study was
performed to assess the performance of the meta-analysis methods under a variety of sce-
narios. We primarily explore the issue of covariate heterogeneity, but also explore sev-
eral other important factors that could potentially affect the relative performance of these
methods: (1) departures from gene-environment (GE) independence; (2) heterogeneity in
minor allele frequencies (MAFs) across cohorts; (3) lack of a common set of confounders
to adjust for in individual studies; (4) misspecification of the genetic susceptibility model
(dominant/co-dominant/additive); and finally (5) the presence of a non-linear form of in-
teraction. In the results section, we report simulation findings followed by an illustrative
example, where we examine whether Single Nucleotide Polymorphisms (SNPs) in FTO
gene modify the effect of environmental factors (age and BMI) on high-density lipopro-
tein cholesterol (HDL-C) levels, a T2D related quantitative trait. We hope this chapter to
provide useful insight and guidelines while conducting meta-analysis of GEI.
4.2 Methods
4.2.1 Detecting GEI via meta-analysis
Consider a quantitative trait Y , a continuous environmental exposureE and a bi-allelic
genetic locus G with genotypes of AA, Aa and aa, where A is the minor allele. Suppose
that there are K independent studies and a total of N participants, with nk participants
in the k-th study, k = 1, ..., K,
∑K
k=1 nk = N . Let Yki, Eki and Gki be the pheno-
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type, environmental exposure and genotype for participant i in study k respectively, for
i = 1, ..., nk, k = 1, ..., K. We consider the possibility of adjusting for demographic co-
variates/confounders Z in the model. The true model for individual responses follows the
FEM
(4.1) Yki = αk+βGGki+βEEki+δGkiEki+β>ZZki+εki, i = 1, ..., nk, k = 1, ..., K,
where αk is the study specific intercept, βG and βE are the main effects corresponding to
the genetic factor and environmental exposure respectively, δ is the GEI effect of interest,
and βZ is the effect of covariates Z. β = (βG, βE, δ,βZ) is assumed to be fixed and
common across studies under model (4.1). We will further discuss certain situations where
the ‘common’ effect assumption can be relaxed in later sections. The random errors εki’s
were assumed as εki ∼ N(0, σ2k). Various susceptibility models including dominant model
(G = 1 if AA and Aa; G = 0 if aa), recessive model (G = 1 if AA; G = 0 if Aa and
aa), additive model (G = 2 if AA; G = 1 if Aa; G = 0 if aa) and co-dominant model
(G = AA,Aa or aa with aa as the reference level) are considered. For co-dominant
models, βG = (βAaG , β
AA
G ) and δ = (δ
Aa, δAA) in model (4.1), corresponding to genotypes
Aa and AA respectively.
We first describe three traditional approaches to detect GEI under model (4.1) but
without Z to simplify the presentation, including IPD analysis, standard meta-analysis
(using UIVW or MIVW), and MR. For the sake of completeness, we also describe REM
meta-analysis as well as a two-step estimator previously suggested by SH. We then propose
an AWE that combines UIVW and MR estimator, which is shown to be an unbiased and
fully efficient estimator as the IPD estimator under certain plausible assumptions, but using
only univariate summary statistics.
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Existing methods
(i) Individual patient data analysis: The IPD analysis fits model (4.1) using the individ-
ual level data. The weighted least square (WLS) method can be used to deal with the




k = 1, ..., K. Let X be the design matrix and Y be the response in model (4.1). The
maximum likelihood estimate (MLE) of δ under linear regression model (4.1) (denote as
δ̂IPD) can be obtained through the corresponding element of (X>X)−1X>Y , and its es-
timated variance v̂(δ̂IPD) can be obtained through the corresponding diagonal element of
(X>X)−1σ̂2. Throughout this chapter, we use the generic notation v(δ̂) for the asymp-
totic model based variance (covariance matrix for multivariate δ̂) of any given estimator
δ̂, and v̂(δ̂) for the corresponding estimated variance. We will present some simplified
expressions for v̂(δ̂) under specific structures ofX>X in section 4.2.2.
(ii) Meta-analysis using inverse-variance weighted estimator: Since the data required
to perform IPD analysis are often not available in published results, meta-analysis that
combines summary statistics from individual studies may be what is practically feasible.
We consider some variants of IVW estimator under the FEM (4.1).
(ii.A) UIVW: A UIVW estimator needs the collection of the MLEs δ̂k and v̂(δ̂k) estimated
from model (4.1) using data from only study k. A FEM assumes that δ̂k
iid∼ N(δ,v(δ̂k)),
where v(δ̂k) is the model based asymptotic variance of δ̂k. Let Xk be the design matrix
andY k be the response of study k. δ̂k and v̂(δ̂k) can be obtained through the corresponding
element of (X>kXk)
−1X>k Y k and (X
>
kXk)
−1σ̂2k respectively. Then the UIVW estimator













The validity of the method requires certain ‘standard condition’, namely: for a large study
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k, δ̂k is asymptotically normal δ̂k
iid∼ N(δ,v(δ̂k)) and the true asymptotic variance v(δ̂k)
can be estimated by v̂(δ̂k) with negligible error (Whitehead and Whitehead 1991). We
refer to the condition as ‘standard’ throughout, and we note that it is often implicitly
assumed to hold in classic meta-analysis literature (e.g., DerSimonian and Laird (1986),
Whitehead and Whitehead (1991), LZ).
(ii.B) MIVW: Let β̂k = (β̂Gk, β̂Ek, δ̂k) be the MLE of β from study k with estimated vari-






















Then δ̂MIVW and v̂(δ̂MIVW) corresponding to the interaction parameter δ can be obtained




) respectively. LZ showed that
δ̂MIVW has full asymptotic efficiency as δ̂IPD under a FEM. However, v̂(β̂k) may be diffi-
cult to acquire in meta-analysis of published results, and δ̂UIVW is the one most commonly
used.
(ii.C) REM: Alternatively, if the set of studies are considered to be a random sample from
the population of studies, one can use a REM assuming δ̂k|δk
iid∼ N(δk,v(δ̂k)), where
δk|δ, τ 2 ∼ N(δ, τ 2) and v(δ̂k) is the same asymptotic variance used in UIVW. Following


















τ̂ 2 + v̂(δ̂k)
}−1]−1
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2 is the Cochran’s Q statistic (Cochran (1954)) used to test homogeneity of δk, i.e.,
H0 : δ1 = δ2 = · · · = δK . Note that, if τ̂ 2 = 0, δ̂REM = δ̂UIVW and v̂(δ̂REM) = v̂(δ̂UIVW).
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(iii) Meta-regression: The IPD model (4.1) implies that the marginal genetic effect de-
pends linearly on E. We consider a linear MR model to reveal the underlying depen-
dence between the marginal genetic effects and the study mean values of E (say mk =∑
iEki/nk). Screening for the marginal effect of G is routinely performed as the first step
in GWA analysis. For each study k, we first consider the marginal genetic association
model
(4.2) Yki = λ0k + λkGki + ηki, i = 1, ..., nk.
where the errors ηki ∼ N(0, σ2ηk). At the second step, the MLE λ̂k is regressed on mk
through the MR model
(4.3) λ̂k = γ0 + γmk + νk, k = 1, ..., K.
Denote v̂(λ̂k) as the model based variance estimated from (4.2). To account for the poten-
tial heterogeneity in v̂(λ̂k) across studies, we consider the WLS estimator of γ (denoted as
δ̂MR) in model (4.3) with weightwk = v̂(λ̂k)−1 assumed as known, i.e., νk ∼ N(0, v̂(λ̂k)).

















The advantage of MR approach is that one can identify GEI with only limited summary
data on E (only the mean mk’s) and published results of marginal genetic effects (λ̂k and
v̂(λ̂k)).
(iv) Two-stage estimator: Let m =
∑
k, i Eki/N denote the overall sample mean of E,
s2E = N
−1∑






2 denote the sample variance of E within the k-th study. Denote the population pa-
rameters for m, mk, s2E , s
2




Ek respectively. We make the usual par-
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tition of the total sum of squares (TSS) of E as the sum of the within-study sum of
squares (WSS) and between-study sum of squares (BSS), i.e., TSS = WSS + BSS,
where TSS =
∑











k nk(mk −m)2. Throughout this chapter, we assume nk/N → rk ∈ (0, 1) as








p→ tss, WSS/N p→ wss, BSS/N p→ bss, as N →∞.
Inspired by our analytical result (shown later in section 4.2.2) that the asymptotic rel-
ative efficiency (ARE) between δ̂MR and δ̂UIVW is bss/wss, we define QE = BSS/WSS
as a statistic for measuring heterogeneity of E between studies relative to the within study
heterogeneity, and consider a two-stage approach
δ̂TS =
 δ̂
UIVW, if QE ≤ 1;
δ̂MR, if QE > 1,
i.e., using δ̂UIVW instead of δ̂MR if WSS ≥ BSS and vice versa. This is an ad-hoc
procedure of discretely determining which method to use. QE is one of the two-stage test
statistics suggested in SH.
Adaptively weighted estimator
We note that, using only summary statistics, both δ̂UIVW and δ̂MR can potentially
lack precision. Moreover, δ̂MR can be subject to significant ecological bias (Morgenstern
(1982), Greenland (1987), Schwartz (1994), Berlin et al. (2002)). Thus, we propose an
adaptive estimator that combines δ̂UIVW and δ̂MR to improve efficiency. We first prove the
following lemma.
Lemma 1. Let Yi be independent random variables with equal variance, for i = 1, ..., n,
and let Xj = (X1j, ..., Xnj)> be the j-th predictor, j = 1, ..., p+ q. Let ζ̂j (j = 1, ..., p)
and θ̂j (j = 1, ..., p+ q) be the MLEs of the parameters under the two nested linear
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regression models
Yi = ζ0 +
p∑
j=1




then ζ̂ = (ζ̂1, ..., ζ̂p) and θ̂2 = (θ̂p+1, ..., θ̂p+q) are asymptotically independent.
Proof of Lemma 1 is presented in Appendix B.3. The notations used in Lemma 1 are
generic and unrelated to the ones defined elsewhere in this chapter. Applying Lemma 1 to
model (4.1) and (4.2), the marginal genetic association λ̂k and GEI δ̂k are asymptotically
independent for each study k, as they are coming from two nested linear regression models.
Note that δ̂UIVW is a linear combination of δ̂k, and that δ̂MR is a linear combination of λ̂k,
then the following corollary holds.
Corollary 4.1. δ̂UIVW and δ̂MR are asymptotically independent.
Borrowing the classic idea of an IVW estimator along with the standard condition, we
propose an AWE of the form
δ̂AWE = {v̂(δ̂UIVW)−1 + v̂(δ̂MR)−1}−1{v̂(δ̂UIVW)−1δ̂UIVW + v̂(δ̂MR)−1δ̂MR},
which combines δ̂UIVW and δ̂MR using the inverse-variances as weights. In order to calcu-
late δ̂AWE, summary statistics of study-specific effect estimates (δ̂k, v̂(δ̂k), λ̂k and v̂(λ̂k))
and study-level covariate means mk are needed from each study k. The intuitive ratio-
nale behind the AWE is that, when v̂(δ̂UIVW) is relatively smaller than v̂(δ̂MR), δ̂AWE puts
more weight on δ̂UIVW and vice versa. The estimated weights can be translated in terms of
the ratio of WSS versus BSS as presented in section 4.2.2. Theorem 4.1 establishes that
with this particular choice of weights, δ̂AWE has the maximal precision within the class of
weighted estimators of the form δ̂AWE(w) = wδ̂UIVW + (1− w)δ̂MR, 0 ≤ w ≤ 1.
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Theorem 4.1. For the class of weighted estimators δ̂AWE(w) = wδ̂UIVW + (1− w)δ̂MR,
0 ≤ w ≤ 1, v(δ̂AWE(w))−1 attains its maximum at v(δ̂UIVW)−1 + v(δ̂MR)−1 if and only if
the weight w = v(δ̂MR)/{v(δ̂UIVW) + v(δ̂MR)}.
Proof of Theorem 4.1 is presented in Appendix B.3. A consequence of Theorem 4.1 is that
the precision of δ̂AWE is the sum of the precisions of δ̂UIVW and δ̂MR. Under the standard
condition, v̂(δ̂AWE)−1 = v̂(δ̂UIVW)−1 + v̂(δ̂MR)−1. We will further show that δ̂AWE is fully
efficient as δ̂IPD under certain natural assumptions described in section 4.2.2.
Remark 4.1: Co-dominant model. For the co-dominant model that δ = (δAa, δAA), it is


















−1}−1; δ̂MIVW and v̂(δ̂MIVW)




); MR model can be modified as a multi-





N(0, v̂(λ̂k)). Corollary 4.1 and Theorem 4.1 also hold following Lemma 1 for bivariate

















This section shows the analytical results regarding bias, variance and power to provide
theoretical support for the proposed methods described in section 4.2.1.
Bias
Following classic linear regression and meta-analysis results, δ̂IPD, δ̂UIVW, δ̂REM and
δ̂MIVW are all asymptotically unbiased estimators of δ. However, δ̂MR is not necessarily
unbiased for δ in general. The relationship between the marginal effect of G and the
study-specific meansmk may differ from the underlying relationship between the marginal
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effect of G and individual level data for E. This phenomenon was termed as ‘ecological
bias’ or ‘ecological fallacy’, and well characterized in the literature (Morgenstern (1982),
Greenland (1987), Schwartz (1994)). However, we note that δ̂MR is an unbiased estimator
of δ under the following GE independence assumption. We use the generic notation P (·)
to denote the distribution of a random variable.
Assumption 4.1. P (G,E| study = k) = P (G| study = k)P (E| study = k), for
k = 1, ..., K, i.e., G and E are independent within each study.
Proposition 4.1. Under assumption 4.1, δ̂MR of model (4.3) is asymptotically unbiased
for δ.
Proof of Proposition 4.1 is presented in Appendix B.3. Proposition 4.1 holds for dominant,
recessive, additive and co-dominant genetic susceptibility models. If the independence as-
sumption is relaxed, a slightly more complex MR model can lead to an unbiased estimator
of δ under each susceptibility model (shown in Appendix B.3). Our simulation study
shows that the bias of δ̂MR is not to a level of practical concern under the current setting of
a linear interaction betweenG and continuousE, even when there is evidence of departure
from GE independence. Therefore, we focus on model (4.3) in order to demonstrate our
results under a global and simple MR model for all the susceptibility models regardless of
GE dependence.
Remark 4.2: Bias of δ̂MR in terms of tss/bss. Without assumption 4.1, we showed (un-
der certain assumptions in Appendix B.3) that the limiting value of the bias of δ̂MR is
proportional to the ratio tss/bss and the correlation between G and E. If the correlations
within each study is 0, then E(δ̂MR)− δ p→ 0. If assumption 4.1 holds, δ̂AWE is an asymp-
totically unbiased estimator of δ under the standard condition, as both components are
unbiased. Moreover, we showed later that the limiting value of the weight corresponding
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to δ̂MR in δ̂AWE is bss/tss. So δ̂AWE adaptively puts less weight on δ̂MR when the bias of
δ̂MR increases.
Variance
Explicit variance formulae v̂(δ̂) as well as the corresponding asymptotic variance v(δ̂)
for each estimator was derived under GE independence assumption (shown in Appendix
B.3). Because the simple linear regression likelihood
∏
k,i P (Yki|Gki, Eki) corresponding
to model (4.1) does not use any assumptions about the joint stochastic distribution of G
and E, the role of the GE independence assumption in this chapter is only to provide the
explicit variance expression. This is different from case-control studies where assuming
GE independence and using the retrospective likelihood leads to huge gain in efficiency
(Piegorsch et al. (1994), Umbach and Weinberg (1997), Chatterjee and Carroll (2005)).
In this section, we assume σ2k = σ
2 for k = 1, ..., K, and consider a dominant sus-
ceptibility model for stating Theorems 4.2 and 4.3. We discuss extension to additive and
co-dominant models later in this section. Let G = 1 (G = 0) indicate whether an individ-
ual is a carrier (non-carrier) of the minor allele A, and let pk denote P (G = 1| study = k)
the carrier frequencies in study k, k = 1, · · · , K.
Theorem 4.2. Under assumption 4.1,
v(δ̂IPD)−1 ≥ v(δ̂UIVW)−1 + v(δ̂MR)−1 = v(δ̂AWE)−1. The equality holds if and only if
pk = p, for k = 1, 2, ..., K, where p is the common carrier frequencies across all studies.
Proof of Theorem 4.2 is shown in Appendix B.3. Under assumption 4.1, the precision of
δ̂IPD is in general greater than that of δ̂AWE. However, under the additional assumption of
homogeneity of the MAFs, we have v(δ̂IPD) = v(δ̂AWE). We call this assumption 4.2.
Assumption 4.2. The MAFs corresponding to the susceptible SNP are constant across all
studies, i.e. pk = p, for k = 1, 2, ..., K.
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Theorem 4.3. Under assumptions 4.1 and 4.2,
v(δ̂IPD)−1 = v(δ̂AWE)−1 = v(δ̂UIVW)−1 + v(δ̂MR)−1, where
v(δ̂UIVW) = {Np(1− p)wss}−1σ2, v(δ̂MR) = {Np(1− p)bss}−1σ2 and
v(δ̂IPD) = v(δ̂AWE) = {Np(1− p)tss}−1σ2.
Proof of Theorem 4.3 is shown in Appendix B.3. Following Theorem 4.3, the asymp-
totic model based variances v(δ̂IPD),v(δ̂UIVW), v(δ̂MR) and v(δ̂AWE) are all translated in
terms of covariate heterogeneity of E. ARE between δ̂UIVW (δ̂MR) and δ̂IPD is wss/tss
(bss/tss). v(δ̂UIVW) ≤ v(δ̂MR), if wss ≥ bss, and vice versa. For the extreme case,
when there is no between-study heterogeneity in the study means of E (i.e. µk = µ),
v(δ̂UIVW) = v(δ̂IPD); in contrast, if all σ2Ek = 0 (i.e. E is constant within each study),
v(δ̂MR) = v(δ̂IPD). This result is consistent with LZ, as their equality condition for
v(δ̂UIVW) = v(δ̂IPD) reduces to µk = µ in our case.
The limiting weight of δ̂AWE can be simplified asw = v(δ̂MR)/{v(δ̂UIVW)+v(δ̂MR)} =
bss−1/{wss−1 + bss−1} = wss/tss. Since WSS/TSS p→ wss/tss and BSS/TSS p→
bss/tss, as N → ∞, we can use the estimated weights WSS/TSS and BSS/TSS in








δ̂AWE adaptively captured the precision trade-off between the two estimators: δ̂AWE puts
more weight on δ̂UIVW if WSS is relatively larger than BSS, and vice versa. In summary,
under assumptions 4.1 and 4.2, δ̂AWE is consistent, unbiased, and asymptotically fully ef-
ficient estimator, which uses only univariate summary statistics without the knowledge of
the original IPD. The operating characteristics for the proposed meta-analytic methods are
summarized in Table 4.1. When assumption 4.1 or 4.2 is relaxed, the statements in Theo-
rems 4.2 and 4.3 are numerically evaluated through a comprehensive simulation study.
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Remark 4.3: Additive and co-dominant models. Following LZ, asymptotically v̂(δ̂UIVW) ≥
v̂(δ̂IPD) = v̂(δ̂MIVW). One sufficient condition for the equality is mk = m, i.e., when δ̂MR
undefined. In general, we have difficulties to show the analytical results of δ̂AWE in The-
orems 4.2 and 4.3 for additive and co-dominant models, though we can directly translate
Theorems 4.2 and 4.3 for δAa and δAA respectively under a co-dominant model if we use
diag(v̂(λ̂Aak ), v̂(λ̂
AA
k )) for v̂(λ̂k) in the MR model, i.e., two separated MRs. The state-
ments in Theorems 4.2 and 4.3 are numerically evaluated for additive and co-dominant
models through comprehensive simulation studies with/without assumption 4.1 and 4.2.
Remark 4.4: Centering of covariate E. Centering is often made for continuous E to fa-
cilitate the interpretation of βG as the main effect of G at the mean value of E. Under a
meta-analysis set-up, it is natural to consider each study k has E centered at study specific









ki + εki, i = 1, ..., nk,
where E ′ki = Eki − mk. When the IPD are available, it is natural to consider that E is
centered at the overall mean m (an IPD analysis using data centered at study mean mk










εki, i = 1, ..., nk, k = 1, ..., K, where E?ki = Eki − m. In this new parametrization,
we have (β′E, δ




?) = (βE, δ) and β?G = βG + mδ
?. It is clear that δ̂IPD, δ̂UIVW, δ̂REM, δ̂MR
and δ̂AWE remain invariant with centered E since δ′ = δ? = δ. Thus, results anal-
ogous to Theorems 4.1-4.3 concerning δ̂IPD, δ̂UIVW, δ̂MR and δ̂AWE also hold for the
centered models. However, results corresponding to δ̂MIVW need to be modified. De-
note δ̂MIVW′ as the MIVW estimator obtained by pooling (β′Gk, β
′
E, δ
′) with 3×3 covari-
ance matrix and denote δ̂MIVW2′ as the MIVW estimator obtained by pooling the two
common effects (β′E, δ
′) with 2×2 covariance matrix from the centered model. We can
show that v(δ̂UIVW) ≥ v(δ̂MIVW2′) = v(δ̂MIVW′) ≥ v(δ̂IPD) (in Appendix B.3). These
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results are consistent with LZ, as the true model has three common fixed-effects and
there is efficiency loss by pooling a subset of the common parameters. For the centered
model, the MIVW estimator is not fully efficient. A solution is to consider an alterna-
tive AWE as δ̂AWE2′ = {v(δ̂MR)δ̂MIVW2′ + v(δ̂MIVW2′)δ̂MR}/{v(δ̂MIVW2′) + v(δ̂MR)}.
Under assumption 4.1, we have (shown in Appendix B.3) v(δ̂IPD)−1 = v(δ̂AWE2′)−1 =
v(δ̂MIVW2
′
)−1 + v(δ̂MR)−1 ≥ v(δ̂UIVW)−1 + v(δ̂MR)−1 = v(δ̂AWE)−1. The equality holds
if and only if pk = p, for k = 1, 2, ..., K. So δ̂AWE2
′ is fully efficient under assumption
4.1.
Remark 4.5: Fixed and uncommon parameters (βGk, βEk). When the uncommon param-
eters (βGk, βEk) and a common δ are considered in the true IPD model (4.1), it is clear that
results regarding UIVW and MR still hold as they focus only on the common parameter
δ (MR model (4.3) needs to be changed as λ̂k = γ0k + γmk + νk). However, according
to discussion in Remark 4.4, δ̂MIVW would lose precision since (βGk, βEk) are uncom-
mon across studies. Actually, v(δ̂MIVW) = v(δ̂UIVW) in this case. Moreover, we have
v(δ̂AWE) < v(δ̂MIVW) since δ̂AWE has the sum of the precision of δ̂UIVW and δ̂MR, when
the effect of G or E are uncommon across studies.
Power
For dominant and additive models, we consider the Wald-type test statistic T = v̂(δ̂)−
1
2 δ̂
for testing the null hypothesis H0: δ = 0 against H1: δ 6= 0. The power to detect an effect







where Φ is the cumulative distribution function (CDF) of a standard normal variable z and
zα
2
is the corresponding α
2
th upper percentile. For co-dominant models, we consider a
joint Wald test statistic T = δ̂
>
v̂(δ̂)−1δ̂
H0∼ χ22 for testing H0: δ = 0 against H1: δ 6= 0,
where χ22 is a Chi-square distribution with two degrees of freedom. The power is ap-
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proximately Pw(δ̂, δ∗) = 1 − Φχ22(χ
2
2,α − δ∗>v̂(δ̂)−1δ∗), where Φχ22 is the CDF for a χ
2
2
distributed random variable and χ22,α is the corresponding α th upper percentile.
The power function Pw(δ̂, δ∗) for a given δ∗, or simply Pw(δ̂), is strict decreasing
function of the variance v̂(δ̂). Thus, the results regarding variances in Theorems 4.1-4.3
can be directly translated in terms of power.
4.3 A simulation study
In the simulation study, we considered a continuousE and a bi-allelicGwith genotype
of AA, Aa and aa. In order to study the role of GE independence (assumption 4.1) and
homogeneity in MAFs across cohorts (assumption 4.2), we considered P (G,E) under
four different settings, which reflect (a) both assumptions 4.1 and 4.2 hold; (b) assumption
4.1 holds but not 4.2; (c) assumption 4.2 holds but not 1; (d) neither assumption 4.1 nor
2 holds. To study the role of covariate heterogeneity in E, we considered both cases that
wss is greater or smaller than bss for a fixed value of tss. The details of generating the
gene environment data pair (Gki, Eki) for the i-th subject in the k-th study are described
in Appendix B.3. Given (Gki, Eki), we generated the continuous trait Yki under the IPD
model (4.1), where the study specific intercepts were sampled from αk
iid∼ U(1.3, 1.5),
the true effect sizes (β∗E, β
∗
G, δ
∗) are determined such that E, G and GEI explain 10%,
1% and 0-1% of the total variation in Y respectively, in terms of partial R2. The random
residuals follow a N(0, σ2k) distribution. The choice of σ
2
k leads to a marginal distribution
of Y ∼ N(1.4, 0.42). The choice of U(1.3, 1.5) and N(1.4, 0.42) are motivated by the
distribution of HDL-C (mmol/l) in our T2D data set. We generated K = 20 studies
with different sample sizes involving a total of N = 10, 000 participants (nk = 200, for
k = 1, ..., 6; nk = 400, for k = 7, ..., 11; nk = 500, for k = 12, ..., 17; n18 = 800;
n19 = 1000; n20 = 2000).
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We calculated δ̂ and v̂(δ̂) corresponding to each proposed estimator, including δ̂IPD,
δ̂UIVW, δ̂REM, δ̂MIVW, δ̂MR, δ̂TS and δ̂AWE. We carried out R = 1, 000 replications under
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and power (the proportion of simulations that reject the null hypothesis using the Wald test
for H0 : δ = 0). When the data is generated under the null, this proportion reduces to an
empirical estimate of the Type-I error.
Lack of common set of confounders to adjust in each study: We then considered the
situation where there exists additional explanatory variables Z in the true IPD model
Yki = αk + βGGki + βEEki + δGkiEki + β
>
ZZki + εki. We consider Z = (Z
1, Z2, Z3)
mimicking typical covariates like (age, gender, race). In particular, age (Z1) is continu-
ous and associated with E, gender (Z2) is binary and independent of both (G,E), race
(Z3) is a 3-level categorical variable and associated with both (G,E), and the true effect
size β∗Z is determined such that the Type-III partial R
2 corresponding to (Z1, Z2, Z3) is
(2%, 1%, 1%) respectively. Let Zk be the set of covariates for the k-th study. We con-
sider an analysis where Zk is only partially available from individual studies, and refer to
















k = 7, 8, 9; Zk = (Z2k , Z
3
k) for k = 10, 11, 12; Zk = Z
1
k for k = 13, 14; Zk = Z
2
k for
k = 15, 16; Zk = Z3k for k = 17, 18; No Zk for k = 19, 20. For IPD analysis without
any imputation of covariates, one can only obtain an IPD estimator based on the common
subset of variables available across all studies, which reduces to an unadjusted model in
our setting. We considered it as a naive IPD estimator (δ̂NIPD), and compared it to the
true gold standard IPD estimator (δ̂IPD) as well as to the other estimators. For the meta-
85
analysis, we obtained δ̂UIVW, δ̂MIVW and δ̂REM from the k-th study model adjusted for
Zk, for k = 1, ..., K. For MR, we adjusted Zk at the first stage in the marginal genetic
association model, and regressed the MLEs of adjusted effects of G on mk.
Non-linear GEI model: We consider a non-linear GEI model where the phenotype-genotype
association parameter βG(E) varies withE through a sigmoid function βG(E) = 2 exp(E − 50)
/{1 + exp(E − 50)} + 2, as shown in Figure 4.1. In this case, βG(E) changes at differ-
ent rates on different ranges of E (sharper around the mean value of E but relatively flat
at more extreme values of E), which leads to non-linear interaction. In Figure 4.1, most
studies only contribute to a restricted range of E, leading to heterogeneity of individual
interaction estimates across studies. In this case, meta-analysis with a misspecified linear
interaction model might fail to detect interaction. In the simulation study, we generated
K = 20 studies, where 4 studies have relatively larger within study variability (studies
5, 10, 11, 15 in Figures 4.1 and 4.2) as compared to the other 16 studies. The complete
description of nk, mk and σEk for the 20 studies are given in Figures 4.1 and 4.2. We
generated Y through the non-linear interaction model Yki = αk+βG(Eki)Gki+εki, where
εki
iid∼ N(0, σ2k). The within study relationship βG(E) are substantially different across
studies. The effect heterogeneity and non-linearity might influence the relative perfor-
mance of the proposed methods where a linear form of interaction is assumed. Therefore,
we evaluated the robustness of the proposed meta-analysis estimators under this non-linear
GEI model.
Simulation results
Comparison of methods: The relative performances of the methods are very similar
across all susceptibility models and under all four settings, among which we only present
the most general setting (d), where the data are generated without either assumption 4.1
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or 2. In the main text, we compare the proposed methods in terms of power using the
Wald test. In Figure 4.3, we observed three groups among the proposed methods: IPD,
UIVW, REM, MIVW, MR, TS and AWE. Group 1: IPD, MIVW and AWE; group 2:
UIVW, REM; group 3: MR. As expected, group 1 has the most powerful tests, which is
consistent with LZ and our analytical results; group 2 is more powerful than group 3 if
QE < 1, and vice versa. TS performs similarly as the better group between groups 2 and
3. Pw(δ̂UIVW) is slightly greater than Pw(δ̂REM) since the underlying model is FEM. The
empirical estimates of Type-I error are close to the true 0.05 level for all tests under all
three susceptibility models and all four settings. Power curves under settings (a)-(c) are
given in Appendix A.3, where similar results were shown. Additional simulation results
for RB, MV, EV and MSE are given in the Appendix A.3.
Covariate heterogeneity in E: We observed that the ARE between δ̂UIVW (δ̂MR) and δ̂IPD
can be well characterized in terms ofwss/tss (bss/tss) respectively. We found that δ̂UIVW
was more efficient than δ̂MR if wss > bss, and vice versa. The precision trade-off is
captured well by the adaptively determined weights in δ̂AWE. We observed that δ̂AWE is
more efficient than the usual meta-analytic estimators δ̂UIVW, δ̂REM, δ̂MR or δ̂TS, and had
almost the same efficiency as δ̂IPD and δ̂MIVW under all three susceptibility models and all
four settings. The findings are consistent with LZ and our analytical results in Theorems
4.2 and 4.3.
Gene-environment independence: Comparing settings (a) to (c) (or alternatively com-
paring settings (b) to (d)), where the only difference is the dependence between G and E,
we observed no substantial difference in RB for all of the proposed estimators, including
the potentially biased estimators δ̂MR and δ̂AWE. When assumption 4.1 is relaxed (settings
(c) and (d)), the magnitude of bias of δ̂MR (up to ±3%) and δ̂AWE (up to ±2%) is not
yet to a level of practical concern compared to the Monte Carlo error (up to ±3% even
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for the unbiased estimators). For variance, we did not observe precision gain by making
the GE independence assumption as expected. When assumption 4.1 is relaxed, results in
Theorem 4.2 hold numerically for all three genetic susceptibility models.
Homogeneity in allele frequencies across cohorts: Comparing settings (a) to (b) (or al-
ternatively comparing settings (c) to (d)), we did not observe precision gain when the MAF
is homogeneous across studies (settings (a) and (c)). When assumption 4.2 is relaxed, re-
sults in Theorem 4.3 hold numerically for all three genetic susceptibility models.
Lack of common set of confounders to adjust in each study: Figure 4.4 shows the power
curves under this situation without either assumption 4.1 or 2. Compared to the basic set-
ting without covariate adjustment (Figure 4.3), there is no substantial difference in the
relative performances of testing among these methods. We observed that the GEI estimate
δ̂ and variance v̂(δ̂) was fairly unchanged, though the main effects of β̂G and β̂E were
substantially influenced under this situation. VanderWeele et al. (2012) also showed sim-
ilar results that, under GE independence, there is no effect of unmeasured environmental
confounding on the GEI parameter; and that if G and E are dependent, the environmental
confounding needs to be very strong to incur substantial bias in GEI. Power curves under
settings (a)-(c) are given in Appendix A.3, where similar results were shown.
Misspecification of the genetic susceptibility model: We examined the power under mis-
specified susceptibility models (dominant/additive), where the true generating model is
co-dominant. When δAA = 1.5δAa (we accordingly choose βAAG = 1.5β
Aa
G ), i.e., the sec-
ond copy of A has an effect size between the two assumed in dominant (δAA = δAa) and
additive (δAA = 2δAa) models, there is no substantial difference of power between the
misspecified dominant/additive model and co-dominant model (shown in Appendix A.3),
because the misspecification is not strong and the fitted dominant or additive models used
one less parameter. When δAA = −δAa (we accordingly choose βAAG = −βAaG ), i.e., the
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second copy of A has a reverse effect, the fitted dominant or additive models had much
less power than the co-dominant model (shown in Figures 4.5). Thus, it could happen that
the co-dominant model has more power compared to other simpler models, though it uses
two additional parameters for capturing GEI.
Non-linear GEI model: When the IPD were generated under the non-linear GEI model,
the power to detect GEI from individual studies were very low (< 0.25), except study
10 where the sample size n10, effect size (depends on E) and variance σ2E10 are all rela-
tively greater than the other studies (Figure 4.2). In Table 4.2, Pw(δ̂IPD), Pw(δ̂MIVW) and
Pw(δ̂
AWE) show the highest powers. Pw(δ̂MIVW) is close to Pw(δ̂IPD) because the model
based standard errors of δ̂IPD and δ̂MIVW are asymptotically the same. Because most of
the 20 studies were unable to represent the true non-linear GEI, especially those with very
short range ofE, the non-linearity of GEI lead δ̂UIVW and δ̂REM to be low. In this particular
example, we observed that Pw(δ̂MR) is greater than Pw(δ̂UIVW). Instead of choosing alter-
natively between δ̂UIVW and δ̂MR, we can use δ̂AWE as the default meta-analytic estimator.
The relative performance of δ̂AWE is close to δ̂IPD. This is a practically noteworthy finding
as a linear interaction model is typically the initial screening tool, and the AWE is able
to pick up signals under model misspecification that univariate meta-analysis methods can
not.
Alternatively, one can consider a stratified analysis where the 3 strata consist of study k
withmk falling into the three intervalsmk ≤ 48, 48 < mk < 52 and 52 ≤ mk respectively
such that the value of GEI is close within each stratum (refer to Figure 4.1). Then δ̂UIVW
was used for meta-analysis of GEI within each stratum. We observed a power of 0.80 for
stratum (48, 52), and only around 0.15 for the other two strata. The Wald test of δ̂UIVW
were still powerful around the mean value of E but lack of power at more extreme values
of E.
89
4.4 Application: Data analysis for a set of studies investigating type 2
diabetes
The proposed methods were applied to a set of studies investigating T2D, including
8 European cohorts: D2D2007, DIAGEN, DPS, FUSION FSIGT, FUSION S2, HUNT,
METSIM and TROMSO. A number of SNPs in the FTO gene region (16q12.2) have pre-
viously been identified to be associated with T2D and BMI in the DIAGRAM consortium
(Zeggini et al. (2008), Voight et al. (2010)). Variants at FTO are known to influence T2D
predisposition through an effect on BMI (Freathy et al. (2008), Voight et al. (2010)). Age,
BMI and gender are all known risk factors for T2D and a T2D related quantitative trait
HDL-C (Scott et al. (2012), Morris et al. (2012)). In this chapter, we investigated whether
SNPs in FTO gene modifies the effect of environmental factors (e.g. age and BMI) on
HDL-C. No association between SNPs in FTO and HDL-C or SNP×BMI interaction on
HDL-C has ever been noted.
Among the 8 cohorts, the T2D patients were identified by the glucose tolerance cate-
gory (fasting glucose≥ 7.0 mmol/l or two-hour glucose≥ 11.1 mmol/l). We genotyped
all the T2D patients and portions of non-T2D participants under budget allowance. Thus,
T2D patients were over sampled in the genotyped data set as compared to the overall co-
horts. The descriptive summary statistics for the genotyped data sets from the 8 cohorts
are shown in Table 4.3. We have a total of N = 11, 729 genotyped participants who have
HDL-C levels available, with sample sizes nk ranging between 172 and 2,730. Since the
SNPs in the FTO gene we examined (10 strongest SNPs associated with T2D/obesity/BMI
that listed on the National Human Genome Research Institute (NHGRI) GWAS catalog)
are in high linkage disequilibrium and show very similar results. Thus, we present our
results for one representative SNP, rs1121980, only. The SNP follows Hardy-Weinberg
equilibrium (HWE), and no imputation was needed as the missing genotype proportion
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is < 0.1%. The MAF of rs1121980 ranges 0.40-0.49 across cohorts, as an evidence for
supporting assumption 4.2. In Table 4.3, the mean age ranges from 56-69 (years) except
FUSION FSIGT cohort (mean age=39). FUSION FSIGT cohort appears younger because
either spouse or offspring of T2D sibpairs were selected as a follow-up to the FUSION
study. The mean BMI ranges from 26-28 (kg/m2) except the DPS cohort (mean BMI=31),
because the DPS cohort has an inclusion criterion requiring all subjects have BMI> 25 at
baseline. Thus, the covariate heterogeneity of E are small, with BSSage/TSSage = 14%
and BSSBMI/TSSBMI = 2% respectively. The two ‘outlier’ cohorts both have only very
small sample sizes compared to the other studies, so their influence on UIVW and MIVW
should be small. However, the influence on MR could be very substantial due to a small
number of studies.
Analysis Model: The IPD model we fitted is given by
log(HDL-Cki) = αk + βGGki + δGki×Eki
+ βageageki + βBMIBMIki + βgendergenderki + εki,(4.4)
for k = 1, ..., 8; i = 1, ..., nk. In model (4.4), SNP rs1121980 was used for G; BMI or
age was considered as E in two separate models for rs1121980×BMI and rs1121980×age
interactions respectively; HDL-C was log-transformed in order to reduce the skewness of
its distribution. The proposed methods, including IPD, UIVW, REM, MIVW (MIVW2’),
MR, TS and AWE (AWE2’), were implemented and compared. GE independence does not
appear to hold for rs1121980×BMI analysis (Spearman correlations across studies were
reported in Table 4.3). This is expected as FTO is an obesity related gene. GE indepen-
dence appears to hold for rs1121980×age (Table 4.3). We also considered adjusting for
the T2D status in model (4.4). Since the results are very similar, we only show the results
corresponding to model (4.4) for demonstration purpose.
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Results: Figure 4.6 shows the forest plots of estimated GEI from individual cohorts (δ̂k)
as well as the combined estimates using joint or meta-analysis. The corresponding nu-
merical results were provided in Table 4.4. There was no evidence of effect heterogene-
ity for both rs1121980×BMI (P = 0.59) and rs1121980×age (P = 0.81) interaction
based on Cochran’s Q test, and UIVW and REM showed similar results. We observed
that, under rs1121980×BMI model, v̂(δ̂IPD)/v̂(δ̂UIVW) is 0.94; v̂(δ̂IPD)/v̂(δ̂MIVW) is
0.95; v̂(δ̂IPD)/v̂(δ̂AWE) is 0.98. Under rs1121980×age model, v̂(δ̂IPD)/v̂(δ̂UIVW) is 0.75;
v̂(δ̂IPD)/v̂(δ̂MIVW) is 0.90; v̂(δ̂IPD)/v̂(δ̂AWE) is 0.98. These ratios were potentially de-
termined by the covariate heterogeneity of E. All these meta-analytical methods UIVW,
REM, MIVW (MIVW2′) and AWE (AWE2′) showed very similar results as IPD, espe-
cially for rs1121980×BMI interaction. The marginal SNP effects of rs1121980 against
mean covariate values of age and BMI across cohorts are shown in Appendix A.3. MR
was very sensitive to outliers when the number of cohorts was small (K=8), and showed
quite different results from the other methods due to outliers (Table 4.4). MR also lacked
efficiency for a small K and small ratio BSS/WSS. δ̂AWE was robust to the bias from
δ̂MR since it only assigned weight v̂(δ̂MR)−1/{v̂(δ̂UIVW)−1 + v̂(δ̂MR)−1} = 0.04 on δ̂MR.
This is further evidence that δ̂AWE can data adaptively shrink to the ‘better’ estimator.
Moreover, δ̂AWE showed almost full efficiency as compared to δ̂IPD.
In the model that drops the interaction term in (4.4), no significant marginal effect of
rs1121980 was found (at 0.05 level) after adjusting for the risk factors of age, gender and
BMI. It is expected since SNPs in FTO are known to influence T2D predisposition through
the effect on BMI. These risk factors themselves were strongly significant. Mean HDL-C
level decreased by: 0.10% (95% CI: (0.05, 0.14)%) for 1 year increase in age; 1.65% (95%
CI: (1.56, 1.75)%) for a 1 kg/m2 increase in BMI; 20.0% (95% CI: (18.7, 21.1)%) from
female to male, conditional on the other risk factors in the model.
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In our interaction model (4.4), positive rs1121980×BMI interactions were found under
all proposed methods (except MR) in Table 4.4, with P-values range from 0.005 to 0.007
(for additive model). In particular, the estimates obtained from model (4.4) when con-
verted in terms of percentage change in actual HDL-C levels, indicated that: with 1 kg/m2
increase in BMI, (1) under additive model, on average HDL-C level decreased by 1.73%
(95% CI: (1.57, 1.90)%) given rs1121980=GG, by 1.54% (95% CI: (1.44, 1.64)%) given
rs1121980=AG or GA; and by 1.35% (95% CI: (1.17, 1.53)%) given rs1121980=AA; (2)
under co-dominant model, HDL-C level decreased by 1.70% (95% CI: (1.51, 1.88)%)
given rs1121980=GG, by 1.58% (95% CI: (1.44, 1.72)%) given rs1121980=AG or GA;
and by 1.31% (95% CI: (1.10, 1.53)%) given rs1121980=AA. The results under addi-
tive and co-dominant models were very close. The trend of the effects of BMI among
the three groups defined by rs1121980 indicated that the presence of minor allele A in
rs1121980 attenuated the negative association between BMI and HDL-C. We did not find
similar rs1121980×BMI interaction effect on other lipid traits related to T2D, including
low-density lipoprotein cholesterol (LDL-C), total cholesterol and LDL-C/HDL-C ratio
(P-value = 0.08).
4.5 Discussion
In this chapter, we proposed and compared a set of meta-analysis approaches for ana-
lyzing GEI. We showed the proposed AWE, as a combination of meta-analysis and meta-
regression estimators, performed better than alternatively choosing between the two esti-
mators in terms of precision and power. We showed that the precision trade-off between
the two components in AWE depends on the covariate heterogeneity of E, and that the
weights in AWE can adaptively capture this trade-off. The resulting AWE retains full ef-
ficiency of the ‘gold standard’ joint analysis using IPD under certain natural assumptions.
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We suggest to use AWE as a default choice for the meta-analysis of GEI based on sum-
mary data. We studied several key features that could potentially influence the efficiency
and power for meta-analysis of GEI, and hoped to provide useful insight and guidelines
for such studies. The features included: (1) departures from GE independence; (2) hetero-
geneity in MAFs across cohorts; (3) lack of a common set of confounders to adjust for in
individual studies; (4) misspecification of the genetic susceptibility model (dominant/co-
dominant/additive); and (5) the presence of a non-linear form of interaction. Under all the
above situations, we found the relative performance of AWE is close to IPD estimator. We
especially would like to point out the simulation findings under the non-linear interaction
model setting, where standard meta-analytical technique failed and the AWE was able to
capture the lost efficiency based on the summary data. We also reported some evidence
for GEI between rs1121980 and BMI on HDL-C levels.
We have mainly focused on quantitative traits with an underlying FEM. The potential
limitation is that the results might not be able to directly translate to dichotomous traits
under a case-control design, where assuming GE independence leads to huge gain in ef-
ficiency (Piegorsch et al. (1994), Umbach and Weinberg (1997), Chatterjee and Carroll
(2005)). We plan to extend our methods using a retrospective likelihood framework under
a case-control design. Investigating the results under a truly random effects meta-analysis
model is another possible extension to our work.
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Figure 4.1: Non-linear GEI model: the (red) sigmoid curve shows the true relationship
between Y -G association and E, βG(E) = 2 exp(E − 50)/{1 + exp(E −
50)} + 2; the boxplots show the covariate heterogeneity of E across studies
where the dots show the corresponding means.
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Figure 4.2: Non-linear GEI model: the barchart shows the power to detect GEI across
individual studies; the (green) curve shows the value of the true non-linear
GEI; the top panel shows the sample sizes nk and the within study standard

































































































































Figure 4.3: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study, where no assumption of G-E independence or ho-
mogeneity in allele frequencies is assumed.






































Figure 4.4: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study (for the situation of lack of common set of con-
founders to adjust), where no assumption of gene-environment independence
or homogeneity in allele frequencies is assumed.








































Figure 4.5: Power curves under misspecified susceptibility models (dominant/additive),
where the generating co-dominant model has δAA=−δAa, and no assumption
of gene-environment independence or homogeneity in allele frequencies is as-
sumed.






































Figure 4.6: Forest plots showing the estimated gene-environment interactions (under ad-
ditive model of rs1121980) across the 8 European cohorts, as well as the
combined estimates through meta-analysis. [IPD: individual patient data;
UIVW: univariate inverse-variance weighted estimator; REM: random ef-
fect model; MIVW: multivariate inverse-variance weighted estimator pool-
ing (βG, βE, δ); MIVW2′: MIVW estimator pooling (β′E, δ
′) under a centered
model; AWE: adaptively weighted estimator combining UIVW and Meta-
regression; AWE2′: AWE combining MIVW2′ and Meta-regression.]
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Table 4.1: Operating characteristics for the meta-analysis of GEI. [IPD: individual patient
data analysis; UIVW: univariate inverse-variance weighted estimator; MIVW:
multivariate inverse-variance weighted estimator; MR: Meta-regression; AWE:
adaptively weighted estimator.]
Methods Data shared Bias AREa
IPD individual level data unbiased 1
UIVW δ̂k, v̂(δ̂k) unbiased wss/tss
MIVW β̂k, v̂(β̂k) unbiased 1
MR λ̂k, v̂(λ̂k) and mk unbiased under assumption
4.1 ecological bias in gen-
eral
bss/tss
AWE δ̂k, v̂(δ̂k), λ̂k, v̂(λ̂k) and mk unbiased under assumption
4.1 bias adaptively con-
trolled
1
a ARE: asymptotic relative efficiency as compared to δ̂IPD under assumptions 1
and 2.
Table 4.2: Comparison of methods in terms of estimate, variance and power, under a
simulation study of non-linear GEI. [IPD: individual patient data; UIVW:
univariate inverse-variance weighted estimator; REM: random effect model;
MIVW: multivariate inverse-variance weighted estimator pooling (βG, βE, δ);
MIVW2′: MIVW estimator pooling (β′E, δ
′) under a centered model; MR:
Meta-regression; AWE: adaptively weighted estimator combining UIVW and
MR; AWE2′: AWE combining MIVW2′ and MR; TS: two-stage approach.]
Methods Estimate SEa Power
IPD 0.21 0.045 0.98
UIVW 0.18 0.070 0.69
REM 0.19 0.076 0.67
MIVW2′ 0.18 0.070 0.73
MIVW 0.21 0.045 0.98
MR 0.23 0.060 0.82
AWE 0.21 0.045 0.98
AWE2′ 0.21 0.045 0.98
TS 0.85
a SE: standard error.
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Table 4.3: Summary statistics for the genotyped data set from the 8 European cohorts.
HDL-C (mmol/l) rs1121980 Age (year) BMI (kg/m2) Gender SNP*Age SNP*BMI
Cohorts N Mean (SD) MAFa Mean (SDa) Mean (SD) Female (%) Corr (P)b Corr (P)
D2D2007 2693 1.44 (0.35) 0.41 59.9 (8.4) 27.5 (4.8) 52 -0.03 (0.16) 0.03 ( 0.19)
DIAGEN 1510 1.45 (0.47) 0.46 63.3 (14.3) 27.9 (5.2) 55 -0.01 (0.76) 0.03 ( 0.24)
DPS 433 1.22 (0.29) 0.44 55.1 (7.1) 31.3 (4.6) 68 -0.02 (0.69) 0.16 (<.01)
FUSION-FS 172 1.29 (0.32) 0.43 38.6 (10.9) 26.2 (4.9) 55 0.04 (0.56) 0.23 (<.01)
FUSION-S2 2730 1.45 (0.41) 0.40 57.2 (8.4) 27.9 (5.1) 44 -0.02 (0.23) 0.06 (<.01)
HUNT 1324 1.26 (0.38) 0.47 67.2 (13.1) 28.0 (4.4) 48 <.01 (0.94) 0.06 ( 0.03)
METSIM 1456 1.42 (0.40) 0.44 56.3 (6.6) 27.9 (4.7) 0 -0.05 (0.08) 0.03 ( 0.32)
TROMSO 1411 1.43 (0.42) 0.49 59.9 (12.5) 27.6 (4.7) 50 <.01 (0.91) 0.04 ( 0.15)
Entire study 11729 1.41 (0.40) 0.43 59.6 (11.1) 27.9 (4.9) 44 <.01 (0.97) 0.05 (<.01)
a SD: standard deviation; BMI: body mass index; MAF: minor allele frequency;
b Corr(P): Spearman correlation between SNP rs1121980 and environmental factor with corresponding P-value.
Table 4.4: IPD/Meta-analysis results of GEI for the T2D study, where the log transformed
HDL-C level was regressed on SNP, age, BMI, gender, cohorts, and either
SNP×BMI or SNP×age interaction in the IPD model. Estimates, SEs and CIs
have been multiplied by 1000.
Methodsa rs1121980 (additive) × BMI P-value*
Estimate SEb 95% CIb Additive Co-dominant
IPD 1.880 0.679 (0.548, 3.212) 0.006∗? 0.013∗
UIVW 1.936 0.700 (0.565, 3.308) 0.006∗ 0.018∗
REM 1.936 0.700 (0.565, 3.308) 0.006∗ 0.018∗
MIVW2′ 1.955 0.698 (0.587, 3.324) 0.005∗ 0.017∗
MIVW 1.957 0.698 (0.589, 3.325) 0.005∗ 0.017∗
MR -0.062 3.484 (-6.890, 6.767) 0.986 0.630
AWE 1.859 0.686 (0.514, 3.204) 0.007∗ 0.016∗
AWE2′ 1.877 0.685 (0.536, 3.219) 0.006∗ 0.015∗
rs1121980 (additive) × age Additive Co-dominant
IPD 0.381 0.314 (-0.235, 0.998) 0.225 0.324?
UIVW 0.354 0.364 (-0.360, 1.068) 0.331 0.372
REM 0.354 0.364 (-0.360, 1.068) 0.331 0.372
MIVW2′ 0.415 0.362 (-0.295, 1.124) 0.252 0.387
MIVW 0.458 0.332 (-0.193, 1.109) 0.168 0.397
MR 0.666 0.633 (-0.575, 1.906) 0.293 0.471
AWE 0.432 0.316 (-0.187, 1.050) 0.172 0.191
AWE2′ 0.477 0.314 (-0.140, 1.093) 0.129 0.184
a IPD: individual patient data; UIVW: univariate inverse-variance weighted estimator;
REM: random effect model; MIVW: multivariate inverse-variance weighted estimator
pooling (βG, βE , δ); MIVW2′: MIVW estimator pooling (β′E , δ
′) under a centered
model; MR: Meta-regression; AWE: adaptively weighted estimator combining UIVW
and MR; AWE2′: AWE combining MIVW2′ and MR.
b SE: standard error; CI: confidence interval.
* indicating significance at α = 0.05 level.
? indicating whether additive or co-dominant model has smaller AIC under the IPD model.
CHAPTER V
Meta-analysis of gene-environment interaction on
dichotomous traits under case-control studies
5.1 Introduction
5.1.1 The role of G-E independence in case-control studies of G-E interaction
Gaining efficiency in studies of gene-environment interaction (GEI) by exploiting in-
dependence between the genetic (G) and environmental (E) factors under case-control
sampling has been noted in multiple papers (Piegorsch et al. (1994); Umbach and Wein-
berg (1997); Chatterjee and Carroll (2005), CC from now on). Piegorsch et al. (1994)
showed that one can estimate multiplicative GEI in logistic model with data from cases
alone, provided that G and E are independent in the population and the disease is rare.
Under such assumptions, the GEI parameter is obtained as the odds ratio between G and
E among cases, which is more precise than that obtained from a case-control analysis us-
ing logistic regression. However, the case-only method can only make inference on the
GEI parameter without getting the corresponding main effect simultaneously. Umbach
and Weinberg (1997) showed that, with data available on both cases and controls, one
can estimate the main effects and interaction, by fitting a suitably constrained log-linear
model under the rare disease assumption and the G-E independence assumption, which
has the same precision of the GEI parameter derived under the case-only method. How-
ever, methods in Piegorsch et al. (1994) and Umbach and Weinberg (1997) only work for
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categorical E. CC proposed a semi-parametric maximum likelihood method to estimate
all the logistic regression parameters under a retrospective likelihood with continuous E
and possible covariate adjustment. Their method addressed many of the limitations of the
existing methods as discussed above, e.g. the rare disease assumption, categoricalE. They
also considered the issue of population stratification whereG-E independence assumption
only holds conditional on the set of stratification variables. However, methods that use G-
E independence assumption might produce severely biased estimates if the assumption is
violated. Several studies have addressed this issue and proposed more robust strategies for
testing GEI (Mukherjee and Chatterjee (2008), MC from now on; Mukherjee et al. (2008);
Li and Conti (2009); Murcray et al. (2009)). MC proposed a solution to the bias versus
efficiency dilemma, using a retrospective method that allows for uncertainty around the as-
sumption of G-E independence. MC used the estimate of the uncertainty parameter in an
empirical Bayes (EB) fashion to obtain a shrinkage estimator that ’shrinks’ the maximum
likelihood estimates (MLEs) of disease odds ratio parameters under G-E dependence to
those under G-E independence, and showed how the shrinkage factor depends on these
MLEs and their corresponding variances. The following is a detailed review.
5.1.2 Review of MC’s empirical Bayes approach
Let D be the binary indicator of presence (D = 1) or absence (D = 0) of a disease.
Let G, E and S be the genotype, environmental exposure and stratification factor (such as
ethnicity). MC considered the following factorization of the retrospective likelihood for a
case-control study,
LR = P (G,E, S|D) = P (D|G,E, S)P (G|E, S)P (E, S)∑
G,E,S P (D|G,E, S)P (G|E, S)P (E, S)
.
MC considered (1) a logistic disease incidence model P (D|G,E, S) = H{γ0 + γGG +
γEE + γGEGE + γSS}, where H(u) = {1 + exp(−u)}−1; (2) a logistic model P (G =
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1|E, S) = H{η0 + θE + ηS} for a binary genetic factor G; (3) the joint distribution for
(E, S) to be nonparametric. In (2), θ is a measure of dependence between G and E condi-
tional on S. Under G-E independence conditional on S, P (G|E, S) = P (G|S). One can
reduce the model for G to P (G = 1|S) = H{η0 + ηS}. Throughout this chapter, we refer
to the model with (without)G-E independence assumption as constrained (unconstrained)
model respectively.
The EB estimator in MC is under a general framework, where one is interested in
inference on a set of focus parameters β in the presence of prior information only on a
set of nuisance parameters θ. For example, under the above formulation (1)-(3), β =
(γ0,γ, η0, η) and θ = θ (We use θ instead of θ below for the general case). Denote
the MLE for β under the unconstrained and constrained model as β̂ and β̂0 respectively.
Denote β̂(θ) as the profile MLE of β for fixed θ, then β̂ = β̂(θ̂) and β̂0 = β̂(0). Denote
β(θ) as the limiting value of β̂(θ). Following the invariant property of MLE, we have
β(θ̂) ∼ MVN(β(θ),Vβ(θ̂)). We use the generic notation V(·) to denote the variance of
(·). Assumes θ ∼ MVN(0,A). Applying Taylor’s expansion around θ = 0, MC used
the linear approximation β(θ) ∼ MVN(β(0),∆>A∆), where ∆> = ∂β(θ)/∂θ|θ=0 is
the Jacobian matrix evaluated at 0. For the Gaussian-Gaussian model, MC proposed an
approximation to the Bayes estimator of β(θ) for a fixedA as
β̂(θ) = ∆>A∆{Vβ(θ̂) + ∆
>A∆}−1β(θ̂) + Vβ(θ̂){Vβ(θ̂) + ∆
>A∆}−1β(0).
MC further used the profile MLE β̂(θ) for β(θ), the estimated asymptotic variance V̂β̂ for
Vβ(θ̂), ∆̂ = ∂β̂
>(θ)/∂θ|θ=0 for ∆, and a conservative estimator Â = θ̂θ̂
>
for A. Then
the resulting ad hoc EB estimator is given by
β̂EB = ∆̂
>Â∆̂ {V̂β̂ + ∆̂
>Â∆̂}−1 β̂ + V̂β̂{V̂β̂ + ∆̂
>Â∆̂}−1 β̂0.
The variance V̂β̂EB of β̂EB can be estimated using the multivariate Taylor’s expansion. A
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Alternatively, one can write β̂EB = β̂+K(β̂0−β̂), whereK = V̂β̂{V̂β̂+∆̂>Â∆̂}−1.
The shrinkage factor K determines the amount of shrinkage between the unconstrained
and constrained MLEs. When K → 1 (evidence of G-E independence), we have β̂EB =
β̂0; when K → 0 (departure from G-E independence), we have β̂EB = β̂. So MC’s
EB shrinkage estimator can relax the G-E independence assumption in a data-adaptive
fashion. Further theoretical development regarding this shrinkage estimator is presented
in Chen et al. (2009). It was noted that this EB estimate can trade off between bias and
efficiency and provide increased power compared to a standard case-control analysis, with
superior control of type 1 error when compared to a case-only analysis. This performance
is noted for modest sample sizes, whereas asymptotically the EB estimator β̂EB converges
to the unconstrained estimator β̂
As the GEIs detected so far only have small to modest effects, there are increasing
demands for large sample sizes and collaboration across different study sites in order to
perform a pooled or meta-analysis with high confidence and power. In this chapter, we
consider possible extensions of EB type shrinkage estimators for a multiple-study set-
ting. To handle this multiple-study problem, we particularly consider strategies to obtain
a shrinkage factor in the EB estimator that can borrow strength across studies, under both
individual patient data (IPD) analysis using individual level data and meta-analysis using
study level summary statistics.
5.2 Methods
5.2.1 Model formulation under multiple-study setting
Suppose there are K independent studies and a total of N participants, with nk par-
ticipants in the k-th study, k = 1, ..., K,
∑K
k=1 nk = N . Let D, G, E and S denote the
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phenotype, genotype, environmental exposure and stratification factor. Let subscript (i, k)
stand for participant i in study k, for i = 1, ..., nk; k = 1, ..., K. Consider the following












P (Dki|Gki, Eki, Ski)P (Gki|Eki, Ski)P (Eki, Ski)∑
Gki,Eki,Ski
P (Dki|Gki, Eki, Ski)P (Gki|Eki, Ski)P (Eki, Ski)
.
The three components P (D|G,E, S), P (G|E, S) and P (E, S) in LRk are modeled in the
following way:
(i) P (D|G,E, S): We consider a logistic disease incidence model P (Dki|Gki, Eki, Ski) =
H{γ0k + γGGki + γEEki + γGEGkiEki + γSSki}. Without loss of generality, we have
assumed γ = (γG, γE, γGE, γS) is the common set of parameters of interest.
(ii) P (G|E, S): For a dominant susceptibility model of G, we consider a logistic model
P (Gki = 1|Eki, Ski) = H{η0k + ηkSki + θkEki},(5.1)
where θk (ηk) is a measure of dependence between G and E (S) in the k-th study. Under
G-E independence conditional on S within each study k, model (5.1) can be reduced to
P (Gki = 1|Eki, Ski) = H{η0k + ηkSki}.(5.2)
For additive susceptibility model ofG, one may consider a proportional odds model to han-
dle P (G|E, S); similarly, for co-dominant susceptibility model, one may consider poly-
chotomous logistic model. Alternatively, in this chapter, we consider a logistic model to
handle the minor allele frequency (MAF) under the Hardy-Weinberg equilibrium (HWE)
assumption (Chen et al. 2009). Let q(Eki, Ski) be the MAF for given (Eki, Ski). We
model the MAF as q(Eki, Ski) = H{η0k + ηkSki + θkEki}, which can be reduced to
q(Eki, Ski) = H{η0k + ηkSki} under G-E independence conditional on Ski.
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(iii) P (E, S): The joint distribution function for (E, S) is allowed to remain completely
nonparametric as in CC.
Remark 5.1. Let γ0 = (γ01, ..., γ0K), (η0;η) = (η01, ..., η0K ; η1, ..., ηK) and θ = (θ1, ..., θK).
Let β = (γ,γ0,η,η0) and θ be the full set of parameters under the unconstrained model.
In models (i)-(iii), we consider γ as our common set of parameters across studies, (γ0,η,η0)
as study level fixed nuisance parameters, and θ as study level random nuisance parameters
(under the EB framework). This formulation is flexible. For example, one may use a sub-
vector of γ as the common parameters with the remaining of γ varying on k; one may also
assume ηk = η for k = 1, ..., K in models (5.1) and (5.2), i.e., a common G-S association
across studies, and treat (γ, η) as the common set of parameters. Then the methods in the
following sections can be modified accordingly. Without loss of generality, we consider
γ as our common set of disease odds ratio parameters that is of interest throughout this
chapter.
Estimation. The MLE of (β,θ) (only β under the constrained model) can be obtained
by the profile-likelihood techniques in CC. In particular, the MLEs under LR can be equiv-
alently obtained by maximizing a pseudo-likelihood L∗, in which estimation of the high
dimensional nuisance parameters involved in the specification of P (E, S) is not required.
More details of the pseudo-likelihood method were provided in CC. The MLEs of (β,θ)
can be estimated using the R ‘CGEN’ package (Bhattacharjee et al. 2012).
5.2.2 Empirical Bayes estimator under multiple-study setting
In this section, we consider both IPD analysis and meta-analysis to handle the multiple-
study problem. An IPD analysis can be performed when the individual level data are
available. The MLEs of γ under the unconstrained and constrained models can be obtained
directly by using the profile-likelihood techniques in CC, and are denoted as γ̂ and γ̂0
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respectively. We then propose an EB shrinkage estimator of γ that combines γ̂ and γ̂0 for
an IPD analysis. When the IPD are not available, e.g. in published results, we alternatively
consider meta-analysis that combines study level summary statistics across studies. Based
on the data from each study k, one collects the MLE γ̃k (with covariance matrix Ṽγ̃k) and
θ̃k (with variance σ̃2θk) from the unconstrained model; and collects γ̃
0
k and Ṽγ̃0k from the
constrained model. We then consider EB shrinkage estimators that combine these study
level summary statistics under a meta-analysis framework, where the shrinkage factors are
estimated by borrowing strength across studies.
Under both IPD analysis and meta-analysis framework, we propose two variants of
the EB estimator, MC type and partially Bayes (PB) type, and show consistency between
the two approaches under certain formulations/assumptions. Throughout this chapter, for
the EB estimator, we consider a strategy for conducting inference on γ with prior dis-
tribution on θ and no further prior specification on β. We consider θk
iid∼ N(0, τ 2),
in matrix notation, i.e., θ ∼ MVN(0,A) where A = diag(τ 2, ..., τ 2)(K×K). Here
diag(a1, ..., aK)(K×K) stand for a K × K diagonal matrix whose diagonal entries are
(a1, ..., aK). In order to borrow strength across studies, we have assumed the uncertainty
around the G-E independence assumption is constant (τ 2) across studies.
IPD analysis
(i) MC-type EB estimator: We propose an EB shrinkage estimator, in the spirit of MC,
combining γ̂ and γ̂0 under the multiple-study setting. We worked with β̂(θ) directly
rather than its limiting value β(θ) as suggested by Meng (2010). Let γ̂(θ) be the sub-
vector of β̂(θ) corresponding to γ. Following Taylor’s expansion, we have the linear
approximation γ̂(θ) ∼ MVN(γ̂(0),∆>A∆), where ∆> = ∂γ̂(θ)/∂θ|θ=0. Following
the invariant property of MLE, we have γ̂(θ̂) ∼MVN(γ̂(θ),Vγ̂(θ̂)). Under the Gaussian-
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Gaussian model, we propose a Bayes estimator (posterior mean) of γ̂(θ) of the form
∆>A∆{Vγ̂(θ̂) + ∆
>A∆}−1γ̂ + Vγ̂(θ̂){Vγ̂(θ̂) + ∆
>A∆}−1γ̂0,(5.3)
where γ̂ and γ̂0 are the MLEs of γ under the unconstrained and constrained models re-
spectively. As in MC, we consider an ad hoc EB estimator γ̂MC-EB for γ̂(θ) by plugging
the estimates of the weights ∆>A∆{Vγ̂(θ̂) + ∆>A∆}−1 and Vγ̂(θ̂){Vγ̂(θ̂) + ∆>A∆}−1 in
(5.3). The components of the weights can be obtained as follows:
(i.a) Vγ̂ : We use V̂γ̂ for Vγ̂ in (5.3). Denote I as the full observed information matrix
under the unconstrained model; denote Î as I evaluated at the MLE. V̂γ̂ can be obtained
as the corresponding sub-matrices of Î−1.
(i.b) ∆: MC proposed to use an approximation IθγI−1γγ |θ=0, where Iθγ and Iγγ are the cor-
responding sub-matrices of I . The appropriateness of using IθγI−1γγ |θ=0 is verified in Ap-
pendix B.4. Note that, applying Taylor’s expansion, we have γ̂(θ̂) ≈ γ̂0+{∂γ̂(θ)/∂θ}|θ=0θ̂,









)−1 for ∆ in (5.3). Note that ∆̂ depends only on the MLEs γ̂, γ̂0
and θ̂, which bypasses the calculation of IθγI−1γγ |θ=0.
(i.c)A: We use EB estimator Â for A. Let θ̂k be the MLE of θk under the unconstrained
model, with variance σ̂2θk . We assume θ̂k | θk ∼ N(θk, σ̂
2
θk
). Note that marginally θ̂k ∼
N(0, τ 2 + σ̂2θk). We consider EB estimator of A using the following strategies: (1) a
conservative estimator Â = θ̂θ̂
>
as in MC; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K), where τ̂ 2 is
the MLE that maximizes the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K),
where τ̄ 2 is the estimated posterior mean of τ 2|θ̂ in the spirit of Morris (1983). The details
are shown in Appendix B.4.
Following (i.a)-(i.c), the resulting MC-type EB estimator is given by
γ̂MC-EB = ∆̂
>Â∆̂{V̂γ̂ + ∆̂>Â∆̂}−1γ̂ + V̂γ̂{V̂γ̂ + ∆̂>Â∆̂}−1γ̂0.(5.4)
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Denote γ̂MC-EB1, γ̂MC-EB2 and γ̂MC-EB3 as the MC-type EB estimators of γ̂(θ) with Â fol-
lowing strategies (1), (2) and (3) in (i.c) respectively.
(ii) Partially Empirical Bayes (PEB) estimator: An alternative strategy is to consider an
EB estimator under the ‘partially Bayes’ framework of Meng (2010). We extend it into a
more general case with multiple parameters and unrestricted variance-covariance matrix














is the model based asymptotic covariance matrix of (γ̂, θ̂) obtained from the correspond-
ing blocks of I−1. Note that Îγγ = V̂γ̂ and Îθθ = V̂θ̂. Before any prior knowledge, the
profile MLE of γ for fixed θ under model (5.5) can be derived as
γ̂(θ) = γ̂ + Iγθ(Iθθ)−1(θ − θ̂).(5.6)
Given the data (γ̂ and θ̂), the only unknown quantity in γ̂(θ) in (5.6) is θ. Under the PB
framework, we can make inference on γ̂(θ) as a function of θ. Let Γ> = Iγθ(Iθθ)−1|θ=0.
Substituting Γ> for Iγθ(Iθθ)−1 in (5.6), we have an approximated distribution γ̂(θ) ∼
MVN(γ̂(0),Γ>AΓ). We use the posterior expectation of γ̂(θ) as the PB estimator of
γ̂(θ) (for a fixedA), which can be given as
Γ>AΓ{Vγ̂ + Γ>AΓ}−1γ̂ + Vγ̂{Vγ̂ + Γ>AΓ}−1γ̂0.(5.7)
Again, we consider an ad hoc EB estimator γ̂PEB for γ̂(θ) by plugging the estimated
weights in (5.7). We use V̂γ̂ for Vγ̂ . Following (5.6), γ̂ = γ̂0 + Iγθ(Iθθ)−1|θ=0θ̂,









)−1. We use the EB estimator Â for A in (5.7) following the strategies
described in section 5.2.2(i.c). The resulting PEB estimator γ̂PEB can be written as
γ̂PEB = Γ̂
>ÂΓ̂{V̂γ̂ + Γ̂>ÂΓ̂}−1γ̂ + V̂γ̂{V̂γ̂ + Γ̂>ÂΓ̂}−1γ̂0,(5.8)
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Note that, since Γ̂ = ∆̂, we have γ̂PEB = γ̂MC-EB.
Meta-analysis
(i) MC-type EB estimator. We propose to use (multivariate) inverse variance weighted









γ̃k to combine γ̃k under the unconstrained









γ̃0k to combine γ̃
0
k
under the constrained model. In order to construct an EB estimator combining γ̃ and γ̃0
in the spirit of MC, we first prove the following Lemma.
Lemma 1. For the unconstrained model, Vγ̃ = Vγ̂ ; γ̃ and γ̂ have the same limiting normal
distribution MVN(γ,Vγ̂). For the constrained model, Vγ̃0 = Vγ̂0; γ̃0 and γ̂0 have the
same limiting normal distribution MVN(γ(0),Vγ̂0).
Proof: Follow Lin and Zeng (2010).
Lemma 2. θ̃k = θ̂k and σ̃2θk ≥ σ̂
2
θk
, for k = 1, ..., K.
Proof: shown in Appendix B.4.
Because γ̂ = γ̂(θ̂) ∼ MVN(γ̂(θ),Vγ̂(θ̂)), along with Lemma 1, we have γ̃ ∼
MVN(γ̂(θ),Vγ̃). Under prior distribution θ ∼ MVN(0,A), we can obtain an approxi-
mated distribution for γ̂(θ) asMVN(γ̂(0),∆>A∆) following Taylor’s expansion. Along
with Lemma 1, γ̂(θ) ∼ MVN(γ̃0,∆>A∆) asymptotically. For the Gaussian-Gaussian
model, we consider an MC-type EB estimator combining γ̃ and γ̃0 as
γ̃MC-EB = ∆̃
>Ã∆̃{Ṽγ̃ + ∆̃>Ã∆̃}−1γ̃ + Ṽγ̃{Ṽγ̃ + ∆̃>Ã∆̃}−1γ̃0.(5.9)






is the EB estimator ofA calculated based on the study level statistics θ̃k and σ̃2θk under the
strategies described in section 5.2.2(i.c), and ∆̃ = (γ̃−γ̃0)θ̃>(θ̃θ̃>)−1. Following Lemma
1 and 2, ∆̃ and ∆̂ have the same limiting value, so we have used ∆̃ as an approximate
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estimator for ∆. Note that all the components in γ̃MC-EB in (5.9) are obtained using only
study level summary statistics.
(ii) PEB estimator. Note that the k-th study only involves parameters βk = (γ, γ0k,
η0k, ηk) and θk. Let β̃k(θk) be the profile MLE of βk for fixed θk for the k-study, and
γ̃k(θk) be the sub-vector of β̃k(θk) corresponding to γ. From each study k, we have the
study level data γ̃k, θ̃k and the full observed information matrix Ĩk under the unconstrained
model, and γ̃0k under the constrained model, for k = 1, ..., K. Under the unconstrained















is the model based asymptotic covariance matrix of (γ̃k, θ̃k) obtained from the correspond-
ing blocks of I−1k . Note that Ĩ
kγγ = Ṽγ̃k and Ĩ
kθkθk = σ̃2θk . Before any prior knowledge,









γ̃k, i.e. γ̃; the MLE of θk
is θ̃k. The conditional distribution γ̃k|θ̃k ∼ MVN(γ + Ikγθk(Ikθkθk)−1(θ̃k − θk), Ikγγ −
Ikγθk(Ikθkθk)−1Ikθkγ). Then we have the profile MLE γ̃k(θk) = γ̃k+Ikγθk(Ikθkθk)−1(θk−
θ̃k), with variance Vγ̃k(θk) = I
kγγ − Ikγθk(Ikθkθk)−1Ikθkγ for fixed θk and Vγ̃k(θ̃k) = I
kγγ




























Given the study level data γ̃k and θ̃k, the only unknown quantity in γ̃(θ) in (5.11) is
θ. Under the PB framework, we can make inference on γ̃(θ) as a function of θ. Again,
applying Taylor’s expansion at θ = 0, we have the linear approximation γ̃(θ) ≈ γ̃(0) +
110
{∂γ̃(θ)/∂θ}|θ=0θ, and then we have the approximated distribution γ̃(θ) ∼MVN(γ̃(0),
Λ>AΛ), where Λ> = ∂γ̃(θ)/∂θ|θ=0. Since γ̃ ≈ γ̃0 + {∂γ̃(θ)/∂θ}|θ=0θ̃, we can ap-
proximate Λ> by (γ̃ − γ̃0)θ̃>(θ̃θ̃>)−1 to avoid the calculation of the derivative of the
profile function γ̃(θ). We consider a PEB estimator γ̃PEB for γ̃(θ) as
γ̃PEB = Λ̃
>ÃΛ̃{Ṽγ̃ + Λ̃>ÃΛ̃}−1γ̃ + Ṽγ̃{Ṽγ̃ + Λ̃>ÃΛ̃}−1γ̃0,(5.12)






(γ̃ − γ̃0)θ̃>(θ̃θ̃>)−1, and Ã is the EB estimator of A calculated based on the study level
statistics θ̃k and σ̃2θk under the strategies described in section 5.2.2(i.c). Since Λ̃ = ∆̃, we
have γ̃PEB = γ̃MC-EB.
Remark 5.2: Equivalence between MC-type EB and PEB estimator. Among the proposed
EB estimators, we note that the MC-type EB and PEB estimator are equivalent under either
IPD analysis or meta-analysis, i.e., γ̂MC-EB = γ̂PEB and γ̃MC-EB = γ̃PEB. Therefore, we no
longer distinguish between MC-type EB and PEB estimators under the Gaussian-Gaussian
model. Denote the proposed EB estimator under the IPD analysis and meta-analysis as γ̂EB
and γ̃EB. Under the IPD analysis (meta-analysis) framework, denote γ̂EB1, γ̂EB2 and γ̂EB3
(γ̃EB1, γ̃EB2 and γ̃EB3) as the EB estimators with Â (Ã) following strategies (1), (2) and
(3) in (i.c) respectively.
Remark 5.3: The conservative estimator Â = θ̂θ̂
>
. Let ψ̂ = γ̂− γ̂0. For the conservative
estimator Â = θ̂θ̂
>







































, so λ = 1. For the IPD





}−1γ̂ + V̂γ̂{V̂γ̂ + ψ̂ψ̂
>
}−1γ̂0.(5.13)
Similarly, if we use the conservative estimator Ã = θ̃θ̃
>









. For the meta-analysis, we have a conservative EB estimator γ̃EB1 of the form
γ̃EB1 = ψ̃ψ̃
>{Ṽγ̃ + ψ̃ψ̃
>}−1γ̃ + Ṽγ̃{Ṽγ̃ + ψ̃ψ̃
>}−1γ̃0.(5.14)
According to lemma 1 and 2, γ̃ and γ̂ have the same limiting normal distribution; γ̃0 and
γ̂0 have the same limiting normal distribution; the corresponding weights have the same
limiting value. Thus, γ̂EB1 and γ̃EB1 converge to the same limiting distribution.
(iii) Inverse variance weighted approach. From each study k, one can obtain an EB esti-
mator γ̃EBk following MC as
γ̃EBk = ∆̃
>
k Ãk∆̃k{Ṽγ̃k + ∆̃>k Ãk∆̃k}−1γ̃k + Ṽγ̃k{Ṽγ̃k + ∆̃>k Ãk∆̃k}−1γ̃0k,
where ∆̃>k Ãk∆̃k is calculated similarly as before but using the data from study k only. In
particular, ∆̃>k = (γ̃k − γ̃0k)θ̃−1k and Ãk follows (i.c), e.g. Ãk = θ̃2k for the conservative
estimator. A naive approach to obtain a pooled EB estimator across studies is just to use








Alternatively, we can estimate the approximated prior variance ∆>A∆ of γ̂(θ) borrowing
strength across all the study, and consider an hybrid EB estimator γ̃EBk of the form
γ̃ ′EBk = ∆̃
>Ã∆̃{Ṽγ̃k + ∆̃>Ã∆̃}−1γ̃k + Ṽγ̃k{Ṽγ̃k + ∆̃>Ã∆̃}−1γ̃0k
for each study k. Here, ∆̃>Ã∆̃ in γ̃ ′EBk is the same as that in (5.9). We consider hybrid










Under the IPD analysis, for γ̂EB1, the variance V̂γ̂EB1 can be obtained by viewing γ̂EB1
as a function of the MLE (γ̂, θ̂, γ̂0). The joint asymptotic multivariate normal distri-
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bution for these three estimates can be obtained in terms of the associated score func-
tions and information matrices. An application of the Delta method provides the asymp-
totic variance-covariance matrix for γ̂EB1. For γ̂EB2 and γ̂EB3 of the more general form
γ̂EB = ∆̂
>Â∆̂{V̂γ̂ + ∆̂>Â∆̂}−1γ̂ + V̂γ̂{V̂γ̂ + ∆̂>Â∆̂}−1γ̂0, it is hard to apply the Delta
method to obtain a variance formula for the EB estimator since Â does not have a closed
form expression in terms of (γ̂, θ̂, γ̂0). Instead, we consider an ad hoc way to calculate
the variance. The derivation and expression of V̂γ̂EB1 , V̂γ̂EB2 and V̂γ̂EB3 is deferred to










}−1. The validity of the above form of V̂γ̃IVW-EB requires
that the true asymptotic variance Vγ̃EBk is estimated with negligible error. We note that this
assumption is often implicitly assumed to hold in classic meta-analysis literature dealing
with Gaussian models (e.g., DerSimonian and Laird (1986), Whitehead and Whitehead
(1991), LZ). As the components of V̂γ̃IVW-EB , Ṽγ̃EBk for the EB estimator γ̃EBk was derived
using a Delta’s method as an approximation, we would evaluate the performance of V̂γ̃IVW-EB
by comparing it with its empirical value, and similarly for V̂γ̃HIVW-EB .
5.2.4 Empirical linear Bayes rule
MC-type EB estimator is derived under the usual Gaussian-Gaussian hierarchical model,
however, the PB approach can be generalized to non-normal cases. In particular, for a gen-
eral prior on θ, we can derive the posterior of θ | θ̂, and then make inference on γ̂(θ) as a
function of θ. We use the posterior expectation Eθ{γ̂(θ)} = γ̂ +Eθ{Iγθ(Iθθ)−1(θ− θ̂)}
as the PB estimator of γ̂(θ), whereEθ is the expectation taken with respect to the posterior
distribution of θ (for fixed hyperparameters of θ, e.g. τ 2). If we replace Iγθ(Iθθ)−1 by
Îγθ(Îθθ)−1, then Eθ{γ̂(θ)} = γ̂ + Îγθ(Îθθ)−1{Eθ(θ)− θ̂}.
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Consider the model θ̂k | θk ∼ N(θk, σ̂2θk) and θk
iid∼ (Mk, Vk). The notation indicating
θk has mean Mk and variance Vk with no other assumptions about the distribution on
θk. Let Wk = Vk/(Vk + σ̂2θk). Following Efron (1973), we have the ‘linear Bayes rule’
Mk + Wk(θ̂k −Mk) for the posterior mean of θk | θ̂k. Let M = (M1, ...,MK)>, V =
(V1, ..., VK)
> and W = diag(W1, ...,WK)(K×K). The ‘linear Bayes rule’ for θ | θ̂ in
matrix form is M + W (θ̂ −M). Thus, the partially linear Bayes (PLB) estimator for
fixedM and V can be given by
γ̂PLB = γ̂ + Î
γθ(Îθθ)−1(1−W )(M − θ̂),
It is easy to show that Vγ̂PLB ≤ Vγ − Iγθ(Iθθ)−1(1−W )Iθθ(1−W )(Iθθ)−1Iθγ ≤ Vγ̂ .
Here we follow the definition that a matrix is greater than the other iff the corresponding
subtracted matrix is symmetric positive definite (SPD). So γ̂PLB has more precision than
γ̂. IfM andW are unknown, we can use the ‘empirical linear Bayes rule’ M̂ + Ŵ (θ̂−
M̂ ) with M̂ and Ŵ estimated from the data (Efron 1973). Then it results in a partially
empirical linear Bayes (PELB) estimator of γ̂(θ) of the form
γ̂PELB = γ̂ + Î
γθ(Îθθ)−1{(1− Ŵ )(M̂ − θ̂)}.
We consider a typical example of a mixture distribution θk ∼ p δ(0) + (1 − p)N(0, τ 2),
where δ(0) is a point mass at 0 reflecting G-E independence. The population level G-E
association structure is assumed as a mixture distribution reflecting that a fraction, say p,
of the studies have G-E independence holding, whereas the remaining studies (a fraction
of 1− p) show some departures from the independence assumption. For this distribution,
we have Mk = 0 and Vk = (1 − p)τ 2 for k = 1, ..., K. So the ‘empirical linear Bayes
rule’ is Ŵ θ̂, where we use Ŵk =
(1−p̂)τ̂2
(1−p̂)τ̂2+σ̂2θk
with p̂ and τ̂ 2 obtained by maximizing the
marginal likelihood of θ̂k ∼ pN(0, σ̂2θk) + (1− p)N(0, σ̂
2
θk
+ τ 2). The details are shown in
Appendix B.4.
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5.3 A Simulation Study
Simulation scenarios
We considered a simulation study to compare the relative performances of the proposed
methods, including (a) the standard logistic regression analysis; (b) the constrained and
unconstrained estimator based on the retrospective likelihood method; (c) the proposed EB
estimator (EB1, EB2 and EB3) that combines the constrained and unconstrained estimator.
The relative performances were also compared under both IPD and meta-analytic setting.
We considered S = (S1, S2), where S1 is a binary variable with P (S1 = 1) = 0.55
and P (S1 = 0) = 0.45, and S2 is a continuous variable follows N(0, 1). We generated the
environmental covariate as E = min(10, exp(X)), where X follows a normal distribution
with the mean parameter depends on S1. In particular, X|S1 = 0 ∼ N(0, 1) and X|S1 =
1 ∼ N(0.05, 1). Conditional on (E,S), we generated a binary genetic factor G through a
logistic model of the form
P (Gki = 1|Eki,Ski) = H{η∗0k + η∗>k Ski + θ∗kEki},




2k). We set η
∗
1k
iid∼ Uniform(0.1, 0.3) and η∗2k
iid∼ Uniform(0, 0.2)
to reflect a strong G-S association. To explore the role of departure from G-E inde-
pendence (conditional on S), the G-E association is set as θ∗k = 0 corresponding to G-
E independence; and set as θ∗k
iid∼ Uniform(−c, c) corresponding to G-E dependence,
where we considered c = 0.2 and 0.5 corresponding to modest and strong G-E associ-
ations. We also considered the situation where G-E associations follow a mixture dis-
tribution θ∗k ∼ p δ(0) + (1 − p)Uniform(−c, c) (choices of p and c are given in Table
5.3). Here a fraction (say p) of the studies have G-E independence holding, whereas
the remaining studies show some departures from the independence assumption. We set
η∗0k
iid∼ Uniform(−1.6,−1.3) so that the MAF of G is 0.2. Conditional on (G,E,S), we
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generated a binary disease outcome D from the logistic regression model
P (Dki = 1|Gki, Eki,Ski) = H{γ∗0k + γ∗GGki + γ∗EEki + γ∗GEGkiEki + γ∗>S Ski}.






S ) = (0.2, 0.1, 0.1; 0.1, 0.05) to reflect small to modest main and
interaction effects between G and E, along with a modest stratification risk factor S. We
set γ∗0k
iid∼ Uniform(−4.6,−4.2) such that the marginal probability of the disease in the
population is 2%. When θ∗k = 0, the low disease prevalence leads to G-E independence in
controls approximately.
We generated data (D,G,E,S) from a large cohort including a total of 5, 000, 000
patients, divided by K = 10 sub-cohorts with different sample sizes (N1 = 1, 000, 000;
N2 = 750, 000; Nk = 500, 000, for k = 3, 4; Nk = 400, 000, for k = 5, .., 9; N10 =
250, 000). In each replication of our simulation, we constructed a case-control data set
with case-control ratio 1:1 and a total sample size N = 5000 from the same cohort. In
particular, we sampled nk = Nk/1000 patients (0.5nk cases and 0.5nk controls) from
each study k (n1 = 1000; n2 = 750; nk = 500, for k = 3, 4; nk = 400, for k = 5, 9;
n10 = 250). Then we analyzed the case-control data set (including K sub-studies) using
the proposed IPD and meta-analytical methods under each replication.
We carried out R = 1, 000 replications under each setting, and summarized the results
in terms of relative bias (RB = ( 1
R
∑R
r=1 γ̂(r) − γ∗)/γ∗ × 100%), mean of model based
variance (MV = 1
R
∑R










The simulation results are shown in Tables 5.1 and 5.2 with G-E independence and
dependence holding respectively.
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Comparison of methods: As for comparison across methods, we make the following key
observations in Tables 5.1 and 5.2: (1) When G and E are independent conditional on
S, all the methods are unbiased for all the regression parameters; when G and E are
dependent given S, the bias for the constrained estimator could be very large, especially
when G-E association is strong (c = 0.5). In this case, the EB estimators controlled
the bias by putting less weight on the constrained estimator. EB1 is more robust to this
bias compared to EB2 and EB3 especially when G-E association is strong (c = 0.5).
(2) Regardless of the G-E association, there is a precision gain for both γG and γGE
using the constrained estimator as compared to the unconstrained estimator, and the gain
is quite dramatic for γGE . EB1 had greater SE compared to EB2 and EB3 since EB1
is a conservative estimator. The performance of EB2 and EB3 were very similar across
all setting in terms of RB, SE and MSE. (3) Given the total sample size N = 5000,
as comparing the empirical standard errors with the means of the model based standard
errors, we found that the proposed variance estimator for each method (except for γ̃IVW-EB)
performed well, when G-E association is not very strong (c = 0, 0.2). The proposed
variance estimator of the EB estimator underestimate the variance when G-E association
is strong (c = 0.5). (4) when G-E are independent conditional on S, the constrained
estimator had the smallest MSE; in this case, the estimated τ 2 were very close to 0 in both
EB2 and EB3, so EB2 and EB3 showed very similar results to the constrained estimator.
When G and E are dependent conditional on S, EB 1-3 had smaller MSE as compared
to constrained/unconstrained estimators. In particular, when G-E association is modest
(c = 0.2), EB2 and EB3 had smaller MSE compared to EB1; when G-E association is
strong (c = 0.5), EB2 and EB3 had greater MSE compared to EB1.
In summary, as for comparison of the methods, when G and E are independent condi-
tional on S, all the methods are unbiased, and the constrained estimator has smallest SE.
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The EB estimators (especially EB2 and EB3) retain this precision gain by putting more
weight on the constrained estimator. When G and E are dependent conditional on S, the
bias for the constrained estimator could be very large. However, the EB estimators can
control for the bias by putting less weight on the constrained estimator while retaining
certain amount of precision gain, and show advantage in terms of MSE. We also compared
the proposed methods in terms of power and type 1 error. The proposed EB estimators
provide increased power compared to a standard case-control analysis, when G and E
are independent; and have superior control of type 1 error as compared to a constrained
estimator, when G and E are dependent.
Comparison of IPD analysis and meta-analysis: Regardless of the G-E association, we
found that the two analysis showed very similar results in terms of RB, SE and MSE,
under each of the method. This is expected from our theoretical results. As for γ̃IVW-EB,
we observed that it had greater SE and MSE compared to EB1-3, especially whenG-E are
dependent, implying that pooling the original EB estimator across studies is less efficient
than modifying the weights to borrow strength across studies.
5.4 Application: Data analysis for the type 2 diabetes study
The proposed methods were applied to the data from a set of studies investigating T2D,
which has been used as the data example in chapter 4 as well. A number of SNPs in the
FTO gene region (16q12.2) have previously been identified to be associated with T2D and
BMI in the DIAGRAM consortium (Zeggini et al. (2008), Voight et al. (2010)). Variants
at FTO are known to influence T2D predisposition through an effect on BMI (Freathy
et al. (2008), Voight et al. (2010)). Age, BMI and gender are all known risk factors for
T2D. In this chapter, we investigate whether SNPs in FTO gene modifies the effect of
environmental factors (e.g. age and BMI) on T2D.
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Among the 8 cohorts, the T2D case-control status was identified by the glucose toler-
ance category, case: fasting glucose≥ 7.0 mmol/l or two-hour glucose≥ 11.1 mmol/l;
control: fasting glucose< 6.1 mmol/l and two-hour glucose< 7.8 mmol/l. We geno-
typed all the T2D cases and portions of controls under budget allowance. FUSION-FSIGT
and DPS cohort are not valid for a case-control study. The descriptive summary statistics
for the genotyped case-control data sets from the remaining 6 cohorts (D2D2007, DIA-
GEN, FUSION S2, HUNT, METSIM, TROMSO) are shown in Table 4.3, by case-control
status. We have a total of N = 7597 individuals (3120 cases and 4477 controls), with
sample sizes nk relatively constant but the case-control ratio varying across studies (Ta-
ble 5.5). The case group has significantly older age (62.7 v.s. 59.2, P-value<0.001),
higher BMI (29.8 v.s. 26.3, P-value<0.001), lower percentage of females (39% v.s.
47%, P-value<0.001) than those in the control group. We examined 9 SNPs in the FTO
gene including rs1121980, rs11642841, rs12149832, rs1421085, rs17817449, rs8050136,
rs9930506, rs9941349 and rs6499640, which are in high linkage disequilibrium. For each
SNP, the MAF ranges 0.4-0.5 and very constant across studies. This is not surprising since
the study populations are all European (most are Finnish).
For demonstration purpose, we present our analysis for three representative scenarios:
(1) weak G-E association between age and rs11642841 (supporting G-E independence);
(2) modest G-E association between BMI and rs1121980; and (3) strong G-E association
between BMI and rs6499640 (supporting G-E dependence), which are reflected in the
(conditional) G-E association in the control group across the 6 case-control studies. The
corresponding G-E correlations were shown in Table 5.5. We explored GEIs on T2D (Y )
under the three scenarios. We consider S = (S1, S2) as the stratification variable, in which
S1 is age (BMI) when E is BMI (age), and S2 is gender.
Comparison of methods: The results comparing across methods, under both IPD analysis
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and meta-analysis, were shown in Table 5.6. Regardless of the G-E association, we ob-
served a precision gain for γGE using the constrained or EB estimators, as compared to
the unconstrained or logistic regression estimator. In particular, we make the following
two key observations: (1) For age×rs11642841 (weak G-E association), all the methods
provide very close estimates for all the regression parameters. The constrained model pro-
vided the smallest SE; since the estimated τ 2 was 0 in both EB2 and EB3, they showed
the same results as the constrained estimator. (2) For BMI×rs1121980 (modest) and
BMI×rs6499640 (strong G-E association), the constrained estimate was quite different
from the unconstrained estimate for γGE . The EB estimates (EB1-3) were intermediate,
and relatively close to the unconstrain estimates. Moreover, the EB estimators improved
the precision substantially as compared to the unconstrained or logistic regression estima-
tor.
Comparison of IPD analysis and meta-analysis: We found that the two analyses showed
very consistent results for each of the method in terms of estimates and SEs. As for the
IVW EB estimator, we observed that it had greater SE compared to EB2 and EB3 for the
GEI parameter γGE , especially when G-E association is strong.
Results: Under an additive model, with 1 kg/m2 increase in BMI, the odds ratio of T2D
is 1.17 (95% CI: (1.15, 1.19)) given rs6499640=GG, 1.20 (95% CI: (1.17, 1.24)) given
rs6499640=AG or GA; and 1.22 (95% CI: (1.19, 1.26)) given rs6499640=AA. The trend
of the odds ratios of T2D among the three groups defined by rs6499640 indicated that the
presence of minor allele A in rs6499640 enhanced the association between BMI and T2D.
5.5 Discussion
There has been abundance of literature on using G-E independence for case-control
studies of G-E interaction. However, there are no papers thus far to study the role of G-
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E independence in a meta-analysis setting where the assumption could vary within each
study/cohort. In this chapter, we proposed a meta-analysis approach that uses retrospec-
tive likelihood as the basis for influence and leverages the G-E independence assumption
in a data-adaptive way. The proposed shrinkage estimator provides optimal choices for
weights corresponding to constrained and unconstrained models by using information on
G-E association parameters derived from multiple studies/cohorts. Our work showed that
this novel estimator has better MSE properties than IVW estimator pooling study spe-
cific constrained, unconstrained or EB estimators. Our work also lead to many possible
extensions such as a mixture distribution prior on the G-E association parameters.
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Table 5.1: Comparison of the proposed methodsa when G-E independence holds, strati-
fied by IPD analysis and meta-analysis.
Method a E G GXE
IPD analysis RBb SE1b SE2b MSEb RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic -0.001 0.020 0.020 0.412 0.006 0.067 0.065 4.151 0.016 0.025 0.024 0.603
Unconstrained -0.007 0.018 0.019 0.353 0.014 0.064 0.062 3.816 -0.023 0.023 0.022 0.461
Constrained -0.004 0.016 0.017 0.276 0.023 0.056 0.054 2.975 -0.036 0.011 0.011 0.127
EB1 -0.007 0.016 0.018 0.310 0.016 0.055 0.058 3.323 -0.026 0.016 0.016 0.254
EB2 -0.004 0.016 0.017 0.276 0.023 0.056 0.054 2.976 -0.036 0.011 0.011 0.128
EB3 -0.004 0.016 0.017 0.276 0.022 0.056 0.054 2.973 -0.036 0.011 0.011 0.127
Meta-analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic (IVW) 0.009 0.020 0.020 0.407 -0.018 0.066 0.064 4.114 -0.011 0.025 0.023 0.534
Unconstrained (IVW) -0.025 0.018 0.018 0.345 0.035 0.064 0.061 3.766 -0.012 0.024 0.022 0.498
Constrained (IVW) -0.024 0.017 0.016 0.273 0.014 0.056 0.054 2.931 -0.034 0.012 0.011 0.123
EB1 -0.018 0.015 0.017 0.300 0.033 0.053 0.057 3.284 -0.025 0.015 0.015 0.276
EB2 -0.024 0.017 0.016 0.273 0.015 0.056 0.054 2.927 -0.025 0.012 0.011 0.124
EB3 -0.024 0.017 0.016 0.273 0.015 0.056 0.054 2.931 -0.026 0.012 0.011 0.125
EB (IVW) -0.030 0.017 0.017 0.294 0.017 0.057 0.056 3.133 -0.013 0.017 0.015 0.329
EB (HIVW) -0.026 0.017 0.017 0.289 0.016 0.057 0.056 3.081 -0.019 0.016 0.015 0.302
a Constrained/unconstrained: the retrospective likelihood method with/without G-E independence assumption. EB1-3: EB
estimators of Â using the following strategies: (1) a conservative estimator θ̂θ̂
>
; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K), where τ̂ 2
is the MLE that maximizes the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K), where τ̄ 2 is the estimated posterior
mean of τ 2|θ̂. EB (IVW): Inverse variance weighted EB estimator combining EB estimators across study.
b RB: relative bias; SE1: mean of model based standard error; SE2: empirical standard error; MSE: mean squared error.
(MSEs have been multiplied by 1000.)
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Table 5.2: Comparison of the proposed methodsa when G-E independence is violated,
stratified by IPD analysis and meta-analysis.
θ∗k
iid∼ Uniform(−0.2, 0.2) E G GXE
IPD analysis RBb SE1b SE2b MSEb RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic -0.001 0.018 0.019 0.395 0.001 0.066 0.063 3.982 -0.013 0.024 0.025 0.619
Unconstrained 0.020 0.018 0.019 0.428 0.029 0.064 0.062 4.022 -0.020 0.023 0.023 0.595
Constrained 0.062 0.016 0.017 0.419 0.070 0.056 0.054 3.841 -0.177 0.012 0.011 0.630
EB1 0.030 0.016 0.018 0.402 0.037 0.055 0.058 3.603 -0.063 0.015 0.018 0.439
EB2 0.048 0.016 0.017 0.407 0.038 0.055 0.054 3.654 -0.072 0.012 0.012 0.384
EB3 0.053 0.016 0.017 0.416 0.039 0.055 0.054 3.639 -0.071 0.012 0.012 0.381
Meta-analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic(IVW) 0.027 0.019 0.019 0.370 -0.017 0.066 0.062 4.047 -0.026 0.024 0.025 0.629
Unconstrained(IVW) 0.025 0.018 0.018 0.383 0.019 0.064 0.061 4.118 -0.025 0.023 0.023 0.595
Constrained(IVW) 0.071 0.016 0.016 0.387 0.056 0.056 0.054 3.847 -0.246 0.012 0.011 0.727
EB1 0.039 0.015 0.017 0.384 0.036 0.052 0.057 3.635 -0.066 0.015 0.017 0.424
EB2 0.043 0.016 0.016 0.384 0.039 0.055 0.054 3.612 -0.085 0.012 0.011 0.391
EB3 0.042 0.016 0.016 0.383 0.038 0.055 0.054 3.608 -0.084 0.012 0.011 0.392
EB (IVW) 0.071 0.017 0.017 0.364 0.038 0.059 0.057 3.593 -0.066 0.018 0.023 0.573
EB (HIVW) 0.062 0.017 0.017 0.374 0.038 0.057 0.057 3.533 -0.062 0.015 0.019 0.413
θ∗k
iid∼ Uniform(−0.5, 0.5) E G GXE
IPD analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic 0.028 0.018 0.017 0.293 -0.040 0.064 0.058 3.462 0.036 0.020 0.019 0.365
Unconstrained 0.041 0.018 0.017 0.300 -0.048 0.063 0.057 3.346 0.011 0.019 0.018 0.353
Constrained -0.221 0.017 0.015 0.719 -0.245 0.058 0.055 5.358 0.414 0.011 0.010 1.808
EB1 -0.002 0.016 0.017 0.303 -0.073 0.054 0.057 3.446 0.073 0.012 0.019 0.345
EB2 -0.112 0.016 0.017 0.408 -0.153 0.058 0.056 4.014 0.240 0.012 0.016 0.616
EB3 -0.105 0.016 0.017 0.396 -0.147 0.058 0.056 3.960 0.229 0.012 0.016 0.675
Meta-analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic(IVW) 0.015 0.018 0.017 0.277 -0.042 0.065 0.057 3.278 -0.023 0.020 0.019 0.351
Unconstrained(IVW) 0.023 0.018 0.017 0.278 -0.035 0.063 0.056 3.219 -0.033 0.020 0.018 0.344
Constrained(IVW) 0.008 0.017 0.015 0.217 -0.202 0.058 0.053 4.436 0.563 0.014 0.010 3.275
EB1 0.023 0.016 0.016 0.272 -0.042 0.056 0.056 3.206 -0.002 0.014 0.018 0.323
EB2 0.022 0.017 0.016 0.250 -0.082 0.058 0.055 3.245 0.160 0.013 0.018 0.567
EB3 0.023 0.017 0.016 0.252 -0.078 0.058 0.055 3.233 0.143 0.013 0.018 0.522
EB (IVW) 0.091 0.018 0.017 0.376 -0.013 0.063 0.060 3.597 -0.153 0.019 0.022 0.709
EB (HIVW) 0.067 0.017 0.017 0.296 -0.012 0.059 0.060 3.467 -0.147 0.017 0.019 0.653
a Constrained/unconstrained: the retrospective likelihood method with/without G-E independence assumption. EB1-3: EB
estimators of Â using the following strategies: (1) a conservative estimator θ̂θ̂
>
; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K), where τ̂ 2
is the MLE that maximizes the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K), where τ̄ 2 is the estimated posterior
mean of τ 2|θ̂. EB (IVW): Inverse variance weighted EB estimator combining EB estimators across study.
b RB: relative bias; SE1: mean of model based standard error; SE2: empirical standard error; MSE: mean squared error. (MSEs
have been multiplied by 1000.)
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Table 5.3: Comparison of the proposed methodsa when G-E independence is violated (G-
E associations follow a mixture distribution), stratified by IPD analysis and
meta-analysis.
θ∗k
iid∼ 0.4δ(0) + 0.6U(−0.3, 0.3) E G GXE
IPD analysis RBb SE1b SE2b MSEb RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic -0.013 0.018 0.018 0.336 0.016 0.064 0.065 4.317 0.019 0.022 0.022 0.489
Unconstrained -0.004 0.018 0.018 0.322 0.015 0.063 0.063 3.944 0.004 0.021 0.021 0.431
Constrained -0.058 0.017 0.017 0.333 0.027 0.056 0.055 3.185 0.055 0.011 0.011 0.136
EB1 -0.036 0.015 0.017 0.317 0.026 0.054 0.058 3.515 0.017 0.015 0.016 0.250
EB2 -0.053 0.016 0.017 0.325 0.028 0.056 0.056 3.232 0.030 0.011 0.012 0.138
EB3 -0.052 0.016 0.017 0.324 0.028 0.056 0.056 3.239 0.029 0.011 0.012 0.140
Meta-analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic(IVW) -0.027 0.018 0.018 0.326 0.010 0.065 0.064 4.249 -0.052 0.022 0.021 0.478
Unconstrained(IVW) -0.025 0.018 0.018 0.315 0.020 0.063 0.062 3.904 -0.047 0.021 0.020 0.434
Constrained(IVW) 0.008 0.017 0.017 0.279 0.044 0.056 0.054 3.115 0.101 0.012 0.011 0.214
EB1 -0.005 0.015 0.017 0.287 0.034 0.050 0.058 3.551 -0.013 0.014 0.017 0.302
EB2 0.007 0.016 0.017 0.278 0.034 0.056 0.055 3.218 0.060 0.012 0.012 0.182
EB3 0.007 0.016 0.017 0.278 0.035 0.056 0.055 3.231 0.056 0.012 0.012 0.183
EB (IVW) 0.031 0.017 0.017 0.309 0.078 0.061 0.061 4.311 -0.138 0.018 0.021 0.617
EB (HIVW) 0.026 0.016 0.017 0.289 0.064 0.059 0.060 3.957 -0.103 0.016 0.018 0.412
θ∗k
iid∼ 0.4δ(0) + 0.6U(−0.5, 0.5) E G GXE
IPD analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic 0.008 0.018 0.017 0.297 -0.020 0.064 0.062 3.749 0.031 0.021 0.021 0.454
Unconstrained 0.040 0.018 0.017 0.310 -0.022 0.063 0.060 3.633 -0.027 0.020 0.020 0.407
Constrained -0.107 0.017 0.016 0.380 -0.096 0.057 0.054 3.262 0.284 0.012 0.011 0.593
EB1 -0.007 0.016 0.017 0.302 -0.027 0.052 0.058 3.351 0.029 0.014 0.018 0.334
EB2 -0.069 0.016 0.017 0.324 -0.064 0.057 0.055 3.175 0.122 0.012 0.013 0.312
EB3 -0.066 0.016 0.017 0.321 -0.061 0.057 0.055 3.179 0.116 0.012 0.013 0.309
Meta-analysis RB SE1 SE2 MSE RB SE1 SE2 MSE RB SE1 SE2 MSE
Standard logistic(IVW) -0.006 0.018 0.017 0.279 -0.011 0.065 0.061 3.811 -0.031 0.021 0.021 0.448
Unconstrained(IVW) 0.019 0.018 0.017 0.280 -0.011 0.063 0.060 3.630 -0.031 0.020 0.020 0.460
Constrained(IVW) 0.080 0.017 0.016 0.315 -0.022 0.058 0.053 2.818 0.240 0.013 0.010 0.673
EB1 0.033 0.016 0.016 0.274 -0.002 0.054 0.058 3.382 -0.037 0.014 0.020 0.400
EB2 0.064 0.017 0.016 0.287 0.003 0.057 0.055 2.979 0.087 0.012 0.016 0.322
EB3 0.062 0.017 0.016 0.285 0.003 0.057 0.055 3.003 0.076 0.012 0.016 0.320
EB (IVW) 0.060 0.017 0.016 0.290 -0.002 0.061 0.059 3.438 -0.130 0.018 0.021 0.594
EB (HIVW) 0.060 0.017 0.016 0.288 -0.001 0.060 0.059 3.295 -0.117 0.018 0.020 0.578
a Constrained/unconstrained: the retrospective likelihood method with/without G-E independence assumption. EB1-3: EB
estimators of Â using the following strategies: (1) a conservative estimator θ̂θ̂
>
; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K), where τ̂ 2
is the MLE that maximizes the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K), where τ̄ 2 is the estimated posterior
mean of τ 2|θ̂. EB (IVW): Inverse variance weighted EB estimator combining EB estimators across study.
b RB: relative bias; SE1: mean of model based standard error; SE2: empirical standard error; MSE: mean squared error. (MSEs
have been multiplied by 1000.)
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Table 5.4: Comparison of the proposed IPD/meta-analytical methods in terms of power
and Type-I error, where E is standardized.
Power (γ∗GE = 0.2) Type-I error (γ
∗
GE = 0)
IPD analysis θ∗k = 0 θ
∗
k
iid∼ U(−0.5, 0.5) θ∗k = 0 θ∗k
iid∼ U(−0.5, 0.5)
Standard logistic 0.69 0.70 0.05 0.05
Unconstrained 0.71 0.72 0.05 0.06
Constrained 0.92 0.95 0.06 0.38
EB1 0.81 0.78 0.05 0.07
EB2 0.84 0.81 0.06 0.11
EB3 0.82 0.80 0.06 0.12
Meta-analysis
Standard logistic 0.68 0.69 0.05 0.05
Unconstrained 0.70 0.72 0.05 0.06
Constrained 0.92 0.94 0.06 0.35
EB1 0.79 0.78 0.05 0.06
EB2 0.81 0.82 0.06 0.10
EB3 0.81 0.81 0.05 0.12
EB (IVW) 0.77 0.81 0.05 0.14


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5.6: Results comparing the proposed IPD and meta-analytical methods under differ-
ent scenarios of G-E dependence/independence for the T2D study, where we
used type 2 diabetes for Y , SNPs on FTO gene for G, either age or BMI for E
(the other for S1) and gender for S2.
Methods a age∗∗∗ rs11642841∗ age×rs11642841
IPD analysis Estb SEb 95% CIb Est SE 95% CI Est SE 95% CI
Standard logistic 0.398 0.039 0.321 0.475 0.733 0.369 0.009 1.456 -0.025 0.034 -0.091 0.042
Unconstrained 0.403 0.037 0.329 0.476 0.731 0.370 0.005 1.457 -0.020 0.031 -0.081 0.041
Constrained 0.410 0.034 0.343 0.477 0.724 0.369 0.001 1.448 -0.028 0.025 -0.077 0.021
EB1 0.410 0.035 0.340 0.479 0.725 0.347 0.044 1.406 -0.027 0.029 -0.084 0.029
EB2 0.410 0.034 0.343 0.477 0.724 0.369 0.001 1.448 -0.028 0.025 -0.077 0.021
EB3 0.410 0.034 0.343 0.477 0.724 0.369 0.001 1.448 -0.028 0.025 -0.077 0.021
Meta-analysis Est SE 95% CI Est SE 95% CI Est SE 95% CI
Standard logistic 0.358 0.039 0.280 0.435 0.789 0.379 0.047 1.531 -0.026 0.034 -0.093 0.040
Unconstrained 0.352 0.038 0.278 0.426 0.753 0.378 0.013 1.493 -0.019 0.031 -0.080 0.042
Constrained 0.357 0.034 0.290 0.424 0.724 0.371 -0.002 1.451 -0.027 0.025 -0.075 0.022
EB1 0.357 0.036 0.286 0.427 0.726 0.348 0.045 1.407 -0.026 0.030 -0.084 0.032
EB2 0.357 0.034 0.290 0.424 0.724 0.371 -0.002 1.451 -0.027 0.025 -0.075 0.022
EB3 0.357 0.034 0.290 0.424 0.724 0.371 -0.002 1.451 -0.027 0.025 -0.075 0.022
EB (IVW) 0.350 0.035 0.280 0.419 0.787 0.376 0.051 1.524 -0.016 0.028 -0.070 0.038
EB (HIVW) 0.353 0.035 0.282 0.422 0.767 0.374 0.042 1.484 -0.024 0.029 -0.081 0.033
BMI∗∗∗ rs6499640 BMI×rs6499640∗
IPD analysis Est SE 95% CI Est SE 95% CI Est SE 95% CI
Standard logistic 1.568 0.093 1.386 1.750 -0.225 0.378 -0.967 0.516 0.229 0.090 0.053 0.405
Unconstrained 1.590 0.085 1.424 1.756 -0.216 0.374 -0.949 0.517 0.202 0.074 0.057 0.347
Constrained 1.735 0.073 1.591 1.878 -0.484 0.365 -1.200 0.232 0.018 0.048 -0.076 0.113
EB1 1.608 0.068 1.474 1.742 -0.251 0.344 -0.924 0.423 0.179 0.052 0.076 0.281
EB2 1.609 0.078 1.456 1.761 -0.252 0.385 -1.006 0.502 0.178 0.061 0.059 0.297
EB3 1.603 0.079 1.448 1.758 -0.241 0.386 -0.998 0.516 0.185 0.064 0.061 0.310
Meta-analysis Est SE 95% CI Est SE 95% CI Est SE 95% CI
Standard logistic 1.452 0.093 1.268 1.635 -0.147 0.387 -0.906 0.612 0.222 0.091 0.044 0.400
Unconstrained 1.479 0.085 1.311 1.646 -0.160 0.381 -0.906 0.586 0.202 0.074 0.056 0.348
Constrained 1.630 0.074 1.485 1.775 -0.447 0.372 -1.175 0.282 0.015 0.048 -0.080 0.110
EB1 1.498 0.070 1.361 1.634 -0.196 0.350 -0.882 0.490 0.179 0.053 0.076 0.282
EB2 1.499 0.078 1.345 1.652 -0.198 0.392 -0.966 0.571 0.177 0.061 0.057 0.297
EB3 1.493 0.080 1.336 1.649 -0.186 0.394 -0.958 0.586 0.185 0.064 0.060 0.310
EB (IVW) 1.572 0.077 1.421 1.724 -0.440 0.375 -1.174 0.294 0.107 0.067 -0.026 0.239
EB (HIVW) 1.543 0.077 1.416 1.718 -0.375 0.381 -1.012 0.286 0.147 0.060 0.029 0.264
BMI∗∗∗ rs1121980 BMI×rs1121980∗
IPD analysis Est SE 95% CI Est SE 95% CI Est SE 95% CI
Standard logistic 1.703 0.100 1.507 1.898 0.476 0.370 -0.250 1.201 0.049 0.087 -0.121 0.218
Unconstrained 1.691 0.090 1.514 1.868 0.466 0.368 -0.256 1.188 0.061 0.073 -0.081 0.204
Constrained 1.621 0.076 1.472 1.769 0.593 0.360 -0.113 1.300 0.142 0.047 0.049 0.235
EB1 1.661 0.071 1.522 1.801 0.520 0.313 -0.094 1.134 0.095 0.050 -0.002 0.193
EB2 1.658 0.074 1.514 1.802 0.525 0.369 -0.197 1.248 0.099 0.043 0.016 0.182
EB3 1.665 0.075 1.517 1.813 0.513 0.372 -0.216 1.241 0.091 0.047 0.001 0.182
Meta-analysis Est SE 95% CI Est SE 95% CI Est SE 95% CI
Standard logistic 1.578 0.101 1.379 1.777 0.578 0.378 -0.164 1.320 0.060 0.088 -0.112 0.232
Unconstrained 1.579 0.091 1.400 1.757 0.563 0.375 -0.172 1.298 0.064 0.073 -0.080 0.207
Constrained 1.514 0.077 1.364 1.664 0.662 0.367 -0.057 1.381 0.138 0.048 0.045 0.232
EB1 1.548 0.071 1.408 1.688 0.609 0.315 -0.008 1.227 0.099 0.049 0.003 0.194
EB2 1.543 0.074 1.398 1.687 0.618 0.372 -0.112 1.347 0.105 0.040 0.026 0.184
EB3 1.549 0.075 1.402 1.696 0.608 0.374 -0.126 1.342 0.098 0.043 0.013 0.182
EB (IVW) 1.511 0.086 1.343 1.679 0.662 0.370 -0.064 1.388 0.137 0.065 0.009 0.264
EB (HIVW) 1.526 0.082 1.356 1.677 0.632 0.371 -0.043 1.418 0.142 0.052 0.029 0.262
a Constrained/unconstrained: the retrospective likelihood method with/withoutG-E independence assumption. EB1-3:
EB estimators of Â using the following strategies: (1) a conservative estimator θ̂θ̂
>
; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K),
where τ̂ 2 is the MLE that maximizes the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K), where τ̄ 2 is the
estimated posterior mean of τ 2|θ̂. EB (IVW): Inverse variance weighted EB estimator combining EB estimators
across study.
b Est: estimate; SE: standard error; CI: confidence interval. (All numbers have been multiplied by 10 to compare the
results in 3 significant digits.)
∗ ∗ < 0.05; ∗∗ < 0.01; ∗ ∗ ∗ < 0.001.
CHAPTER VI
Conclusion
My dissertation work is around the theme of Bayesian modeling for environmental
association and gene-environment interaction under complex epidemiologic study designs.
The first two projects considered the problems of characterizing effect of environmental
exposure on health outcomes under complex sampling designs, in particular, a matched
case-control study with multiple disease sub-types and nonlinear odds ratio functions for
point source modeling in project 2 and Bayesian analysis of time-series data under case-
crossover designs under project 3. In the last two projects, we addressed several important
issues in meta-analysis ofG-E interactions. We studied the role ofG-E independence and
environmental heterogeneity across studies on the characteristics of several meta-analysis
approaches. We focused on quantitative traits in project 3 and dichotomous traits under
case-control sampling in the last project. The following paragraphs list the corresponding
conclusion remarks for each chapter respectively.
In the first project, we considered sub-types within cases under a matched case-control
design for point sources modeling with nonlinear odds ratio functions. Frequentist and
Bayesian inference methods were evaluated. With multiple parameters and non-linear
model, Bayesian methods using MCMC techniques appear to have advantages in terms of
estimation stability and precision over the frequentist alternatives. Moreover, the posterior
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estimate of the odds ratio function f̂k and the corresponding HPD interval can be obtained
based on exact posterior draws that avoids large sample approximation such as the Delta
theorem for a frequentist MLE. For a MLE, the asymptotic properties might not hold for
the complex likelihood derived from the non-linear models, especially when the sample
size is not large. The proposed methods were applied to a population-based matched case-
control study investigating associations between acute asthma outcomes and proximity
of residence to major roads by analyzing Medicaid claims data for the pediatric asthma
population in Detroit, MI, from 2004-2006. We addressed the research problem regarding
associations between acute asthma risk and proximity of residence to major roads, and
showed that the proposed PCM offered better fit compared to the model with standard
case-control status. The results indicated that the odds ratio at the point source is 1.2-1.3
as compared to the background odds of disease in the case-control population, and the
freeway effect on asthma lasts up to around 500 meters where the first 250 meters have
stronger influence.
The second project considered Bayesian analysis of time-series data under case-crossover
designs. The contribution of this project is two-fold. First, we established Bayesian equiv-
alence results that require characterization of the time function St in a log-linear model
for a given choice of window W (t) under a particular case-crossover design, and re-
quire characterization of the set of priors under which the posterior distributions of the
risk ratio parameters based on a case-crossover design and log-linear model are identical.
Second, we considered a more general full likelihood-based approach which made less
restrictive assumptions on the baseline risk models and exposure series. We proposed a
semi-parametric Bayesian approach using a Dirichlet process prior to handle the random
nuisance parameters that appear in a full likelihood formulation under a case-crossover
design. This work leads to many potential extensions where a Bayesian analysis may have
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attractive features, such as distributed lag linear/non-linear models and hierarchical mod-
els for meta-analyses. The proposed methods were illustrated through the DAMAT study,
but instead of the distance to the major roads, we focused on the effect of ambient air pol-
lutant concentrations on the acute asthma risk. Evidence of significant increases in acute
asthma risk was found with 10 µgm−3 increase in PM2.5 concentrations leading to a risk
ratio ranging from 1.02 to 1.06 across different methods.
The third project considered meta-analysis of G-E interaction for quantitative traits.
In this project, we studied the effect of environmental covariate heterogeneity (within and
between cohorts) on two approaches for fixed-effects meta-analysis: the standard inverse-
variance weighted meta-analysis and a meta-regression approach. Akin to the results ob-
tained in Simmonds and Higgins (2007), we obtain analytical efficiency expressions for
both methods under the assumption of gene-environment independence. The relative effi-
ciency of the two methods depend on the ratio of within versus between cohort variance of
the environmental covariate. We propose to use an adaptively weighted estimator (AWE),
as a combination of meta-analysis and meta-regression estimators, that can be used as a
default choice, retaining full efficiency of the ‘gold standard’ joint analysis for the in-
teraction parameter using individual level data under certain natural assumptions. The
AWE improves efficiency by combining meta-analysis and meta-regression based on only
univariate summary statistics from each study, and bypasses issues with sharing of indi-
vidual level data or multivariate information matrices across studies without sacrificing
efficiency. AWE also has advantage over MIVW when the effect of G or E are uncom-
mon across studies. We compared the performance of the proposed methods under a wide
spectrum of scenarios and showed that the AWE can serve as a default estimator. The
methods were illustrated through meta-analysis of GEI between SNP in the FTO gene and
BMI on HDL-C data from a set of T2D studies. Under an additive model, with 1 kg/m2
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increase in BMI, HDL-C level on average decreased by 1.73% (95% CI: (1.57, 1.90)%)
given rs1121980=GG, by 1.54% (95% CI: (1.44, 1.64)%) given rs1121980=AG or GA;
and by 1.35% (95% CI: (1.17, 1.53)%) given rs1121980=AA. The results indicated that
the presence of minor allele A in rs1121980 attenuated the negative association between
BMI and HDL-C.
The last project extended the work of project 3 to dichotomous traits under case-control
studies. In this project, we proposed a meta-analysis approach that uses retrospective like-
lihood as the basis for inference and leverages the G-E independence assumption in a
data-adaptive way. The proposed shrinkage estimator provides optimal choices for weights
corresponding to constrained and unconstrained models by using information on G-E as-
sociation parameters derived from multiple studies/cohorts. Our work showed that this
novel estimator has better MSE properties than IVW estimator pooling study specific con-
strained, unconstrained or EB estimators. The results were illustrated through the T2D
studies as well. We used T2D status as the case-control outcome and studied the GEI be-
tween SNPs in the FTO gene and environmental factors such as age and BMI for demon-
stration purpose. Under an additive model, with 1 kg/m2 increase in BMI, the odds ratio
of T2D is 1.17 (95% CI: (1.15, 1.19)) given rs6499640=GG, 1.20 (95% CI: (1.17, 1.24))
given rs6499640=AG or GA; and 1.22 (95% CI: (1.19, 1.26)) given rs6499640=AA. The
trend of the odds ratios of T2D among the three groups defined by rs6499640 indicated
that the presence of minor allele A in rs6499640 enhanced the association between BMI
and T2D.
In summary, my dissertation work is expected to contribute to important analytical






(Appendix Figures and Tables)
A.1 Supplementary Figures and Tables for Chapter 2
Figure A.1: Estimated posterior densities for different settings of prior choices for the one
point source polychotomous category model for the Detroit Medicaid data,
as a sensitivity analysis.
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(a) Estimated posterior densities using normal priors on log (1 +α) and log (β)
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(−1, βmax)
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Figure A.2: Estimated posterior densities for different settings of prior choices for the one
point source binary model and homogeneous adjacent category model for
the Detroit Medicaid data. Prior 1: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) =
(0.25, 150); Prior 2: (µα, µβ) = (0.5, 400) and (σ2α, σ
2
β) = (0.5, 400).
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Figure A.3: Estimated posterior densities for different settings of prior choices for the one
point source adjacent category model and polychotomous category model
for the Detroit Medicaid data. Prior 1: (µα1 , µβ1) = (µα2 , µβ2) = (0.5, 400)
and (σ2α1 , σ
2
β1
) = (σ2α2 , σ
2
β2
) = (0.25, 150); Prior 2: (µα1 , µβ1) = (µα2 , µβ2) =
(0.5, 400) and (σ2α1 , σ
2
β1
) = (σ2α2 , σ
2
β2
) = (0.5, 400).
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Table A.1: Summary statistics across the five inference methods for the one point source
adjacent category model (homogeneousness), based onR = 500 simulations
with sample sizeN = 500.
Sample size N=500 u = log(1 + α) v = log(β)
(α, β) Methoda RBb(%) MSEb CPb(%) RB(%) MSE CP(%)
(0.7, 500) MLE 19.6 0.036 97 1.7 0.113 92
Profile 12.9 0.024 98 0.3 0.089 90
IRLS 13.0 0.024 98 0.2 0.088 90
Bayesian P1 -10.3 0.006 98 -0.6 0.017 99
Bayesian P2 5.7 0.008 98 1.2 0.055 98
(0.7, 300) MLE 9.4 0.018 95 0.9 0.087 90
Profile 9.0 0.017 98 -0.8 0.076 91
IRLS 9.4 0.018 98 -0.8 0.076 90
Bayesian P1 -14.2 0.010 93 3.3 0.049 94
Bayesian P2 -1.4 0.010 99 2.0 0.055 93
(0.4, 500) MLE 24.8 0.021 96 -0.2 0.228 80
Profile 24.7 0.023 98 -0.2 0.218 92
IRLS 24.8 0.021 98 -0.2 0.199 92
Bayesian P1 4.4 0.003 100 -0.8 0.016 99
Bayesian P2 17.6 0.009 95 2.7 0.112 98
(0.4, 300) MLE 25.6 0.025 96 -0.3 0.196 87
Profile 25.3 0.025 96 -0.3 0.196 88
IRLS 25.6 0.025 96 -0.3 0.196 88
Bayesian P1 4.1 0.003 100 4.5 0.080 97
Bayesian P2 13.4 0.008 96 4.9 0.204 96
(0.5, 200) MLE 16.2 0.026 98 -0.3 0.192 81
Profile 16.3 0.026 99 -0.3 0.192 89
IRLS 16.2 0.026 99 -0.2 0.192 90
Bayesian P1 -15.8 0.007 96 5.3 0.321 91
Bayesian P2 -5.1 0.007 99 6.0 0.539 86
a MLE: Maximum likelihood estimate; Profile: Profile likelihood based estimate
and confidence interval; IRLS: iteratively re-weighted least squares; Bayesian P1
and P2 refer to two settings of prior choice; Prior 1: (µα, µβ) = (0.5, 400) and
(σ2α, σ
2




β) = (0.5, 400).






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A.2 Supplementary Figures and Tables for Chapter 3
































































































































































































































































































































































































































































































A.3 Supplementary Figures and Tables for Chapter 4
Figure A.5: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study. Setting (a), under both assumptions 1 and 2.






































Figure A.6: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study. Setting (b), under assumption 1 but not 2.







































Figure A.7: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study. Setting (c), under assumption 2 but not 1.






































Figure A.8: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study, for the situation of lack of common set of con-
founders to adjust under both assumptions 1 and 2 (setting a).








































Figure A.9: Comparison of the proposed meta-analytical methods (in terms of power) un-
der different scenarios of susceptibility models and covariate heterogeneity
through a simulation study, for the situation of lack of common set of con-
founders to adjust under assumption 1 but not 2 (setting b).







































Figure A.10: Comparison of the proposed meta-analytical methods (in terms of power)
under different scenarios of susceptibility models and covariate heterogene-
ity through a simulation study, for the situation of lack of common set of
confounders to adjust under assumption 2 but not 1 (setting c).








































Figure A.11: Power curves under misspecified susceptibility models (dominant/additive),
where the generating co-dominant model has δAA = 1.5δAa, and no assump-
tion of gene-environment independence or homogeneity in allele frequencies
is assumed.






































Figure A.12: Marginal SNP (rs1121980) effect against mean covariate values of age and
BMI across cohorts in the FUSION study. Solid line: Meta-regression line;
Dashed line: Meta-regression line without outlier (cohort FUSION-FS for
age and cohort DPS for BMI).












































study specific mean BMI (kg/m2)
DPS
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Table A.6: Comparison of the proposed meta-analytical methods under different scenar-
ios of susceptibility models and covariate heterogeneity through a simulation
study. Setting (a): under both assumptions 1 and 2.
E(WSS/BSS)=2 E(BSS/WSS)=2
Methoda RBb(%) MVb EVb MSEb Power RB (%) MV EV MSE Power
R2=0 Dominant IPD 1.14 1.12 1.12 0.04 1.15 1.12 1.12 0.05
UIVW 1.73 1.71 1.71 0.05 3.39 3.46 3.46 0.05
REM 2.08 1.78 1.78 0.04 4.07 3.58 3.57 0.04
MIVW 1.13 1.12 1.12 0.05 1.15 1.12 1.12 0.05
MR 3.91 4.06 4.06 0.07 1.95 1.82 1.82 0.08
AWE 1.13 1.19 1.19 0.06 1.16 1.19 1.19 0.07
Additive IPD 0.75 0.75 0.75 0.06 0.76 0.68 0.68 0.05
UIVW 1.15 1.11 1.11 0.05 2.25 2.39 2.38 0.06
REM 1.38 1.15 1.15 0.04 2.69 2.44 2.44 0.06
MIVW 0.75 0.75 0.75 0.06 0.76 0.68 0.68 0.04
MR 2.62 2.55 2.55 0.06 1.25 1.24 1.25 0.06
AWE 0.75 0.79 0.79 0.06 0.76 0.72 0.72 0.05
R2= 0.05% Dominant IPD 0.44 1.14 1.15 1.15 0.56 -1.78 1.13 1.29 1.29 0.59
UIVW 1.60 1.71 1.75 1.75 0.39 0.11 3.31 3.28 3.28 0.24
REM 1.67 2.06 1.79 1.79 0.33 0.02 3.98 3.42 3.42 0.20
MIVW 0.42 1.13 1.15 1.15 0.56 -1.78 1.13 1.29 1.29 0.58
MR 0.27 4.05 4.20 4.20 0.24 -2.14 1.90 2.01 2.01 0.44
AWE 0.50 1.13 1.21 1.21 0.56 -1.90 1.13 1.36 1.36 0.57
Additive IPD 0.64 0.75 0.76 0.76 0.55 -0.81 0.75 0.79 0.79 0.59
UIVW -0.85 1.14 1.14 1.14 0.41 2.12 2.19 2.35 2.35 0.24
REM -0.52 1.34 1.17 1.16 0.36 2.11 2.60 2.38 2.38 0.20
MIVW 0.71 0.75 0.76 0.76 0.54 -0.66 0.75 0.80 0.80 0.58
MR 5.59 2.64 2.89 2.90 0.22 -1.25 1.26 1.24 1.24 0.43
AWE 1.15 0.75 0.81 0.81 0.54 -0.59 0.75 0.83 0.83 0.58
R2= 0.15% Dominant IPD 1.29 1.11 1.26 1.26 0.98 -0.28 1.14 1.44 1.44 0.99
UIVW 1.22 1.69 1.78 1.78 0.92 -1.14 3.31 3.38 3.38 0.72
REM 1.62 2.01 1.84 1.84 0.88 -1.50 4.00 3.52 3.53 0.66
MIVW 1.33 1.10 1.26 1.26 0.98 -0.34 1.14 1.44 1.44 0.98
MR 1.50 3.95 4.57 4.57 0.63 0.02 1.95 2.46 2.46 0.90
AWE 1.47 1.11 1.34 1.34 0.98 -0.29 1.14 1.53 1.53 0.98
Additive IPD -0.20 0.73 0.76 0.76 0.99 -0.32 0.75 0.95 0.95 0.99
UIVW 0.33 1.12 1.10 1.10 0.93 0.09 2.20 2.46 2.46 0.69
REM 0.58 1.33 1.14 1.14 0.89 0.27 2.68 2.58 2.58 0.62
MIVW -0.18 0.73 0.76 0.76 0.99 -0.30 0.75 0.96 0.96 0.99
MR -2.43 2.59 2.61 2.61 0.67 0.06 1.30 1.45 1.45 0.90
AWE -0.39 0.74 0.81 0.81 0.99 -0.36 0.76 1.02 1.02 0.99
R2= 0.25% Dominant IPD 0.44 1.11 1.30 1.30 1.00 0.66 1.11 1.71 1.71 1.00
UIVW 0.36 1.68 1.97 1.97 0.98 0.12 3.28 3.79 3.79 0.85
REM 0.30 1.97 2.00 2.00 0.97 -0.00 3.93 4.02 4.02 0.81
MIVW 0.47 1.11 1.30 1.30 1.00 0.70 1.11 1.72 1.72 1.00
MR 0.20 4.02 4.31 4.31 0.82 0.75 1.90 2.48 2.48 0.98
AWE 0.50 1.12 1.37 1.37 1.00 0.73 1.12 1.79 1.79 1.00
Additive IPD 0.13 0.74 0.87 0.86 1.00 -0.30 0.74 1.02 1.02 1.00
UIVW -0.34 1.12 1.22 1.22 0.99 -0.31 2.18 2.49 2.48 0.85
REM -0.40 1.31 1.26 1.26 0.97 -0.42 2.67 2.60 2.60 0.80
MIVW 0.12 0.73 0.87 0.87 1.00 -0.27 0.74 1.03 1.02 1.00
MR 0.48 2.73 2.79 2.79 0.80 0.02 1.25 1.59 1.58 0.98
AWE -0.01 0.75 0.89 0.89 1.00 -0.03 0.74 1.07 1.07 1.00
a IPD: individual patient data analysis; UIVW: univariate inverse-variance weighted estimator; REM: random effect model; MIVW:
multivariate inverse-variance weighted estimator; MR: Meta-regression; AWE: adaptively weighted estimator.
b RB: relative bias; MV: mean of model based variance; EV: empirical variance; MSE: mean squared error. (MV, EV and MSE have been
multiplied by 100.)
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Table A.7: Comparison of the proposed meta-analytical methods under different scenar-
ios of susceptibility models and covariate heterogeneity through a simulation
study. Setting (b): under assumption 1 but not 2.
E(WSS/BSS)=2 E(BSS/WSS)=2
Methoda RBb(%) MVb EVb MSEb Power RB (%) MV EV MSE Power
R2= 0 Dominant IPD 1.16 1.21 1.21 0.05 1.18 1.04 1.04 0.03
UIVW 1.79 1.89 1.88 0.04 3.49 3.35 3.36 0.04
REM 2.09 1.92 1.92 0.04 4.15 3.42 3.43 0.04
MIVW 1.16 1.21 1.21 0.05 1.17 1.04 1.04 0.03
MR 4.18 4.20 4.20 0.06 1.96 1.78 1.78 0.05
AWE 1.19 1.28 1.28 0.07 1.18 1.08 1.08 0.04
Additive IPD 0.75 0.75 0.75 0.05 0.77 0.81 0.81 0.06
UIVW 1.17 1.18 1.18 0.05 2.28 2.50 2.50 0.06
REM 1.37 1.19 1.19 0.05 2.75 2.56 2.56 0.04
MIVW 0.75 0.75 0.75 0.05 0.77 0.81 0.81 0.06
MR 2.70 2.54 2.54 0.05 1.32 1.31 1.31 0.07
AWE 0.77 0.81 0.81 0.06 0.78 0.86 0.86 0.07
R2= 0.05 Dominant IPD -0.13 1.15 1.15 1.15 0.56 -1.93 1.16 1.23 1.23 0.57
UIVW 0.88 1.78 1.86 1.86 0.40 -2.00 3.45 3.65 3.65 0.25
REM 0.89 2.13 1.91 1.91 0.34 -1.88 4.15 3.74 3.74 0.21
MIVW -0.13 1.15 1.16 1.16 0.56 -1.95 1.16 1.23 1.23 0.57
MR -0.80 4.11 4.00 4.00 0.25 -2.55 2.00 2.02 2.02 0.40
AWE 0.45 1.17 1.26 1.26 0.54 -2.03 1.19 1.30 1.30 0.56
Additive IPD -0.78 0.75 0.79 0.79 0.56 -1.15 0.76 0.83 0.83 0.57
UIVW 0.05 1.16 1.22 1.21 0.39 -0.10 2.27 2.40 2.39 0.23
REM 0.06 1.39 1.28 1.28 0.34 1.20 2.72 2.51 2.51 0.19
MIVW -0.84 0.75 0.80 0.80 0.56 -1.24 0.76 0.83 0.83 0.57
MR -3.05 2.72 2.79 2.79 0.25 -1.25 1.29 1.34 1.34 0.38
AWE -0.98 0.77 0.86 0.86 0.56 -0.81 0.77 0.87 0.87 0.55
R2= 0.15 Dominant IPD -0.00 1.14 1.16 1.16 0.99 0.82 1.15 1.51 1.51 0.98
UIVW -1.33 1.75 1.67 1.68 0.94 0.28 3.42 3.73 3.73 0.66
REM -1.15 2.10 1.73 1.73 0.90 0.41 4.09 3.81 3.81 0.58
MIVW -0.02 1.13 1.17 1.17 0.99 0.80 1.15 1.52 1.52 0.98
MR 2.56 4.23 3.95 3.96 0.60 0.99 2.02 2.25 2.25 0.89
AWE -0.13 1.17 1.24 1.24 0.99 0.90 1.17 1.56 1.56 0.98
Additive IPD -0.65 0.74 0.82 0.82 0.99 0.57 0.75 0.97 0.96 0.99
UIVW -0.81 1.15 1.23 1.23 0.92 1.35 2.24 2.34 2.34 0.66
REM -0.90 1.37 1.26 1.26 0.90 1.30 2.71 2.44 2.44 0.59
MIVW -0.73 0.74 0.82 0.82 0.99 0.57 0.75 0.97 0.97 0.99
MR -0.29 2.76 2.58 2.58 0.63 -0.05 1.32 1.51 1.51 0.89
AWE -0.63 0.77 0.87 0.87 0.99 0.36 0.77 1.01 1.01 0.98
R2= 0.25 Dominant IPD -0.38 1.13 1.18 1.18 1.00 -0.32 1.13 1.75 1.75 1.00
UIVW -0.95 1.74 1.85 1.85 0.99 -0.33 3.38 4.08 4.07 0.84
REM -1.08 2.06 1.91 1.91 0.98 -0.48 4.07 4.17 4.16 0.80
MIVW -0.35 1.12 1.19 1.19 1.00 -0.39 1.13 1.76 1.76 1.00
MR -0.58 4.08 4.39 4.39 0.82 -0.92 1.97 2.57 2.57 0.98
AWE -0.59 1.15 1.28 1.28 1.00 -0.43 1.17 1.86 1.86 1.00
Additive IPD 0.77 0.74 0.84 0.84 1.00 1.17 0.74 1.15 1.15 1.00
UIVW 0.07 1.15 1.24 1.24 0.99 1.71 2.22 2.69 2.70 0.83
REM 0.16 1.37 1.26 1.26 0.97 1.55 2.67 2.72 2.72 0.79
MIVW 0.81 0.74 0.84 0.84 1.00 1.10 0.74 1.15 1.15 1.00
MR 2.13 2.76 2.86 2.87 0.78 0.88 1.28 1.81 1.81 0.98
AWE 0.74 0.77 0.90 0.90 1.00 1.34 0.76 1.20 1.21 1.00
a IPD: individual patient data analysis; UIVW: univariate inverse-variance weighted estimator; REM: random effect model; MIVW:
multivariate inverse-variance weighted estimator; MR: Meta-regression; AWE: adaptively weighted estimator.
b RB: relative bias; MV: mean of model based variance; EV: empirical variance; MSE: mean squared error. (MV, EV and MSE have
been multiplied by 100.)
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Table A.8: Comparison of the proposed meta-analytical methods under different scenar-
ios of susceptibility models and covariate heterogeneity through a simulation
study. Setting (c): under assumption 2 but not 1.
E(WSS/BSS)=2 E(BSS/WSS)=2
Methoda RBb(%) MVb EVb MSEb Power RB (%) MV EV MSE Power
R2= 0 Dominant IPD 1.21 1.30 1.30 0.06 1.19 1.24 1.24 0.05
UIVW 1.92 1.98 1.98 0.05 3.76 3.95 3.96 0.06
REM 2.28 2.03 2.03 0.04 4.56 4.13 4.14 0.05
MIVW 1.21 1.30 1.30 0.06 1.19 1.24 1.24 0.05
MR 4.01 3.82 3.82 0.06 2.05 1.97 1.97 0.07
AWE 1.22 1.41 1.41 0.08 1.24 1.41 1.41 0.07
Additive IPD 0.76 0.73 0.73 0.04 0.76 0.75 0.75 0.05
UIVW 1.18 1.17 1.17 0.06 2.30 2.24 2.24 0.05
REM 1.40 1.20 1.20 0.04 2.78 2.26 2.25 0.03
MIVW 0.76 0.73 0.73 0.04 0.76 0.75 0.75 0.05
MR 2.61 2.56 2.56 0.07 1.37 1.44 1.44 0.06
AWE 0.76 0.79 0.79 0.06 0.80 0.83 0.83 0.06
R2= 0.05 Dominant IPD 2.60 1.20 1.34 1.34 0.54 1.44 1.17 1.20 1.20 0.56
UIVW 0.14 1.90 1.99 1.98 0.40 4.08 3.73 3.74 3.74 0.21
REM 0.09 2.28 2.05 2.05 0.35 3.14 4.46 3.84 3.84 0.18
MIVW 2.68 1.19 1.35 1.35 0.55 1.34 1.17 1.20 1.20 0.56
MR 6.78 3.99 4.18 4.20 0.24 0.55 2.09 2.20 2.19 0.39
AWE 2.25 1.21 1.39 1.39 0.54 1.06 1.24 1.36 1.36 0.54
Additive IPD 1.66 0.75 0.78 0.78 0.55 -1.80 0.76 0.86 0.86 0.58
UIVW 2.22 1.16 1.24 1.24 0.39 -5.26 2.28 2.30 2.30 0.25
REM 2.64 1.38 1.25 1.25 0.34 -4.94 2.73 2.38 2.39 0.22
MIVW 1.85 0.75 0.78 0.78 0.55 -1.73 0.75 0.86 0.86 0.57
MR 2.33 2.67 2.83 2.83 0.25 0.72 1.36 1.40 1.40 0.40
AWE 2.56 0.76 0.85 0.85 0.54 -1.42 0.80 0.96 0.96 0.56
R2= 0.15 Dominant IPD -0.20 1.18 1.20 1.20 1.00 -0.93 1.19 1.63 1.63 0.99
UIVW -0.32 1.86 1.85 1.85 0.94 -1.91 3.66 4.26 4.26 0.70
REM -0.10 2.23 1.93 1.93 0.89 -1.68 4.42 4.35 4.35 0.63
MIVW -0.17 1.18 1.20 1.20 1.00 -0.95 1.18 1.62 1.62 0.99
MR -0.78 4.09 3.86 3.85 0.69 -0.52 2.19 2.67 2.67 0.90
AWE -0.11 1.21 1.26 1.26 0.99 -0.82 1.26 1.72 1.72 0.98
Additive IPD 0.10 0.74 0.76 0.76 0.99 -0.39 0.76 1.08 1.08 0.99
UIVW 0.12 1.14 1.15 1.15 0.93 -1.12 2.23 2.35 2.35 0.71
REM -0.01 1.36 1.19 1.19 0.90 -1.13 2.72 2.48 2.48 0.65
MIVW 0.12 0.74 0.77 0.77 0.99 -0.34 0.76 1.08 1.08 0.99
MR -0.29 2.69 2.65 2.65 0.64 -0.19 1.43 1.83 1.83 0.88
AWE -0.26 0.75 0.80 0.80 0.99 -0.34 0.81 1.19 1.19 0.98
R2= 0.25 Dominant IPD -0.66 1.15 1.35 1.35 1.00 -0.70 1.13 1.77 1.77 1.00
UIVW -0.51 1.84 2.09 2.09 0.99 -1.03 3.60 4.24 4.24 0.84
REM -0.29 2.16 2.15 2.15 0.97 -1.43 4.31 4.34 4.35 0.79
MIVW -0.71 1.15 1.36 1.36 1.00 -0.70 1.12 1.79 1.79 1.00
MR -1.69 3.94 4.03 4.04 0.87 -1.01 1.99 2.61 2.62 0.97
AWE -1.10 1.18 1.49 1.49 1.00 -1.19 1.20 1.94 1.95 1.00
Additive IPD -1.31 0.73 0.88 0.89 1.00 0.93 0.73 1.04 1.04 1.00
UIVW -1.19 1.13 1.27 1.27 0.99 1.15 2.21 2.49 2.49 0.85
REM -1.29 1.35 1.31 1.31 0.98 1.20 2.67 2.56 2.56 0.79
MIVW -1.36 0.72 0.89 0.89 1.00 0.90 0.72 1.04 1.04 1.00
MR -2.50 2.56 2.84 2.85 0.84 0.26 1.38 1.71 1.71 0.96
AWE -1.68 0.74 0.95 0.96 1.00 0.46 0.79 1.19 1.19 1.00
a IPD: individual patient data analysis; UIVW: univariate inverse-variance weighted estimator; REM: random effect model; MIVW:
multivariate inverse-variance weighted estimator; MR: Meta-regression; AWE: adaptively weighted estimator.
b RB: relative bias; MV: mean of model based variance; EV: empirical variance; MSE: mean squared error. (MV, EV and MSE have
been multiplied by 100.)
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Table A.9: Comparison of the proposed meta-analytical methods under different scenar-
ios of susceptibility models and covariate heterogeneity through a simulation
study. Setting (d): without assumption 1 or 2.
E(WSS/BSS)=2 E(BSS/WSS)=2
Methoda RBb(%) MVb EVb MSEb Power RB (%) MV EV MSE Power
R2= 0 Dominant IPD 1.23 1.21 1.21 0.04 1.22 1.16 1.16 0.04
UIVW 1.99 2.08 2.08 0.06 3.89 4.02 4.02 0.05
REM 2.40 2.13 2.13 0.04 4.68 4.18 4.18 0.04
MIVW 1.22 1.22 1.22 0.04 1.22 1.16 1.16 0.04
MR 4.05 4.13 4.13 0.07 2.12 2.05 2.06 0.06
AWE 1.26 1.35 1.35 0.05 1.29 1.33 1.33 0.06
Additive IPD 0.76 0.74 0.74 0.05 0.78 0.76 0.75 0.04
UIVW 1.20 1.21 1.21 0.05 2.35 2.42 2.42 0.06
REM 1.43 1.24 1.24 0.04 2.84 2.48 2.48 0.04
MIVW 0.76 0.74 0.74 0.04 0.77 0.75 0.75 0.04
MR 2.67 2.66 2.66 0.07 1.38 1.35 1.35 0.06
AWE 0.78 0.84 0.84 0.05 0.81 0.85 0.85 0.06
R2= 0.05 Dominant IPD -2.87 1.21 1.21 1.21 0.59 0.54 1.21 1.34 1.34 0.55
UIVW -3.68 1.95 2.11 2.12 0.42 1.82 3.81 4.03 4.03 0.23
REM -3.78 2.34 2.18 2.19 0.37 1.18 4.66 4.12 4.12 0.19
MIVW -2.96 1.20 1.22 1.22 0.59 0.51 1.21 1.35 1.34 0.56
MR 0.19 4.17 4.03 4.02 0.26 -0.59 2.16 2.45 2.45 0.40
AWE -3.18 1.25 1.32 1.32 0.57 0.04 1.29 1.46 1.46 0.53
Additive IPD 0.23 0.75 0.80 0.80 0.55 -0.16 0.77 0.83 0.83 0.57
UIVW 1.14 1.18 1.22 1.22 0.37 0.85 2.31 2.46 2.46 0.23
REM 1.40 1.40 1.27 1.27 0.33 1.21 2.80 2.52 2.52 0.19
MIVW 0.35 0.75 0.81 0.81 0.55 -0.18 0.77 0.84 0.84 0.57
MR 0.93 2.67 2.96 2.95 0.24 -0.10 1.44 1.35 1.35 0.37
AWE 0.84 0.77 0.86 0.86 0.54 -0.15 0.82 0.93 0.93 0.54
R2= 0.15 Dominant IPD 0.52 1.19 1.25 1.25 0.99 0.09 1.17 1.51 1.51 0.98
UIVW 1.30 1.92 2.00 2.01 0.91 0.03 3.75 4.13 4.13 0.65
REM 1.18 2.28 2.08 2.08 0.87 0.16 4.50 4.21 4.21 0.59
MIVW 0.58 1.18 1.26 1.26 0.99 0.14 1.17 1.52 1.52 0.98
MR -0.82 4.04 4.28 4.28 0.67 -0.31 2.07 2.45 2.45 0.90
AWE 0.62 1.23 1.36 1.36 0.99 0.01 1.25 1.63 1.63 0.98
Additive IPD 0.85 0.74 0.78 0.78 0.99 0.74 0.75 0.86 0.86 0.99
UIVW 0.40 1.17 1.24 1.24 0.92 1.29 2.27 2.28 2.28 0.67
REM 0.63 1.41 1.29 1.28 0.87 1.40 2.73 2.36 2.37 0.59
MIVW 0.85 0.74 0.78 0.78 0.99 0.73 0.75 0.86 0.86 0.99
MR 1.62 2.70 2.56 2.56 0.65 0.05 1.40 1.60 1.60 0.87
AWE 0.78 0.76 0.86 0.86 0.98 0.87 0.80 0.95 0.95 0.97
R2= 0.25 Dominant IPD -0.54 1.18 1.36 1.36 1.00 -0.04 1.16 1.62 1.62 1.00
UIVW 0.09 1.90 2.17 2.17 0.98 -0.13 3.75 4.32 4.32 0.82
REM 0.15 2.23 2.19 2.19 0.97 -0.21 4.54 4.45 4.45 0.77
MIVW -0.54 1.18 1.37 1.37 1.00 -0.05 1.15 1.63 1.63 1.00
MR -1.68 4.22 4.43 4.43 0.83 0.18 2.04 2.66 2.66 0.98
AWE -0.63 1.23 1.51 1.51 1.00 0.19 1.24 1.82 1.82 1.00
Additive IPD -1.22 0.74 0.85 0.85 1.00 -0.28 0.74 1.13 1.13 1.00
UIVW -0.98 1.15 1.22 1.22 0.99 -0.50 2.28 2.73 2.73 0.83
REM -0.98 1.38 1.27 1.27 0.97 -0.65 2.74 2.75 2.75 0.80
MIVW -1.26 0.73 0.85 0.85 1.00 -0.28 0.74 1.14 1.14 1.00
MR -2.67 2.73 3.00 3.02 0.83 0.32 1.41 1.84 1.84 0.96
AWE -1.23 0.76 0.93 0.93 1.00 -0.12 0.81 1.25 1.25 1.00
a IPD: individual patient data analysis; UIVW: univariate inverse-variance weighted estimator; REM: random effect model; MIVW:
multivariate inverse-variance weighted estimator; MR: Meta-regression; AWE: adaptively weighted estimator.
b RB: relative bias; MV: mean of model based variance; EV: empirical variance; MSE: mean squared error. (MV, EV and MSE have




B.1 Technical details for chapter 2
B.1.1 Computational details for Bayesian inference
(i) Random walk Metropolis-Hastings algorithm
Without loss of generality, take one point source homogeneous ACM as an example of
two-parameter model. The following mutually independent priors are considered
log(1 + α) = u ∼ N(µu, σ2u),
log(β) = v ∼ N(µv, σ2v).
The joint posterior distribution of (u, v) is





[1 + (exp (u)− 1) · exp (−(xi1/ exp (v))2)]ki∑M+1
j=1 [1 + (exp (u)− 1) · exp (−(xij/ exp (v))2)]ki
× exp (Ku+Kv)︸ ︷︷ ︸
Jacobian︸ ︷︷ ︸
likelihood in terms of (u,v)
.
A random walk Metropolis-Hastings algorithm is used to generate the desired draws from
the target posterior distribution. The bivariate normal distributionBV N(M ,V ) is chosen
as the proposal distribution. Initially, the mean M (0) and variance V (0) of this bivariate
normal distribution are estimated using the Laplace transform of the posterior distribution.
Then the Random walk Metropolis-Hastings algorithm can be proceeded as follows:
150
• Step 1: The Markov chain starts with a random initial guess of (u(0), v(0)).
• Step 2: In the t-th step (t ≥ 1), the proposal distribution follows (u(t−1), v(t−1))T +
ωZ, where ω is the step size and Z ∼ BV N(0,V ). A random draw (u∗, v∗) is
generated from this proposal distribution.
• Step 3: The ratio R = π(u∗, v∗|X, Y )/π(u(t−1), v(t−1)|X, Y ) is calculated, and the
draw (u∗, v∗) is accepted with probability of P = min(R, 1), i.e,
(u(t), v(t)) = (u∗, v∗), if 0 ≤ π ≤ P,
= (u(t−1), v(t−1)), if P < π ≤ 1,
where π ∼ Uniform(0, 1).
• Step 4: Step 2 and 3 was repeated T times to generate a Markov chain of length T ,
i.e. (u(t), v(t)), t = 1, 2, ..., T .
The accept ratio of (u, v) is defined as the proportion of times that the proposed draws
(u∗, v∗)’s are accepted. The step size ω in step 2 is chosen such that the accept ratios laid
within (0.25, 0.40).
(ii) Metropolis-Hastings within Gibbs algorithm
Without loss of generality, take one point source ACM as an illustration example. The
following mutually independent priors are considered
log(1 + αi) = ui ∼ N(µui , σ2ui),
log(βi) = vi ∼ N(µvi , σ2vi), i = 1, ..., K.
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The joint posterior distribution of (u,v) is











h=1[1 + (exp (uh)− 1) · exp (−(xi1/ exp (vh))2)]∑M+1
j=1
∏ki
h=1[1 + (exp (uh)− 1) · exp (−(xij/ exp (vh))2)]︸ ︷︷ ︸
likelihood in terms of (u,v)
.
A Metropolis-Hastings within Gibbs algorithm is used to generate the draws from the
above posterior distribution. In the t-th step of the block Gibbs algorithm, (u(t)1 , v
(t)
1 ) is
supposed to be drawn from the conditional distribution π(u1, v1|u(t−1)2 , v
(t−1)









2 ) is supposed to be drawn from the conditional distribution















and so on. However, the above conditional densities are not from standard distributions.
Instead, random walk Metropolis-Hastings algorithm is used to generate the desired draws
from these full conditional distribution. The bivariate normal distribution BV N(M ,V )
is chosen as the proposal distribution. Initially, the mean M (0) and variance V (0) of
this bivariate normal distribution are estimated using the Laplace transform of the poste-
rior distribution. The Metropolis-Hastings within Gibbs algorithm can be proceeded as
follows:
• Step 1: The Markov chain starts with a random initial guess of (u(0),v(0)).
• Step 2: In the t-th step, (u(t),v(t)) is supposed to be generated by
drawing (u(t)1 , v
(t)








K , X, Y )
drawing (u(t)2 , v
(t)












K , X, Y )
· · ·
drawing (u(t)K , v
(t)








K−1, X, Y )
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However, these conditional densities are not from standard distributions. Step 2 is
actually proceeded as












T + ω1Z, where ω1 is the step
size for (u1, v1) and Z ∼ BV N(0,V ). A random draw (u∗1, v∗1) is generated
from this proposal distribution.









































1 ), if P < π ≤ 1,
where π ∼ Uniform(0, 1).
– Step 2.4: Step 2.1-2.3 is repeated for the other pairs of sub-parameter (u2, v2)









• Step 3: Step 2 is repeated T times to generate a Markov chain of length T , i.e.
(u(t),v(t)), t = 1, 2, ..., T .
The accept ratio of (uk, vk) is defined as the proportion of times that the proposed draws
(u∗k, v
∗
k) is accepted, k=1,...,K. The step size ωk in step 2 is chosen such that the accept
ratios laid within (0.25, 0.40).
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B.2 Technical details for chapter 3
B.2.1 Proofs of the equivalence results






















I(s ∈ W (t)) exp(νt + β>Xs)Xs











I(t ∈ W (s)) exp(νs + β>X t)X t












YsI(s ∈ R(t)) exp(νs)
















where R(t) is the set of days that contain day t in their reference window. For SBD and
TSD but not more generally, R(t) = W (t) (Lu and Zeger 2007). Comparing with the






Yt − exp(β>X t + St)
}
,
So, if Ŝt(ν,β) = log(
∑
s∈R(t) Ys exp(νs)/{1 + exp(νs + β
>X t)}), then UTfull(β) will
provide the same estimate for β as Ull(β). Under a TSD, while the conditional likelihood
approach or an equivalent log-linear model would only allow the risk changes abruptly
among different time stratifications, the full likelihood approach does not require such
constraint because Ŝt′(ν,β) is not necessarily equal to Ŝt(ν,β) for t′ ∈ W (t) and t′ 6= t.
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Bayesian equivalence using conditional likelihood











exp{− exp(β>X t + S ′k)}.
Let ϕk = exp(S ′k). The marginal posterior distribution of β derived from Lll(β, St) is
π(β |X,Y ) ∝
∫






























































































which is the marginal posterior distribution of β derived from Lcc(β).
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Bayesian equivalence using full likelihood
Let ys·t = ys1t + ys0t, and let Φst = exp(φst). Then



























































































[ exp(νt + β>X t)∏




B.2.2 Computational details for Bayesian inference
Metropolis-Hastings within Gibbs algorithm
Sampling of β under conditional likelihood formulation: We take conditional likelihood
under the shared exposure as an example. For mutually independent normal priors β ∼
N(µβ, σ
2
βIp), the joint posterior distribution of β = (β1, ..., βp)
> is not a standard distri-
bution. Let π(θ | ·) denote the full conditional distribution as a function of θ given the
data and all other parameters. The posterior distribution π(β | X,Y ) can be obtained
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using a Gibbs sampler through the following full conditional distributions,
π(βr| ·) = exp
{









, r = 1, ..., p.
To sample from π(βr | ·), we followed these steps of a Metropolis-Hastings algorithm:
• Step 1. Start with initial value β(0) = (β(0)1 , ..., β
(0)
p )>.
• Step 2. For r = 1, ..., p, at the k-th iteration with the current value as β(k) =
(β
(k)




r , ..., β
(k−1)
p )>. Generate a new value β∗r from a candidate den-
sity g(βr) and replace β
(k)












the candidate density g(βr) as the prior density π(βr). Since the full conditional










. Then β(k)r , 1, ..., p, is updated accordingly.
• Step 3. Run the chain with 10,000 iterations.
Sampling of (ν,β) under full likelihood formulation: We take full likelihood LTfull(β,ν)
under the shared exposure as an example. To sample from the posterior distribution of ν
and β, we adopted a componentwise Metropolis-Hastings algorithm. The full conditional
distributions used are:
π(βr| ·) ∝ exp
{






s∈W (t)[1 + exp(νt + β
>Xs)]
}yt
, r = 1, ...., p
π(νt| ·) ∝
{ 1∏



























At each iteration, we first update the value of β similarly as described above, and then
move on to the cycle for ν with the updated value of β substituted. Particularly, given
current values of β, ν is updated in the following way:
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• Step 1. As a metropolis-Hastings step, ν∗t was drawn from the candidate distribution




s=1, s 6=t I(νs = νt). In
particular, one either get a distinct value for ν∗t from the normal component with
probability α
T−1+α or get a draw of ν
∗
t with equal probability from the current set of
the (T − 1) entries of ν−t. We adopt the algorithm in to generate observations from
this candidate density.









where ν ′t is the current working value of νt.
• Step 3. Repeat steps 1-2 5 times and consider the last of these updates of νt as the
value of ν(k)t , say at the k-th iteration.
• Step 4. Repeat steps 1-3 for all ν(k)t for t = 1, ..., T . One complete iteration of the
Markov chain consists of the foregoing updates for both the parameters β and ν.
Given current values of β(k) and ν(k), we can go to the next iteration for β(k+1) and
ν(k+1). We run the chain with 10,000 iterations.
Prior choices under the simulation study
Assume the informative prior on β has the form β ∼ N(µβ, σ2β). According to the ad-
hoc prior eliciting strategy for the DAMAT study, when β∗ = 0.1 we a priori postulated a
95% confidence interval (1.02, 1.15) for exp(β), and solved for the approximated values
of (µβ, σβ) as (0.05, 0.02). Thus our informative prior was chosen as N(0.08, 0.032) when
β∗ = 0.1. Similarly, when β∗ = 1 we presumed a 95% confidence interval (0.4, 1.2) for
exp(β) and deduced the corresponding informative prior β ∼ N(0.8, 0.22). To complete
the hierarchy, we have used α ∼ Gamma(2, 0.1); G0 ∼ N(µ, σ2), µ ∼ N(0, 10) and
σ−2 ∼ Gamma(4, 1) in all our simulations.
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Construction of power priors for the DAMAT study data example
Asthma risk has been associated with PM2.5/PM10 in many studies using both time-
series and case-crossover designs. Among recent papers, an Alaskan study (Chimonas
et al., 2007) found that a 10 µgm−3 increase in PM10 was associated with a 0.6% (95%
CI: 0.1%, 1.3%) increase in outpatient asthma visits, and a 1.8% (95% CI: 0.6%, 3.0%)
increase in inhaled quick-relief mediation prescriptions. In Rio de Janeiro (Moura et al.,
2009), a 10 µgm−3 increase of PM10 was found to be associated with 6.7% (95% CI:
1.8%, 11.5%) increase for bronchial obstruction. In two Idaho cities (Ulirsch et al., 2007),
a 24.3 µgm−3 increase in PM10 was associated with 4.3% increase for respiratory disease.
In the Detroit Medicaid population (Li et al., 2011), we found a 3-7% increase in asthma
risks for a 9.2 µgm−3 increase in PM2.5. Larger effects were found when only the warmer
season was considered (Villeneuve et al., 2007). These results are converted in terms of
risk ratios in the following table. More detailed reviews can be found in Li et al. (2011).
Study Risk Ratios∗
Chimonas et al., 2007 1.006, 1.018
Moura et al., 2009 1.065
Ulirsch et al., 2007 1.017
Li et al., 2011 1.03-1.09
∗ Risk ratios exp(β̂PM2.5) and exp(β̂PM10) corresponding to 10 µgm
−3 increase in PMx concentrations
Based on these studies where different cohorts, statistical models, and variant asthma
outcomes were used, we have a belief that the asthma-PM2.5 association is in general
modest with an odds ratio ranging (1.01-1.09) for a 10 µgm−3 increase in PM2.5 (if
we assume that effect of PM10 has no substantial difference from that of PM2.5). In
our DAMAT data analysis section, we constructed a presumed 95% confidence interval
(1.01,1.09) based on the above information, and took the prior mean to be the center
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(µβ = [log(1.09) + log(1.01)]/2 = 0.05) and the prior standard deviation to be one-
fourth the width of the interval (σβ = [log(1.09) − log(1.01)]/4 = 0.02), i.e., βPM2.5 ∼
N(0.05, 0.022).
For the power priors, suppose we observed D0 in terms of summary statistics from
previous studies, e.g. the MLEs β̂k’s with variance σ̂2β̂k’s. We assume the sampling distri-
bution of β̂k is normal, namely, β̂k|β ∼ N(β, σ̂2β̂k), k = 1, ..., K. Assuming the studies









In particular, we considered K = 3 prior studies having small, modest and strong ef-





) = (0.02, 0.02, 0.03) respec-
tively, to reflect PM2.5-asthma association (change in asthma risk for a 10 µgm−3 increase
in PM2.5) based on the evidence in a recent review paper (Li et al. 2011). L(β|D0) is then
described by the product of the three independent normal likelihoods.
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B.3 Technical details for chapter 4
B.3.1 Proofs of the theoretical results
Proof of Lemma 4.1 and Theorem 4.1















Let A = I −X1(X>1X1)−1X>1 , then θ̂2 can be written as (X>2AX2)−1X>2AY . We
have
Cov(ζ̂, θ̂2) = Cov{(X>1X1)−1X>1 Y , (X>2AX2)−1X>2AY }
= (X>1X1)






−1X>1 Cov(Y ,Y ){I −X1(X>1X1)−1X>1 }X2(X>2AX2)−1
= V ar(Yi){(X>1X1)−1X>1 − (X>1X1)−1X>1 }X2(X>2AX2)−1
= 0
Because the MLEs ζ̂ and θ̂2 are asymptotically normal, then ζ̂ and θ̂2 are asymptotically
independent.
(2) Proof of Theorem 4.1: Follow lemma 4.1, δ̂k and λ̂k are asymptotically independent
because they come from two nested linear regression models. So cov(δ̂k, λ̂k) = 0. We
also have cov(δ̂j, λ̂k) = 0 for j 6= k among the K independent studies. Under the standard
condition, δ̂UIVW is a linear combination of δ̂k and δ̂MR is a linear combination of λ̂k, it
follows cov(δ̂UIVW, δ̂MR) = 0.
For δ̂AWE(w) = wδ̂UIVW + (1 − w)δ̂MR, 0 ≤ w ≤ 1, we have v(δ̂AWE(w)) =
w2v(δ̂UIVW) + (1 − w)2v(δ̂MR) + 2w(1 − w)cov(δ̂UIVW, δ̂MR) = w2v(δ̂UIVW) + (1 −
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w)2v(δ̂MR) = {v(δ̂UIVW)+v(δ̂MR)}[w−v(δ̂MR)/{v(δ̂UIVW)+v(δ̂MR)}]2+v(δ̂UIVW)v(δ̂MR)
/{v(δ̂UIVW)+v(δ̂MR)}. So v(δ̂AWE(w)) reaches its minimum if and only if w = v(δ̂MR)/
{v(δ̂UIVW) + v(δ̂MR)}. With this choice of w, v(δ̂AWE)−1 = v(δ̂UIVW)−1 + v(δ̂MR)−1.
Proof of Proposition 4.1
(1) Proof of Proposition 4.1: Assumption 4.1 implies the distributions P (E|G = g) are
the same for g = 0, 1, 2 (corresponding to (aa,Aa,AA) respectively), within each study







Eki/ngk; and µgk = E(Eki|Gki = g, study = k), µk = E(Eki|study = k).
Assumption 4.1 implies: (i) µgk = µk; (ii)
∑nk



































→ βG + δµk, as ngk →∞
So δ̂MR is asymptotically unbiased for δ under assumption 4.1. The above calculation
holds for dominant, recessive and additive genetic susceptibility models. For co-dominant
model, the calculation holds for AA and Aa respectively.
(2) Unbiased MR when assumption 4.1 is relaxed: If assumption 4.1 is relaxed, unbiased
estimator of δ can still be found through different MR models for different susceptibility
model. For example, under dominant model,








E(λ̂k) = βG + βE
−Gkn0km0k + (1−Gk)n1km1k + (2−Gk)n2km2k
(1−Gk)n1k + 2(2−Gk)n2k




(3) Bias of δ̂MR in terms of bss/tss: For simplicity, we derive the bias of δ̂MR under as-
sumption 4.2 for a dominant model. Let the sample mean of E for the carrier (non-carrier)
















k n1kn0k) and E(λ̂k) = βG +












rk(µk − µ){βE(µ1k − µ0k) + δµ1k}.












then we can write














Asymptotically, µ1k − µk = (1− p)(µ1k − µ0k) = (1− p)ρk[σ2Ek/{p(1− p)}]
1
2 . The bias
of δ̂MR















rk(µk − µ)σEk[βEρk + δ(1− p)ρk].
Clearly, if assumption 4.1 holds (implying ρk = 0, for k = 1, ..., K), E(δ̂MR)− δ
p→ 0. If
not, we have 0 ≤ βEρk + δ(1− p)ρk ≤ βE + δ(1− p). From Cauchy-Schwarz inequality,
we have
∑
k rk(µk−µ)σEk ≤ (bss×wss)
1





µ)2} ≤ (wss/bss) 12 . When N is large, the limiting value of E(δ̂MR)− δ is bounded from




2 . Given p, βE and δ, the upper bound
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increases aswss/bss increases, or equivalently, as bss/tss decreases. So δ̂AWE can control
for the bias by putting less weight on δ̂MR when the bias of δ̂MR increases.
Derivation of v̂(δ̂) and v(δ̂) under G-E independence assumption
Under the dominant model, for the k-th study, denote n1k (n0k) as the number of car-
riers (non-carrier), for k = 1, ..., K; denote the sample mean of E for the carrier (non-
carrier) group as m1k (m0k), and denote the sample variance of E for carrier (non-carrier)














Ek under assumption 4.1. v̂(δ̂) can be derived as follows:
(1) IPD analysis: Under model (1), v̂(β̂IPD) is the sub 3×3 matrix of (X>X)−1σ̂2, where
(X>X)−1 =

n1 0 · · · 0 n11 n1m1 n11m1
n2
... n12 n2m2 n12m2
































































































· · · ·
...
























































































(4) Asymptotic model based variance v(δ̂): Suppose nk/N → rk ∈ (0, 1) as N → ∞. If
we assume σ2k = σ
2 for k = 1, ..., K, we have σ̂2
p→ σ2, σ̂2k
p→ σ2, as N → ∞. Under
the IPD model, where the homoscedasticity assumption has been implicitly made for the










2. Moreover, under assumption 4.1, we have
the facts that: (i) m1k
p→ µk, m0k
p→ µk, mk




p→ σ2Ek, as nk → ∞. For dominant model, n1k/nk → pk, as nk → ∞.




k nkpk(1− pk)}. m
p→ µ as N →∞. The asymptotic
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nkpk(1− pk)(µk − µ)2}−1 σ2.
By Slutsky’s theorem, for large N , v̂(δ̂IPD), v̂(δ̂MIVW), v̂(δ̂UIVW), v̂(δ̂MR) are consistent
estimators of v(δ̂IPD), v(δ̂MIVW), v(δ̂UIVW), v(δ̂MR) respectively.
Proof of Theorem 4.2
We first prove the following four propositions.
Propositions. Under assumption 4.1, we have
P1. v(δ̂MIVW′) = v(δ̂MIVW2′).
P2. v(δ̂IPD)−1 = v(δ̂MIVW2′)−1 + v(δ̂MR)−1.
P3. v(δ̂UIVW) ≥ v(δ̂MIVW2′). The equality holds if and only if pk = p, for k = 1, 2, ..., K.
P4. For δ̂AWE2′ = wδ̂MIVW2′ + (1−w)δ̂MR, 0 ≤ w ≤ 1, we have that v(δ̂AWE2′)−1 attains
its maximum at v(δ̂MIVW2′)−1 + v(δ̂MR)−1 if and only if w = v(δ̂MR)/{v(δ̂MIVW2′) +
v(δ̂MR)}.


















































































There is no efficiency gain by pooling all three parameters (β′Gk, β
′
E, δ
′) over polling the
two common parameters (β′E, δ


























































i 6=j ninjpi(1−pj)σ2Eiσ2Ej .
Then it is sufficient to show for ∀ i, j, ninjpi(1 − pi)σ2Eiσ2Ej + njnipj(1 − pj)σ2Ejσ2Ei ≤
ninjpi(1− pj)σ2Eiσ2Ej +njnipj(1− pi)σ2Ejσ2Ei⇔ ∀ i, j, ninj(pi− pj)2σ2Eiσ2Ej ≥ 0, which
is apparently true. All the above equalities hold if and only if pi = pj, ∀ i, j, i.e., pk = p,
for k = 1, 2, ..., K.
Proof of P4: Following Lemma 4.1, cov(δ̂k, λ̂k) = 0 and cov(β̂Ek, λ̂k) = 0. Because δ̂MR
is a linear combination of λ̂k and β̂MIVW2
′ is a linear combination of β̂Ek and δ̂k, we have
cov(δ̂MIVW2
′
, δ̂MR) = 0. The rest of the proof is similar as Theorem 4.1.
Denote δ̂MIVW2 as the MIVW pooling (βE, δ) from the un-centered model. We have
δ̂MIVW2 = δ̂MIVW2
′ since (βE, δ) = (β′E, δ
′). Propositions P1-P4 still hold if δ̂MIVW2′ is
substituted by δ̂MIVW2.
Proof of Theorem 4.2: Following propositions P1 and P2, v(δ̂IPD)−1 ≥ v(δ̂UIVW)−1 +
v(δ̂MR)−1 under assumption 4.1. The equality holds if and only if pk = p, for k =
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1, 2, ..., K.
Proof of the results in Remark 4.4: According to propositions P1 and P3, v(δ̂IPD)−1 =
v(δ̂AWE2
′
)−1 under assumption 4.1. Together with the results in Theorem 4.1 and Propo-
sition P2, v(δ̂IPD)−1 = v(δ̂AWE2′)−1 ≥ v(δ̂AWE)−1. The equality holds if and only if
pk = p, for k = 1, 2, ..., K.
Proof of Theorem 4.3
Proof of Theorem 4.3: Under both assumptions 1 and 2, the variance of δ̂IPD, δ̂UIVW and
δ̂MR can be further simplified as v(δ̂IPD) = [p(1 − p)
∑
k nk{σ2Ek + (µk − µ)2}]−1σ2,




Ek}−1σ2 and v(δ̂MR) = {p(1− p)
∑
k nk(µk − µ)2}−1σ2.
Now we have v(δ̂IPD)−1 = v(δ̂UIVW)−1 + v(δ̂MR)−1. From Theorem 4.1, v(δ̂AWE)−1 =
v(δ̂UIVW)−1 + v(δ̂MR)−1, then v(δ̂IPD)−1 = v(δ̂AWE)−1.





p→ σ2E , as N → ∞. Then TSS/N = s2E










k nk(mk − m)2/N
p→
∑
k rk(µk − µ)2, as N → ∞. Be-





k rk(µk − µ)2. So we have σ2E =
∑
k rk{σ2Ek + (µk − µ)2}, i.e., tss = wss + bss.
Therefore, v(δ̂UIVW) = {Np(1 − p)wss}−1σ2, v(δ̂MR) = {Np(1 − p)bss}−1σ2 and
v(δ̂IPD) = v(δ̂AWE) = {Np(1− p)tss}−1σ2.
B.3.2 Details of the simulation study
For G, without assumption 4.2, the MAF qk is generated from U(0.15, 0.35) inde-
pendently for each study k, and then Gki is generated as (AA,Aa, aa) with probability(
q2k, 2qk(1 − qk), (1 − qk)2
)
that follows HWE. With assumption 4.2, the MAF q is gen-
erated from U(0.15, 0.35), and then Gki is generated as (AA,Aa, aa) with probability
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(
q2, 2q(1 − q), (1 − q)2
)
. Susceptibility models including dominant, additive and co-
dominant models are considered under each simulation.
For E, the k-th study mean of E was sampled from µk ∼ N(µ, σ2µ) with known µ and
between study variance σ2µ. The k-th study variance σ
2
Ek
was sampled from σ2Ek ∼ σ
2
µ ×
U(c1, c2) with choices of constant (c1, c2) satisfy the two cases that E(WSS/BSS) = 2
and E(BSS/WSS) = 2 respectively. With assumption 4.1, the values of E of the k-th
study were sampled from Eki|µk, σ2Ek ∼ N(µk, σ
2
Ek
) that is independent of G. Without
assumption 4.1, potential G − E dependence was considered through the group mean
µgk as follows. (µ0k, µ1k, µ2k) was calculated from the following equations µknk =∑
g=0,1,2 ngkµgk and µ2k = µ1k + d1σEk = µ0k + d2σEk , where d1 ∼ U(0, 0.5) and
d2 ∼ U(d1, 1). In general, σEk > σEk,w  σEk,w/
√
ngk, where the common within group








g=0,1,2 ngk(µgk − µk)2. Thus, the
k-th study mean is µk, and the group means µgk are potentially dependent on G. Then Eki
were sampled from Eki|Gki = g, µgk, σ2Ek,w ∼ N(µgk, σ
2
Ek,w
) in order to guarantee that
the k-th study variance of E is σ2Ek . Then the first and second moments of E are the same
with or without assumption 4.1. Numerically, E has identical marginal distributions with
or without assumption 4.1, as it has symmetric distributions under this setting.
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B.4 Technical details for chapter 5
Modeling P (G|E,S) under HWE
Let q(Eki,Ski) be the minor allele frequency for given (Eki,Ski). Under the HWE
conditional on (E,S), we have
P (Gki = 0|Eki,Ski) = (1− q(Eki,Ski))2,
P (Gki = 1|Eki,Ski) = 2q(Eki,Ski)(1− q(Eki,Ski)),
P (Gki = 2|Eki,Ski) = q(Eki,Ski)2.
Then
log
{P (Gki = 1|Eki,Ski)
P (Gki = 0|Eki,Ski)
}






{P (Gki = 2|Eki,Ski)







We can model the MAF as
q(Eki,Ski) = H{η0k + ηkS>ki + θkEki},
which can be reduced to
q(Eki,Ski) = H{η0k + ηkS>ki}
under G-E independence conditional on Ski.
Chain rule of derivatives: ∆̂ = ∂β̂>(θ)/∂θ|θ=0 ≈ IθβI−1ββ |θ=0























Let Iθβ = − ∂
2`
∂θ>∂β
and Iββ = − ∂
2`
∂β>∂β
be the corresponding sub-matrices of the full ob-












) = −E( ∂2`
∂β>∂β
), we use IθβI−1ββ |θ=0 as an approximation to the estimator
∆̂ = ∂β̂>(θ)/∂θ|θ=0.
EB estimator Â
We consider the EB estimator Â using the following strategies: (1) a conservative
estimator θ̂θ̂
>
forA; (2) Â = diag(τ̂ 2, ..., τ̂ 2)(K×K), where τ̂ 2 is the MLE that maximizes
the marginal likelihood of θ̂; (3) Â = diag(τ̄ 2, ..., τ̄ 2)(K×K), where τ̄ 2 is the estimated
posterior mean of τ 2|θ̂.
(1) and (2) Note that θ̂k ∼ N(0, τ 2 + σ̂2θk) after marginalizing over θk. clearly, θ̂θ̂
>
can
serve as a conservative estimator forA. One could alternatively estimate τ 2 by maximizing
the marginal likelihood of θ̂k,
m(θ̂k| τ 2) =
K∏
k=1
































τ 2 − (θ̂2k − σ̂2θk)
(τ 2 + σ̂2θk)
2
= 0










τ̂ 2 does not have a closed form expression, however, we could implement an iterative
scheme to calculate τ̂ 2. If the convergence is to a negative value of τ̂ 2, then the MLE
of τ 2 is probably 0 Berger (1985). If one assumes θk
iid∼ N(0, τ̂ 2) and proceeds with a
Bayesian analysis that ignores the fact τ̂ 2 being estimated, then the errors introduced in
the hyperparameter estimation would not be reflected in the inference.
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(3) Let Bk =
σ̂2θk
τ2+σ̂2θk
. The posterior distribution π(θk|θ̂k, Bk) for given Bk (or equivalently




τ 2 + σ̂2θk
= (1−Bk)σ̂2θk .
Rubin (1981), Morris (1983a and 1983b), Laird and Louis (1987) all introduced a vague





where H(Bk|θ̂) is the posterior distribution of the hyperparameters Bk given θ̂. The
marginal posterior mean µk and variance Vk of θk|θ̂ are
µk = E(µk,Bk) = (1− E(Bk))θ̂k,
Vk = E(Vk,Bk) + var(µk,Bk) = (1− E(Bk))σ̂2θk + var(Bk)θ̂
2
k,
where E(·) and var(·) are taken with respect to H(Bk|θ̂).
To avoid integration in E(Bk) and var(Bk), Morris (1983a and 1983b) used the fol-












τ̂ 2 + σ2θk
τ̂ 2 + σ̂2θk











The estimated posterior mean of τ 2|θ̂, τ̄ 2, can be calculated accordingly. The EB estima-
tors for µk and Vk are






τ̂ 2 + σ2θk
τ̂ 2 + σ̂2θk
.
Note that µ̂k reduced to the James-Stein estimator of θk if all σ̂2θk are equal (Morris 1983).
The factor K−2
K
in B̂k is used to adjust for the error in the estimation of τ̂ 2. When K
is large, B̂k →
σ̂2θk
τ̂2+σ̂2θk
and ˆvar(B̂k) → 0, thus µ̂k = τ̂
2
τ̂2+σ̂2θk




a naive analysis by plugging in the estimated prior via MLE τ̂ 2 in N(µk,Bk , Vk,Bk) will
work well when K is large. When K is small or moderate, one must take into account the
uncertainty in τ̂ 2 while obtaining the posterior distribution of θk in the EB spirit (Morris
(1983), Berger (1985)).
Proof of lemma 5.2
(i) Proof of θ̃k = θ̂k: Let `k(βk, θk) = log(LRk (βk, θk)) be the log retrospective likelihood





















`1(β1, θ1), ..., argmax
θK
`K(βK , θK)) = θ̃.
(ii) Proof of σ̃2θk ≥ σ̂
2
θk
: Let ζk = (γ0k, η0k, ηk) and ζ = (ζ1, ..., ζK). It follows that βk =
(γ, ζk) and β = (γ, ζ). Note that the derivative of the log likelihood `, with respect to any


























































 ∑k Ikγγ (Iγζ1 , ..., IγζK )
(Iγζ1 , ..., IγζK )
> diag(I1ζ1ζ1 , ..., IKζKζK )
 .
Then Iββ can be considered as the summation of a sequence of matrices Ck defined as





Ikγγ 0 · · · Ikγζk · · · 0
0 0
... . . .
Ikζkγ Ikζkζk







In above, all the unmarked elements inCk are zero. Ck only has four nonzero blocks (cor-
responding to position (1, 1), (1, k + 1), (k + 1, 1) and (k + 1, k + 1) in terms of block),
which are the same as the blocks in Ikβkβk . Clearly,Ck’s only have nonnegative eigenval-
ues: positive eigenvalues identical to that of Ikβkβk and zero eigenvalues elsewhere. Thus,
all Ck’s are symmetric positive semi-definite.
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Since (Iθθ)−1 = Iθθ − IθβI−1ββ Iβθ, we can write
σ̂−2θk = Ikθkθk − IθkβI
−1
ββ Iβθk
= Ikθkθk − (Iθkγ, Iθkζ1 , ..., IθkζK )I−1ββ (Iθkγ, Iθkζ1 , ..., IθkζK )
>




−1(Ikθkγ,0, ..., Ikθkζk , ...,0)
>




= Ikθkθk − (Ikθkγ, Ikθkζk)I−1kβkβk(Ikθkγ, Ikθkζk)
>.
= Ikθkθk − (Ikθkγ,0, ..., Ikθkζk , ...,0)C
−1
k (Ikθkγ,0, ..., Ikθkζk , ...,0)
>.
In order to show σ̃2θk ≥ σ̂
2
θk




each k. It is equivalent to show
∑
j 6=kCj ≥ 0 for each k, which is true because all Ck’s
are symmetric positive semi-definite.
The equality in σ̃2θk ≥ σ̂
2
θk
hold iff Cj = 0 for all j 6= k. The symmetric positive
semi-definite matrix Cj = 0 iff Ikβkβk = 0, i.e., `k contains no information. Therefore,
the inequality in σ̃2θk ≥ σ̂
2
θk
is usually strict in practice. Although each θ̃k is derived under
individual likelihood LRk and θ̂k’s are derived jointly under L
R, we actually have θ̃k = θ̂k





(1) cov(γ̂, γ̂0): Denote I (I0) as the full observed information matrix for the uncon-
strained (constrained) model; denote Uki(β,θ) and U0ki(β) as the individual score func-




 β̂ − β∗
θ̂ − θ∗











where β∗ and θ∗ are the true parameter values, and β(0) denotes the limiting value of the
profile MLE β̂(0). The joint asymptotic variance-covariance matrix ΣΩ̂ of Ω̂ = (β̂, θ̂, β̂
0)















Then cov(γ̂, γ̂0) can be obtained as the corresponding sub-matrix of ΣΩ̂.






}−1γ̂0 = f(γ̂, γ̂0)
as a function of (γ̂, γ̂0). Applying Delta method, the approximate variance-covariance
matrix of γ̂EB1 is given by f ′(γ̂, γ̂0)>cov(γ̂, γ̂
0)f ′(γ̂, γ̂0), where f ′ is the p× 2p gradient
































(3) V̂γ̂EB2 and V̂γ̂EB3: For γ̂EB2 and γ̂EB3 of the more general form γ̂EB = ∆̂
>Â∆̂{V̂γ̂ +
∆̂>Â∆̂}−1γ̂+V̂γ̂{V̂γ̂+∆̂>Â∆̂}−1γ̂0, it is hard to apply the above Delta method to obtain
a variance formula for the EB estimator since Â does not have a closed form expression
in terms of Ω̂. Instead, we consider an ad hoc way to calculate the variance. Let w =
∆>A∆{V̂γ̂ + ∆>A∆}−1. We derive the functional form of Vγ̂EB treating w as fixed,
i.e., γ̂EB = wγ̂ + (1p −w)γ̂0, and then plug in the estimated weight ŵ = ∆̂>Â∆̂{V̂γ̂ +
∆̂>Â∆̂}−1 into the functional form to get V̂γ̂EB . In particular, Vγ̂EB = wV̂γ̂w> + (1p −
w)V̂γ̂0(1p−w)>+2wcov(γ̂, γ̂0)(1p−w)>. Then the ad hoc estimator V̂γ̂EB = ŵV̂γ̂ŵ
>+
(1p − ŵ)V̂γ̂0(1p − ŵ)> + 2ŵ ˆcov(γ̂, γ̂0)(1p − ŵ)>.
A mixture distribution: θk ∼ p δ(0) + (1− p)N(0, τ 2)
For the mixture distribution θk ∼ p δ(0) + (1 − p)N(0, τ 2), we have E(θk) = 0
and var(θk) = (1 − p)τ 2 (This can be proved via E(θk) = E[E(θk|L)] and V ar(X) =
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E[V ar(θk|L)] + V ar[E(θk|L)]). For a latent random variable L ∼ Bin(p), θk|L = 1 ∼
δ(0); θk|L = 0 ∼ N(0, τ 2). Marginalizing over θk, it follows that θ̂k|L = 1 ∼ N(0, σ̂2θk);
θ̂k|L = 0 ∼ N(0, σ̂2θk+τ
2). So marginally, θ̂k has a mixture distribution θ̂k ∼ pN(0, σ̂2θk)+
(1 − p)N(0, σ̂2θk + τ
2), which has mean 0 and variance σ̂2θk + (1 − p)τ
2. Similarly, we
estimate the prior hyperparameter p and τ 2 by maximizing the marginal likelihood of θ̂k




















2(τ 2 + σ̂2θk)
}]
.
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